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Detecting small molecules and biomarkers is important in 
environmental monitoring, food safety, and medical diagnosis. Traditionally, 
chromatography methods (such as HPLC or GC) and enzyme-linked 
immunosorbent assay (ELISA) methods are used to detect target molecules. 
However, these methods require sophisticated instrumentation or tedious 
procedure. In Chapter 3, we developed a liquid crystal (LC)-based optical 
sensor to detect vaporous butylamine in the air. This LC sensor doped with 
lauric aldehyde (LA) shows fast and distinct bright-to-dark optical response to 
butylamine vapor. For example, when the LA doping concentration is 0.1 wt%, 
the LC shows a rapid bright-to-dark optical response within 2 min after it is 
exposed to 10 ppmv (parts per million by volume) of butylamine. This optical 
response is attributed to an orientational transition of LC triggered by a 
reaction between LA and butylamine. This LC sensor also exhibits 
reversibility after the sensor is exposed to open air because the reaction 
between lauric aldehyde and butylamine is reversible. In addition to primary 
amines (such as butylamine and octylamine), this LC-based sensor also 
responds to secondary amines (such as diisopropylamine), but the detection 
limit is 200 ppmv, which is much higher than butylamine. For specificity, this 
LC sensor does not respond to vapors of water, ethanol, acetone, and hexane. 
However, this sensor can also respond to other amines such as 
diisopropylamine (DIPA) and octylamine. To improve specificity, more 
selective sensing layers are needed. 
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In Chapter 4, we identified two highly specific oligopeptide sequences 
RKRIRRMMPRPS and RNRHTHLRTRPR for binding to neonicotinoids 
such as thiacloprid and imidacloprid, by using phage display library. The 
former oligopeptide shows high affinity for thiacloprid whereas the latter 
shows high affinity for imidacloprid. Surprisingly, cross binding is minimal 
despite the similarity in molecular structure of thiacloprid and imidacloprid. 
These two oligopeptides are also immobilized on the surface of a surface 
plasmon resonance (SPR) chip to develop a neonicotinoid biosensor. This 
oligopeptide functionalized SPR biosensor can rapidly detect thiacloprid and 
imidacloprid in buffer solutions in a real-time manner. The limit of detection 
(LOD) for thiacloprid and imidacloprid is 1.2 μM and 0.9 μM respectively. 
In Chapter 5, we developed a biosensor for detecting a herbicide, 
glyphosate. However, glyphosate is highly soluble and the original phage 
display method cannot be applied. To address this issue, we developed a 
modified phage display screening method by immobilizing glyphosate on 
glass beads. By using this method, we successfully identified a 12-mer 
oligopeptide sequence, TPFDLRPSSDTR, which binds to glyphosate 
specifically. To develop a biosensor for detecting glyphosate, a gold SPR 
sensor chip is modified with an oligopeptide, TPFDLRPSSDTRGGGC. This 
SPR biosensor can rapidly detect glyphosate in PBS buffer in a real-time 
manner. This biosensor also shows good specificity, and the LOD of this 
biosensor can reach 0.89 µM. 
The above studies were focused on detection of small molecules. 
However, small molecules do not disrupt LC orientation easily. To develop a 
sensor by combining LC and oligopeptide, we aim to detect a large 
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biomolecule such as human chorionic gonadotropin (hCG). We identified a 
linear oligopeptide, PPLRINRHILTR, which can bind to hCG specifically. 
Furthermore, we use liquid crystal (LC) to detect binding signal. The detection 
principle is based on the disruption of LC by hCG, which binds to the surface-
immobilized oligopeptide. This disruption leads to distinct optical transition 
visible to the naked eye. The LOD of this method is approximately 1 IU/mL (2 
nM), and only 0.6 μL of hCG solution is required for each spot, which means 
that as little as 45.5 pg of hCG can be detected by using this method. This LC-
based optical sensor is a testimony of the novel principle for detecting 
biomolecules, and has high potential to be developed as portable diagnostic 
devices. 
However, we note that the LOD of the LC-based optical sensor for 
hCG detection is 1 IU/mL (2 nM), which is not sufficient for early pregnancy 
test (which requires a LOD of 20 mIU/mL). To improve the LOD, a key step 
is to find a mechanism to further amplify the oligopeptide-protein binding 
signal. Thus, enzymatic silver deposition is chosen to enhance the optical 
response of the LC 1. To achieve this goal, we first immobilize biotinylated 
oligopeptide (PPLRINRHILTRGGG-biotin) on the glass slide surface. Then 
the streptavidin-alkaline phosphatase (SA-ALP) is conjugated to promote in 
situ silver deposition on the surface. After a thin layer of silver particle is 
deposited to the glass slide surface, the LC orientation can be disrupted by the 
silver layer, and thus the LC signal can be amplified. As a result, this 
mechanism has the potential to amplify the presence of protein or oligopeptide 
on the surface. We show that the LOD of SA-ALP is improved 3.3-fold after 
silver deposition. This result is presented in the last chapter.   
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1.1.1 Principles of LC-Based Sensor 
Principles of using liquid crystals (LCs) for protein sensing have been 
developed over the past decades. Gupta et al. 2 first described a principle of 
building a protein sensor by using LC. Briefly, protein is first immobilized on 
a solid surface. This thin layer of protein can disrupt the LC orientation at the 
solid/LC interface, and the interfacial orientational change of the LC can 
propagate into the bulk of LC over several micrometers due to their long-range 
interactions. Then, the orientational transition of bulk LC can be transduced 
into optical signals which can be easily visualized with ambient light and the 
naked eye due to the birefringence of LC. Later, Shah and Abbott 3 developed 
an LC-based optical sensor for detection of small molecules, such as 
organoamines and organophosphorus. Unlike biomolecules such as proteins or 
DNAs, small molecules cannot disrupt LC orientation easily. To address this 
issue, self-assembled monolayers (SAMs) of carboxylic acid (COOH)-
terminated thiols were immobilized on a thin layer of gold film patterned with 
nanometer-scale topography, and pretreated with copper perchlorate. In this 
case, the LC molecules are perpendicular to the substrate surface due to the 
interaction between nitrile groups of LC molecules and Cu2+ which bound to 
SAM receptors, as shown in Figure 1.1A. Once the SMA modified substrate is 
exposed to a target molecule, such as dimethyl methylphosphonate (DMMP), 
the target molecules bind to Cu2+ on SAM receptors to displace LC from its 
weak complex with Cu2+, and the LC orientation changes from perpendicular 
to parallel to the nano-structured substrate surface, as shown in Figure 1.1B. 
 





This orientational transition of LC leads to an optical transition from dark to 
bright when the sample is observed under a microscope equipped with a pair 
of crossed polarizers. 
 
Figure 1.1 Schematic illustration of liquid crystal orientational transition (A) 
before and (B) after exposure to small molecule weight target compounds. 
 
Two design rules for the LC-based sensors have been established in the 
work mentioned above. The first rule is that LC should be pre-orientated 
uniformly before exposing to target analytes. Previously, uniform planar 2, 3 
orientation of LC is used. The orientational transition of LC from uniform 
planar to homeotropic can be distinguished by using microscope equipped 
with a pair of crossed polarizers, and optical response of LC can be observed. 
However, the optical response of LC is dependent on the sample position (or 
angle) in the light field. Besides, it is difficult to quantify the differences 
between uniform and random orientation of LC. To overcome these 
limitations, in previous studies of our group, LC sensors were developed from 
homeotropic-pretreated LC orientation 4-6. For example, on a N,N-Dimethyl-
N-octadecyl-3-aminopropyltrimethoxysilylchloride (DMOAP)-coated glass 
slide, the LC orientation is homeotropic, and the optical appearance of LC is 
dark. Once the glass slide is immobilized with protein molecules, the 
 





homeotropic orientation of LC can be disrupted, and the optical appearance 
changes to bright. This method can achieve better contrast ratio for sample and 
background, and the optical signal can be observable under any angle of 
polarizer. Secondly, binding of analytes to the surface must trigger an 
orientational transition and disrupt the uniform orientation of the LC. However, 
there are some limitations in applying LC-based sensors to the real world. 
First, LC lacks functional groups to render specificity. To address this issue, 
functional surfaces are needed to provide specificity. One common strategy is 
to immobilize proteins (such as antibodies) which selectively bind to analytes 
6, 7. However, the surface-immobilized antibodies easily disrupt LC orientation 
when its surface density exceeds a critical value. This is unfavorable because a 
higher surface density of immobilized antibodies is often required to achieve a 
lower limit of detection. Besides, the antibodies are vulnerable to 
environmental factors, such as high temperature. To circumvent the limitations, 
in this thesis we applied oligopeptides as a replacement for antibodies. Short 
oligopeptides also exhibit specificity to target molecules, but cannot disrupt 
LC orientation easily, so it is easier to build a LC sensor by using 
oligopeptides. For example, the oligopeptide can be easily immobilized on 
DMOAP-coated glass slide through the formation of imine bond, and the 
imine bond can be further reduced by sodium cyanoborohydride (NaBH3CN) 
in buffer solution to form more stable secondary amines. After this, the 
oligopeptide functionalized glass slide was used to fabricate an LC cell against 
another piece of DMOAP-coated glass slide. Besides, oligopeptides are more 
robust than antibodies in harsh environments. 
 






1.1.2 Detection of Aliphatic Amines 
Aliphatic amines are one of the major air pollutants in chemical plants 
and important marker molecules in food quality control 8 and medical 
diagnosis 9,10. In the past, detection of aliphatic amines mainly relies on 
chromatography methods, such as gas chromatography (GC) 11, 12 and high-
performance liquid chromatography (HPLC) 13, 14, coupled with mass 
spectrometry (MS). However, these analytical methods require expensive and 
bulky equipments and experienced operators. To achieve a portable detection 
device for aliphatic amines, electrochemical 15-18, quartz crystal microbalance 
(QCM) 19, 20, surface plasmon resonance (SPR) 21, spectrophotometery 22, 23, 
enzymatic 24, 25, and polymer-based 26, 27 sensing techniques have been 
developed. However, these methods still lack specificity, and the produced 
signals are not easily visualized. To develop colorimetric sensors, reactive 
agents including calixarene 28, bromocresol green dye 29, indium(III) 
octaethylporphyrin 23, n-type organic semiconductor molecules 30, and 
cholesteric liquid crystals 31, 32 have been used. However, these colorimetric 
sensors are limited by their relatively low sensitivity and long response time. 
Therefore, a new mechanism for fast and sensitive detection of aliphatic 
amines is required. 
 






1.1.3 Detection of Neonicotinoids and Glyphosate Herbicide 
Neonicotinoids are a class of pesticides that act on the central nervous 
system of insects. Although the application of neonicotinoids has greatly 
improved crops production, risks of neonicotinoid pesticides to environment 
have attracted more and more attention 33-35. For example, the application of 
neonicotinoids may cause colony collapse disorder (CCD) of bees 36. 
Neonicotinoids may also cause adverse effects to birds, aquatic invertebrates, 
and other wildlives 37, 38. Despite low toxicity to mammals, exposures to such 
compounds may cause potential risk to consumers 39. On April 29, 2013, the 
European Union passed a two-year ban on the use of three neonicotinoids 
(imidacloprid, clothianidin, and thiamethoxam), which are suspected to be the 
primary cause of bee CCD.  
Glyphosate (N-(phosphonomethyl)glycine) is another herbicide which 
is widely used in farms, parks and gardens to wipe out weeds. Glyphosate kills 
weeds by interfering the synthesis of aromatic amino acids phenylalanine, 
tyrosine and tryptophan by inhibiting the enzyme activity of 5-
enolpyruvylshikimate-3-phosphate synthase (EPSPS) 40. On the other hand, 
the genetically modified crops, which contain glyphosate-resistant genes, will 
not be affected 41, 42. In 2007, over 80,000 tons of glyphosate was used in 
agriculture, and over 2,000 tons of glyphosate was used in home and garden in 
the United States. With its widespread application, residues of glyphosate in 
water may cause adverse effects on some aquatic plant species 43, 44. Recent 
 





studies also show that glyphosate is a potential endocrine disruptor 45. 
Currently, the maximum residue levels (MRLs) of glyphosate in the United 
States and Canada are 0.70 μg/mL (4.14 μM) 46 and 0.28 μg/mL (1.66 μM) 47, 
respectively. Therefore, monitoring of glyphosate in the environment is 
becoming more and more important. 
Currently, fast detection of neonicotinoids and glyphosate, is a 
challenge. For example, detection of neonicotinoids and glyphosate can be 
accomplished by using standard analytical methods such as gas 
chromatography-mass spectroscopy (GC-MS) 48-52 or high-performance liquid 
chromatography-mass spectroscopy (HPLC-MS) in the laboratory 53-56. 
However, the chromatography-based analytical methods require large and 
expensive equipment and long running time. Especially for detection of 
glyphosate, the chromatography methods require derivatization procedures to 
convert glyphosate to its derivatives containing chromophore or fluorophore 
groups to enhance the sensitivity 57, 58. To avoid derivatization step, some 
electrochemical methods have been developed 59-64. To render specificity, 
enzyme-linked immunosorbent assay (ELISA) was also be reported to detect 
neonicotinoids 65-68 and glyphosate 69, 70. These ELISA-based methods show 
good selectivity and sensitivity (μg/L). However, the production of antibodies 
is tedious and time-consuming. For example, small molecules such as 
neonicotinoids and glyphosate do not trigger immune system of the animals 
and the small molecules need to be conjugated to carrier protein (such as BSA) 
to form an immunogen 71, 72. Besides, the antibodies are vulnerable to 
environmental factors, especially high temperature 73. These issues hinder the 
 





widespread use of ELISA for routine analysis of neonicotinoids. To overcome 
these limitations, we applied short oligopeptides to replace antibodies as a 
molecular receptor in a biosensor system. The oligopeptides were identified 
from phage library to render binding affinity and specificity for both 
neonicotinoids and glyphosate.  
 
1.1.4 Detection of Human Chorionic Gonadotropin (hCG) 
Human chorionic gonadotropin (hCG) is a glycoprotein hormone 
produced by the placental trophoblasts, to support the corpus luteum of 
pregnancy, allowing continued progesterone production and maintenance of 
the gestational endometrium 74. hCG contains two subunits: the α-subunit is 
identical to other proteins in glycoprotein family, such as luteinizing hormone 
(LH), follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), 
and β-subunit is unique to hCG 75, 76. hCG is a common biomarker for the 
diagnosis of pregnancy 77, 78 and several cancers 79-81. A “sandwich-type” 
immunoassay is the most prevalent technique to detect hCG. Briefly, a 
primary capture antibody is immobilized on solid substrate. Then a sample 
solution containing hCG is mixed with a secondary antibody (labeled with 
fluorophores or gold nanoparticles) to form an antigen-antibody complex. 
Subsequently, this complex can be captured by the surface-immobilized 
antibody to form a sandwich-type structure, and a positive signal will be given. 
Although the immunoassay exhibits high sensitivity and specificity, it still 
relies on the application of antibodies. Besides, additional labeling steps are 
 





often required to produce a positive signal. Therefore, a new type of molecular 
receptor is needed to replace antibodies, and a novel label-free signal 
transduction mechanism is required.  
 
1.1.5 New Amplification Mechanism of LC-Based Sensor 
LC provides a new method to amplify and transduce binding of 
proteins on surfaces into optical signals 2. However, the current amplification 
mechanism is limited. The LOD can only reach µg/mL or nM 5, 6. This LOD is 
not sufficient because picomolar (10-12 M) or even femtomolar (10-15 M) level 
of proteins is often required in diagnostic applications. To enhance the LOD of 
LC-based optical sensors, Chen and Yang 7 developed an LC-based optical 
sensor using a secondary antibody to amplify the binding signal to detect 
hepatitis B antibody. Although the LOD of hepatitis B antibody can be 
improved from 150 nM to 15 nM, it is still not sufficient for rare protein in 
serum. Therefore, new strategies are required to further improve the LOD of 
LC-based optical sensor. Tan et al. 1 developed a new amplification 
mechanism by using enzymatic silver deposition to enhance LC signal for 
DNA detection. In this design, once the target DNA hybridized to capture 
DNA probe, a biotinylated detection DNA probe is introduced and hybridized 
to the target DNA. Next, streptavidin-alkaline phosphatase (ALP) conjugate to 
the biotinylated detection DNA probe, and catalyze dephosphorylation of 
ascorbic acid 2-phosphate (AH2-p) in substrate solution to produce ascorbic 
acid (AH2). AH2 is a mild reducing agent which can reduce silver ions in the 
 





substrate solution to metallic silver and deposit a layer of silver on the surface. 
This layer of silver is able to disrupt LC orientation and improve the LOD. 
This study uses DNA as a template for silver deposition because DNA 
molecules are negatively charged, and it is easier to promote the accumulation 
of silver ions before reduction. The applicability of the enzymatic silver 
deposition to protein-modified surface is unknown. To address this issue, we 
studied the kinetics of enzymatic silver deposition on ALP modified surface, 
and the effect of silver deposition to enhance LC signal. 
 
1.2 Research Objectives 
The research objectives of this project are stated as follows: 
(1) The first objective of the PhD study is to investigate how to render 
LC specificity in a chemical sensor. Because LC lacks functional groups, one 
strategy is doping LC with functional molecules which can specifically react 
with the target molecules. To achieve this objective, lauric aldehyde (LA) is 
doped into LC to render specificity to butylamine. The role of LA is two-fold. 
First, the LA molecules can react with butylamine, and the imine product can 
adsorb at the glass slide surface to trigger orientational transition of LC. 
Second, the LA molecules can cause planar orientation of LC at LC/air 









(2) The second objective of the PhD study is to investigate whether 
short oligopeptides (12mer) can be used to replace antibodies for the 
developments of biosensors for small molecules such as thiacloprid, 
imidacloprid and glyphosate. To identify such oligopeptide, we employed 
phage display library. For the phage display library of thiacloprid and 
imidacloprid, we use solid crystals of thiacloprid and imidacloprid as targets 
because both the two neonicotinoids have low solubility in water. However, 
this strategy is not applicable to glyphosate because it is highly soluble in 
water and the phage library target will be lost in screening procedures. To 
address this issue, we covalently immobilize glyphosate on solid surface of 
glass beads, and the glass beads will be used as a solid support for phage 
display library to prevent the loss of glyphosate during screening procedures. 
To rule out the phages bound to glass beads, we carried out “negative 
screening” after each round of phage panning. Next, the oligopeptides that 
identified from the phage library will be characterized, and incorporated into 
an LC sensor. However, the LC sensor does not work because small molecules, 
such as thiacloprid and imidacloprid, do not disrupt liquid crystal orientation 
effectively. Then we tried to use surface plasmon resonance (SPR) biosensor 
for online detection of the target molecules in buffer solution. 
 
(3) Our next objective is to combine oligopeptides with LC to develop 
an innovative immunoassay which can be used to detect human chorionic 
gonadotropin (hCG). In this assay, we demonstrate that the oligopeptides 
identified from phage library can replace antibodies to capture hCG. To 
 





develop a biosensor, a thin layer of LC is used as a medium to transduce the 
binding of hCG to oligopeptide into optical signals. The advantages of using 
oligopeptides to replace antibodies are two-fold. First, the short oligopeptides 
do not disrupt LC orientation easily before binding to hCG targets. Second, 
oligopeptides are more robust than antibodies in harsh environments. 
 
(4) The last objective in this thesis is to develop an enzymatic silver 
deposition mechanism to amplify molecular binding events on the surface. To 
achieve this objective, a biotinylated oligopeptide (PPLRINRHILTRGGG-
biotin) is first immobilized on glass surface. Next, a streptavidin-alkaline 
phosphatase (SA-ALP) is immobilized onto the glass slide through 
streptavidin-biotin conjugation. The ALP promotes silver deposition in the 
presence of ascorbic acid 2-phosphate (AH2-p) and silver ions. We also study 
the enzymatic reaction kinetics of ALP to understand the theoretical limit of 
ALP-catalyzed silver deposition, and investigate the effectiveness of the 
enzymatic silver deposition to amplify LC signal. 
  
 











In this chapter, we review literature related to various types of sensing 
layers used in biosensor, transduction mechanism, phage library, and liquid 
crystals in sensing applications.  
  
 




2.1 Sensing Layers Used in Sensors 
Most sensors consist of a sensing layer and a signal transducer. 
Interactions of sensing layers with target analytes generate certain signals, 
which can be converted into detectable signals by the transducers 82. The 
sensing layers used in sensors can be functional molecules, enzymes, 
antibodies, and oligopeptides. Without the sensing layer, the sensor would not 
have any specificity for the target molecules.  
 
2.1.1 Functional Molecules (Abiotic Molecules)  
Functional molecules have been engineered as sensing layers to render 
specificity to target molecules. One common strategy is to prepare a solid 
surface with immobilized functional groups on it. Self-assembled monolayers 
(SAMs) provide an effective way to immobilize functional groups. For 
example, to detect 2,4,6-trinitrotoluene (TNT), Pinnaduwage et al. 83, 84 
developed a carboxyl (-COOH) functionalized surface on gold substrates by 
immobilizing SAMs of 4-mercaptobenzoic acid (4-MBA). The carboxyl 
groups strongly bind to the basic nitro groups of the TNT molecules through 
hydrogen bonding. Although this TNT sensor shows high sensitivity at ppb 
level, the signals are easily interfered by humidity in the air because water 
molecules also adsorb on the carboxyl functionalized surface through 
hydrogen bonding. To address this limitation, Zuo et al. 85 developed dual-
SAMs as sensing layers to detect TNT vapors in air. In this study, a SAM of 6-
mercaptonicotinic acid (6-MNA) was immobilized to a cantilever sensing 
surface to provide carboxyl functional groups for TNT binding, and secondary 
 




hydrophobic SAM of FAS-17 (heptadecafluorodecyltrimethoxysilane) is 
immobilized to the non-sensing SiO2 surfaces of the cantilever to reduce non-
specific adsorption of moisture from ambient air. Besides carboxyl functional 
groups, amine-functionalized monolayers can also be used as sensing layer for 
TNT detection. For example, Engel et al.86 immobilized SAMs of 3-
aminopropyltriethoxy silane (APTES) to bind to TNT molecules through the 
interactions between electron-deficient aromatic ring of TNT and the electron-
rich amino groups on the sensor surface. However, both the carboxyl groups 
and amine groups functionalized sensing layers can bind to other molecules 
with basic nitro groups, such as 2,4-dinitrotoluene (DNT), 1,3-dinitrobenzene 
(DNB), and 2,4,6-trinitrophenol (picric acid). 
 
2.1.2 Molecular Imprinting 
Functional molecules described above are all active molecules which 
react with the target molecules to produce detectable signals. Alternately, 
molecular imprinting can also be used as sensing layers. Molecular imprinting 
is a technique to create template-shaped cavities in polymer matrices with 
memory of the template molecules to be used in molecular recognition 87. In 
particular, non-covalent imprinting provides higher flexibility and versatility, 
since it is applicable to all kinds of analytes. The attractive forces such as 
hydrogen bonding, van der Waals’ forces and dipole–dipole interactions play 
important role in imparting selectivity to molecularly imprinted polymers 
(MIPs). MIPs have been widely used as sensing layers for a variety of analytes 
such as small molecules 88, 89, biomolecules 90, and microorganisms 91, 92. 
 




However, one limitation of the three-dimensional MIPs is the slow response 
time because target molecules need to diffuse to recognition sites embedded 
deep inside the polymer. To overcome this problem, a two-dimensional (2D) 
molecular imprinting method has been proposed recently. For example, Bi and 
Yang 93 developed 2D molecular imprinting monolayers to recognize 
thiacloprid and imidacloprid. In this method, inert monolayers of thiols are 
self-assembled on a gold surface in the presence of two template molecules, 
thiacloprid and imidacloprid. After the removal of the templates, the resulting 
cavities formed in the self-assembled monolayers (SAMs) can be used to 
adsorb template molecules. 
 
2.1.3 Antibodies  
Antibodies are Y-shaped protein molecules produced by immune 
systems to identify and neutralize foreign molecules or microorganisms, such 
as bacteria and viruses. The active sites of an antibody can recognize the 
epitope on an antigen. Therefore, the application of antibodies in 
immunoassays can provide specific binding to the target. Currently, 
immunoassays have been widely applied, and specific antibodies have been 
developed as sensing layers for detection of many explosives 94-98, pesticides 66, 
68, 99, 100, industrial chemicals 101, and microbial toxins 102. Immunoassays rely 
on the ability of an antibody to recognize and bind a specific target in a 
complex mixture, and the signals can be readout by using labeling of enzymes, 
fluorogenic reporters, radioactive isotopes, or label-free techniques such as 
surface plasmon resonance (SPR) and quartz crystal microbalance (QCM).   
 




The sensing layers employed in these immunochemical sensors can be 
constructed with various structures. One common structure is direct 
competitive immunoassay. First, the antibody is immobilized on solid surface, 
then a tracer target labeled with radioactive isotopes or fluorophores is mixed 
with target-containing solution, the target competes with the labeled tracer 
molecule in binding to antibody. Then, the fluorescent or radioactive analysis 
will be performed for the detection purpose 103. The second structure of the 
immunoassay is called “sandwich-type immunoassay”. The antibody is first 
immobilized on solid surface. After binding to the target molecules, the 
secondary antibody which can bind to the target molecule on other site is 
introduced. The second antibody is usually labeled with fluorophores or 
enzymes, which can produce detectable signals 103. Currently, the “sandwich-
type” immunoassays are more favorable.  
For example, Tomoda and Hreshchyshyn 104 first reported the 
application of radioimmunoassay using human chorionic gonadotropin (hCG)-
specific antibodies. However, in this study, the antibodies raised against whole 
hCG will usually recognize other pituitary hormones, such as human follicle 
stimulating hormone (hFSH), human luteinizing hormone (hLH), and human 
thyroid stimulating hormone (hTSH), because they have identical α-subunits.77 
To improve specificity, Vaitukaitis et al. 105 developed a radioimmunoassay to 
detect hCG in serum using antibodies raised to β-hCG (anti-β-hCG) as capture 
molecule. In the immunoassay, the β-hCG is labeled with 125I, and introduced 
to anti-β-hCG immobilized substrate together with serum sample containing 
hCG, as shown in Figure 2.1. Although this method exhibits substantially 
reduced cross-reactivity toward hFSH, hLH, and hTSH, there is still ~10% 
 




cross-reactivity remains, and the LOD is limited to about 5 mIU/mL. Later, 
Kardana and Bagshawe 106 described an optimized radioimmunoassay in 
which the LOD reaches 0.68 mIU/mL in serum. To further improve the 
specificity, Katoh et al. 107 developed a radioimmunoassay by using 
monoclonal anti-β-hCG as capture molecule. The cross-reactivity was reduced 
to 0.4%, and the LOD reached 0.5 mIU/mL.   
 
 
Figure 2.1 Schematic illustration of direct competitive radioimmunoassay 
using 125I-labeled β-hCG as a marker to detect hCG in serum. 
 
To avoid application of radioactive isotopes, Urios et al. 108 developed 
fluorescent immunoassay using FITC-labeled hCG as a tracer marker. 
However, the LOD of this study is only 2 IU/mL, which is too high for early-
stage pregnancy test. To achieve lower LOD, Lovgren et al. 109 used 
monoclonal antibodies to enhance binding affinities between antibody and 
hCG molecules. To enhance fluorescent intensity, several fluorophores has 
been reported to label a secondary antibody, including europium chelate 109, 
 




Alexa Fluor 647 110, polymer fluorescent nanoparticles 111, and colloidal gold 
nanoparticles 112. For example, Vareiro et al. 110 reported a “sandwich-type” 
immunoassay using anti-β-hCG as capture molecule. As shown in Figure 2.2, 
the anti-β-hCG was first immobilized on solid surface. After the hCG is 
captured, a secondary fluorescent labeled anti-α-hCG was introduced as a 
probe, which was excited by surface plasmon resonance near to the metal-
dielectric liquid interface. Because of the high binding affinity of antibodies to 
hCG and the strong fluorescence signal, the LOD can reach 2 mIU/mL. To 
further improve the LOD, the capture anti-β-hCG was replaced by Fab-hCG 
(hCG antigen binding fragment) to render a more oriented and organized 
surface, and a LOD of 0.3 mIU/mL was achieved. Alternately, Zhu and Trau 
113 developed “sandwich-type” microfluidic microbeads array system to detect 
hCG. Monoclonal anti-β-hCG was immobilized on polystyrene microbeads 
(d=10 µm) as a sensing layer, and the microbeads were trapped in the 
intersections of polyacrylamide gel pads as the detection platform. After the 
capture of hCG, a secondary fluorescent labeled anti-α-hCG was introduced as 
a probe. This microfluidic microbeads array system can reach an LOD of 0.88 
mIU/mL, and allows the incorporation of “sandwich-type” immunoassay into 
a microfluidic system, which facilitates the transportation of analyte samples. 
 





Figure 2.2 Schematic illustration of “sandwich-type” immunoassay using 
fluorescent-labeled anti-α-hCG as a marker to detect hCG in serum. 
 
Antibodies can also be used as sensing layers to detect small molecules. 
However, the generation of antibodies for small molecules, such as those of 
pesticides, is difficult because small molecules are unable to illicit an immune 
response. Therefore, strategies for the design of haptens and immunogens for 
the development of antibodies to small molecules are required. For example, 
Clegg et al. 69 conjugated glyphosate with bovine serum albumin (BSA) to 
form an immunogen which can elicit an immune response in animals. Then 
the antibodies were harvested and used as capture molecule in a competitive 
enzyme-linked immunosorbent assay (ELISA) for the detection and 
quantitation of glyphosate with a detection limit of 7.6 μg/mL. To detect small 
molecules lacking functional groups for conjugation with carrier proteins, 
special haptens need to be designed to mimic the target molecules to elicit an 
immune response. For example, Li and Li 66 designed two haptens, Hapten-I 
and Hapten-II (as shown in Figure 2.3), to be conjugated with two carrier 
proteins, keyhole limpet hemocyanin (KLH) and bovine serum albumin (BSA), 
respectively to form immunogens which elicit an immune response. Then, 
 




polyclonal antibodies were raised from rabbits immunized with two 
immunogens of which the haptens had a spacer at either the pyridinyl ring or 
the imidazolidinyl ring of imidacloprid. The authors found that the antibodies 
harvested from Hapten-II showed better binding specificity, while the 
antibodies harvested from Hapten-I showed approximately equal recognition 
toward imidacloprid and its two major metabolites, 5-hydroxy imidacloprid 
and imidacloprid olefin. After that, similar studies have been reported for the 
design of haptens and development of immunoassays for detection of 
pesticides, such as imidacloprid 65, 67, acetamiprid 99, and thiamethoxam 68. 
 
Figure 2.3 Synthetic scheme of imidacloprid haptens. 
 
Currently, the antibodies are most favorable sensing layers for 
detection of biomolecules and small molecules. However, the production of 
antibodies is time-consuming and expensive, and the batch-to-batch variation 
is also a concern 114. In addition, despite their good binding affinity and 
specificity, the antibodies are vulnerable to environmental factors, especially 
high temperature 73. 
 




2.1.4 Oligopeptides  
Oligopeptides are short biopolymers of 5-20 amino acids linked by 
peptide bonds. Because of their diversity in chemical functionality and 
structure, oligopeptides are able to recognize a wide range of targets with high 
specificity. Oligopeptides are promising candidates to replace antibodies as 
molecular receptors in biosensors 73, 115. Short oligopeptides have several 
advantages over antibodies. For example, they are more stable and resistant to 
harsh environments 116. Secondly, they can be synthesized with high purity 
and immobilized on solid surfaces with a single anchoring point. As a result, it 
is much easier to immobilize oligopeptides on solid surfaces, either by a 
reaction between a thiol group and a gold surface 117, 118, or through the 
formation of thiazolidine ring between N-terminal cysteine and an aldehyde 
decorated surface 119. However, the challenge of using oligopeptide as a 
receptor is how to identify a specific amino acid sequence that provides the 
strongest multivalent binding among all possible combination of amino acid 
sequences. One way is using known binding sites of proteins that bind to the 
target. For example, Kuang et al. 120 developed a trinitrotoluene (TNT) sensor 
by using an oligopeptide HSSYWYAFNNKTGGGGWFVI as a sensing layer 
on single-wall carbon nanotubes. The role of HSSYWYAFNNKT is to bind to 
single-wall carbon nanotube (SWNTs), and the role of GGGG is a spacer. The 
four amino acids residues WFVI were derived from the binding site of the 
honeybee odor binding protein ASP1, which binds to TNT. Similarly, 
Sankaran et al. 121 developed a QCM-based biosensor using an oligopeptide 
SLMAGTVNKKGEF, which was derived from an odorant binding protein 
from Drosophila (a fruit fly), as a sensing layer to detect alcohols. However, 
 




this method is limited because binding sites of the odorant binding proteins are 
only known for a few targets. To address this issue, a biopanning process is 
developed by using phage library. 
Phage library is a genetic technique to study protein–ligand 
interactions. It was described by Smith 122 in 1985. In this technology, the 
most commonly employed bacteriophage is filamentous phage (shaped like a 
rod filament), including M13, f1, fd, etc. M13 phage is composed of circular 
single stranded DNA (ssDNA) encapsulated in approximately 2700 copies of 
the major coat protein capsid, called pVIII 123. The surface exposed a coating 
protein pIII is located at one end of the rod-like phage particle. The M13 
phage can be engineered with random oligopeptide sequences by shot-gun 
cloning of random oligonucleotide segments at the 5 ′ end of the pVIII or 
pIII genes of filamentous phage 124-126. Phage display screening is a powerful 
tool to identify a specific oligopeptide sequence that provides the strongest 
binding to the target. Briefly, phage panning is carried out by incubating a 
phage library containing billions of phages with random peptides with a plate 
(or bead) coated with the target, washing away the unbound phage, and eluting 
the specifically-bound phage with an excess of a known ligand for the target 
or by lowering pH. The eluted phage is then amplified in E. coli culture. 
Additional binding/amplification cycles are conducted to enrich the phage that 
expresses the most desirable oligopeptide sequence. After 3–4 rounds, 
individual clones are characterized by DNA sequencing. 
At the beginning, phage display was used to select oligopeptides that 
specifically binds to certain targets, such as antibodies, enzymes, cell-surface 
 




receptors, by using panning process 125, 127. For example, random peptide 
phage libraries were used for mapping the epitopes 128. When an antibody is 
used as the screening target, the consensus sequence of the oligopeptides that 
identified from random phage library are often easily recognized in the 
sequence of the natural antigen, thus allowing the epitope recognized by the 
antibody to be mapped 126, 129, 130. Later, phage library was used to identify 
oligopeptide sequences bind specifically to certain protein molecules. For 
example, Devlin et al. 131 successfully identified oligopeptides containing a 
His-Pro-Gln (HPQ) motif that binds to streptavidin. However, in this study, 
the binding affinity of the oligopeptide to streptavidin is not known because 
phage particles, rather than oligopeptides, were used in the binding experiment. 
Pillutla et al. 132 identified oligopeptides which can bind to insulin receptor by 
using phage library. They also studied interactions between insulin and insulin 
receptor in the presence of oligopeptides by using radioreceptor assays. More 
recently, Fields et al. 133 identified oligopeptides, GAMHLPWHMGTL, which 
bind to Bowman-Birk inhibitor (BBI) by using phage library. This 
oligopeptide can work as a sensing layer in a SPR biosensor to detect BBI. 
They also used oligopeptide-modified magnetic particles to isolate BBI from 
soybean extracts. The above studies show that phage library is a powerful tool 
to identify oligopeptides which bind to target proteins with high affinity and 
specificity. 
More recently, the application of phage library has been expanded to 
other targets. For example, Belcher’s group reported that phage can bind to 
inorganic materials, such as GaAs 134 and ZnS 135. For example, the authors 
employ phage library to couple with ZnS quantum dots solution to 
 




spontaneously evolve a self-supporting hybrid film material that was ordered 
at the nanoscale. This study provided new pathways to organize nanosized 
materials. More recently, phage libraries have been used to develop biosensors 
for selective detection of small molecules. For example, Goldman et al. 136 
identified an oligopeptide sequence, WHRTPSTLWGVI, for selective 
detection of 2,4,6-trinitrotoluene (TNT) in sea water. In the phage library 
screening, an analog, 2,4,6-trinitrobenzene conjugated bovine serum albumin 
(TNB-BSA) was used as phage display target. Then the whole phage carrying 
the desired oligopeptide was used in a continuous flow immunosensor 
platform for the detection of TNT. Later, Takakusagi et al. 137 identified one 
oligopeptide sequence, NSSQSARR, which specifically binds to camptothecin. 
Then the oligopeptide was chemically synthesized, and the dissociation 
constant (KD) of oligopeptide to camptothecin was determined by using SPR 
and QCM respectively. This result shows that the short oligopeptides can work 
as a sensing layer in a biosensor. Jaworski et al. 118 identified oligopeptide 
sequences, WHWQRPLMPVSI and HPNFSKYILHQR, which can 
specifically bind to 2,4,6-trinitrotoluene (TNT) and 2,4-dinitrotoluene (DNT), 
respectively. Unlike Goldman’s work, the authors use crystal powder of TNT 
or DNT as phage display substrates. The mutational analysis show that the 
amino acids of WHWX (X=Q, S, N, and K) are responsible for the binding of 
oligopeptides to TNT molecules. Last, the authors employed the oligopeptides 
as sensing layer for detection of TNT and DNT in air phase. This experiment 
demonstrates that the oligopeptide screening in liquid can be translated to 
selective gas-phase target binding. Later, Cerruti et al. 117 developed a QCM 
biosensor using the oligopeptides as sensing layer to detect TNT and DNT in 
 




water, showing that the oligopeptide receptor coating can be used as a sensing 
element in real applications. Besides, the cross-binding of TNT and DNT to 
the oligopeptide functionalized QCM biosensor is minimal despite the 
similarities of TNT and DNT molecules. 
 
2.2 Surface Plasmon Resonance (SPR) 
In the past, many signal transduction mechanisms have been developed 
to transduce the reaction or binding signal produced from the sensing layer 
into detectable signals through the changes on electrochemical 138-142, 
colorimetric 143-146, fluorescent 147-152, optical 153-156, and piezoelectric 
properties 157-161. Among the above transduction mechanism, surface plasmon 
resonance (SPR) shows great advantages because it is a label-free mechanism, 
and the binding of the target molecules can be directly detected. 
 
2.2.1 Principles of SPR Sensors 
Surface plasmon is a electromagnetic mode which may exist at the 
surface of a metal 162. Surface plasmon resonance (SPR) sensors employ 
surface plasmon propagating on a planar metal-dielectric interface, called 
“propagating surface plasmons” (PSPs) 163. Since the PSPs are on the 
boundary of the metal and the external medium (such as air or water), they are 
very sensitive to the changes of this boundary, such as the adsorption of 
molecules to the metal surface. The electromagnetic field of the PSP reaches 
its maximum at the metal-dielectric interface and decays exponentially into 
 




both media. The penetration depth of the PSP at the boundary of gold and a 
dielectric (typically an aqueous medium) is typically between 100 and 600 nm 
163. In SPR sensors, PSPs are excited using prism couplers, grating couplers or 
metal-dielectric waveguides 164. The most common approach to the excitation 
of PSPs is through the use of a prism coupler via the attenuated total reflection 
method (ATR) 165, 166. There are two well-known configurations to excite PSP 
waves using light, the Otto configuration and the Kretschmann configuration. 
In the Otto configuration 167, the light passes through a high refractive index 
prism, and is totally internally reflected. A thin metal film is positioned close 
enough to the prism wall so that an evanescent wave can interact with the 
plasma waves on the surface and hence excite the surface plasmons, as shown 
in Figure 2.4A. In the Kretschmann configuration 166, the metal film is 
evaporated onto the bottom of prism. The light passes through a prism, and 
excites a PSP on the outer side of the metal film, as shown in Figure 2.4B. 
This configuration is used in most practical applications. 
 
Figure 2.4 Schematic illustration of (A) Otto configuration, and (B) 
Kretschmann configuration, to excite surface plasmons using a prism coupler. 
 
 




The excitation of the PSP results in a drop in the intensity of the 
reflected light 168. A change in the refractive index of the dielectric medium in 
the evanescent wave of the PSP produces a change in the propagation constant 
of the PSP. Figure 2.5 shows the schematic illustration of an SPR 
experimental setup. In SPR biosensors, a capture molecule is immobilized on 
to the surface of the SPR sensor chip. When a solution containing target 
molecules flows over the SPR sensor chip, the target molecules bind to the 
capture molecules, resulting in an increase in the refractive index at the SPR 
sensor chip surface. Then the change in the refractive index of the medium 
near the surface of the metal film causes a change in resonance angle (θm), 
which will be recorded by the SPR instrument 169. 
 
Figure 2.5 Schematic illustration of SPR experimental setup. 
 
2.2.2 SPR Biosensors 
SPR has several intrinsic features that allow for label-free, real-time 
monitoring of biomolecular interactions. SPR biosensors have been applied in 
numerous important fields including medical diagnostics 170-172, environmental 
monitoring 173-175, food safety 176-178 and security 179, 180. Figure 2.6 shows four  
 





Figure 2.6 Schematic illustration of four detection formats used in SPR 
biosensors: (A) direct detection; (B) sandwich detection format; (C) 
competitive detection format; (D) inhibition detection format. 
 
frequently used detection formats used in SPR biosensors, including direct 
detection, sandwich detection, competitive detection, and inhibition detection. 
In the direct detection mode (Figure 2.6A), the capture molecules, such as 
antibodies, are immobilized on the SPR sensor chip surface. When the analyte 
molecules present in the solution, the analyte molecules bind to the capture 
molecules, and cause a refractive index change at the SPR sensor chip surface, 
producing a resonance angle shift, which can be detected by the SPR photo 
detector. The direct detection is favorable when the binding of analyte can 
produce sufficient response at the concentrations of interest. For example, 
Dostalek et al. 181 developed an SPR biosensor for detection of hCG using an 
integrated optical waveguide-coupled SPR sensing device. The authors used 
monoclonal anti-hCG antibody as the capture molecule for direct detection of 
hCG in 1% BSA solution. The LOD in this biosensor can reach 26.4 mIU/mL. 
 




However, in this study, the immobilization of monoclonal anti-hCG on SPR 
sensor chip was realized by crosslinking of glutaraldehyde, which is 
deleterious to the activity of the antibodies. To address this problem, Boozer et 
al. 182 improved the immobilization of antibodies on SPR sensor chip through 
biotin-streptavidin conjugation, and an LOD of 66 mIU/mL was achieved. We 
noticed that the LOD is getting worse compared to Dostalek’s work as 
described above. This is probably because different sources of antibodies are 
used in different studies. Later, the same group improved the immobilization 
of antibodies through DNA hybridization using antibody-DNA conjugates 
composed of an antibody and a single-stranded DNA 183. The antibody-DNA 
conjugates bind specifically to the sites immobilized with complementary 
DNA strand on the surface to functionalize the SPR sensor chip, and this 
system showed a 10-time lower LOD at 6.6 mIU/mL than the one with 
biotinylated antibodies. To resist nonspecific protein adsorption, a non-fouling 
background was created by the mixed SAM with an OEG-thiol to reduce false 
alarms. In the previous studies, one limitation to achieve lower LOD is 
because the nonspecific protein adsorption from the complex medium, and the 
SPR system will produce false positive signals at concentrations below LOD. 
To further reduce the nonspecific protein adsorption, Zhang et al. 184 
developed a zwitterionic poly(carboxybetaine methacrylate) (polyCBMA) 
based hydrogels to resist nonspecific protein adsorption. In this work, the SPR 
sensor chip grafted with polyCBMA brushes showed protein adsorption less 
than 0.3 ng/cm2. Then, hCG antibody was chemically immobilized on the 
surfaces using the EDC/NHS chemistry. The antibody functionalized surface 
 




specifically bound to hCG and highly resisted the nonspecific adsorption of 
other nontargeted proteins.  
The LOD and specificity of SPR biosensors can be further improved 
by using the sandwich detection format (Figure 2.6B), in which the sensor 
surface with captured analyte is incubated with a second antibody. The 
purpose of a “sandwich-type” immunoassay in SPR is to enhance the binding 
signal when the target molecules bind to the capture molecules, especially for 
the target molecules with lower molecule weight, or the target molecules 
present in complex matrix, which interfere with the detection of the targets. 
For example, Teramura and Iwata 185 developed a sandwich-type 
immunoassay for detection of α-fetoprotein (AFP) in human plasma by using 
SPR as signal transducer. In this system, three kinds of antibodies were used. 
First, a primary monoclonal antibody was immobilized on SPR sensor chip as 
a capture molecule through EDC/NHS chemistry. After AFP bound to the 
primary antibody, a secondary polyclonal antibody was introduced to amplify 
the binding signal. The SPR signal was further enhanced by applying a tertiary 
polyclonal antibody against the second antibody. With this method, the SPR 
signals were highly intensified, and the LOD can reach nanogram levels 
(ng/mL) in human plasma matrix with a high signal/noise ratio. To further 
improve the LOD, the same group also described a “sandwich-type” 
immunoassay for detection of brain natriuretic peptide (BNP), using 
functionalized nanobeads to amplify SPR signal 186. In this system, after BNP 
bound to the primary monoclonal antibody, a biotinylated secondary 
monoclonal antibody was introduced to form a “sandwich-type” binding. To 
further amplify the SPR signal, streptavidin conjugated nanobeads (d=50 nm) 
 




were introduced and accumulated on the secondary antibody via biotin–avidin 
binding at presence of biotinylated anti-streptavidin antibody. By using this 
method, the SPR signals were highly intensified, and thus picogram levels 
(pg/ml) of BNP could be detected.  More recently, Wang et al. 187 developed 
an SPR biosensor using antibody-functionalized magnetic nanoparticles 
(MNPs) to further enhance SPR signal. After the secondary antibody (dAb)-
immobilized MNPs were introduced to form a “sandwich-type” complex, a 
magnetic field was applied to assist the affinity binding. In this configuration, 
the LOD for hCG can be lowered by 10-fold.  
However, small molecules cannot be easily detected by using SPR 
because small molecules often do not generate sufficient changes in the 
refractive index at low concentrations. The “sandwich-type” immunoassay for 
signal amplification is also not applicable because small molecules usually 
cannot provide two binding sites for “sandwich-type” immunoassay. To 
address this problem, competitive or inhibition detection format can be used. 
Figure 2.6C shows an example of the competitive detection format, in which 
the sensing surface is coated with an antibody interacting with the analyte. 
When a conjugated analogue is added to the sample, the analyte and its 
conjugated analogue compete for a limited number of binding sites on the 
surface. The binding response is inversely proportional to the analyte 
concentration. For example, Wu et al. 101 developed an SPR biosensor to 
detect melamine in milk powder solution using competitive immunoassay. In 
this assay, an LOD of 0.02 µg/mL was reached. This value compared 
favorably to an LOD of 1.13 µg/mL from direct immunoassay.  
 




In the inhibition detection format (Figure 2.6D), a fixed concentration 
of an antibody with affinity to analyte is mixed with a sample containing an 
unknown concentration of analyte. Then, the mixture is injected in the flow 
cell of the SPR sensor and passed over a sensor surface to which analyte or its 
analogue is immobilized. Noncomplexed antibodies are measured as they bind 
to the analyte molecules immobilized on the sensor surface. When the 
antibodies bind to the analyte in solution, the binding sites of the antibody 
were occupied, and the complexed antibodies cannot bind to the SPR surface. 
Therefore, the binding response is also inversely proportional to the 
concentration of analyte in solution. Recently, there is a growing attention in 
the use of indirect inhibition SPR immunoassays for detection of small 
molecules in medical diagnosis, environmental monitoring and food quality 
control, as shown in Table 2.1. To functionalize the SPR sensor chip surface, 
the analyte or its analogue can be directly immobilized on functionalized SPR 
sensor chip through chemical reaction 188, or first react with one carrier protein 
and then the analyte-protein conjugate physically adsorb 189-191 or covalently 
immobilized 192-194 on the SPR sensor chip. To improve LOD, Kawaguchi et al. 
195 developed a label-free detection of trinitrotoluene (TNT) immunosensor by 
using gold nanoparticles functionalized SPR sensor chip. In this study, 
(AuNPs) were immobilized on thiolated SPR sensor chip, and functionalized 
with TNT derivative (trinitrophenol-β-alanine). 
Although the immunoassay-based biosensors show good sensitivity 
and specificity, these immunochemical sensors suffer from some limitations. 
First, the production of antibodies is tedious and expensive, and batch-to-batch 
variation is also a concern. Second, the immunoassays are limited to aqueous 
 




environments within a limited pH range, temperature range, and ionic activity 
to retain their active binding configuration. Third, the surface density of the 
immobilized antibodies is usually not high enough for the engineering of a 
sensing layer for analytical sensing applications due to the large size of 
antibodies. Last, the antibodies easily lose activity or even become degraded 
during storage and strict conditions. 
Table 2.1 SPR biosensors for detection of small molecules in medical 
diagnosis, environmental monitoring and food quality control using indirect 
inhibition immunoassays 
Analyte 





Physical adsorption of an 
cortisol-BSA conjugated 
1.0 ng/mL (191) 
Morphine 
Physical adsorption of an 
analyte–protein conjugate 
0.1 ppb (190) 
Dopamine 
Physical adsorption of an 
analyte–protein conjugate 
0.085 ppb (189) 
Progesterone 
Covalent binding of 
progesterone on CM–dextran 
layer 
0.15 ppb (188) 
Estradiol 
Covalent coupling of a protein 
conjugate on CM–dextran layer 
0.468 nM (193) 
Food Quality Control： 
Aflatoxin B1 Covalent coupling of a protein 3 ppb (194) 
 




conjugate on CM–dextran layer 
Aflatoxin B1 
Covalent coupling of analyte 
on CM–dextran layer 
0.3 ppb (192) 
Deoxynivalenol 
Covalent binding of a 
conjugate of casein 
2.5 ppb (196) 
Tylosin 
Covalent coupling of tylosin 
on CM–dextran layer 
2.5 ppb (197) 
Penicillin  
Covalent coupling of antibody 
on CM–dextran layer 
2 ppb (198) 
Penicillin 
Covalent coupling of analyte 
derivative on CM–dextran 
layer 
1.5 ng/g (199) 
Ractopamine 
Covalent coupling of 
ractopamine–ovalbumin  
on SAM of 
mercaptoundecanoic 
0.12 ng/mL (200) 
Thiabendazole 
Covalent coupling of TN3C–
BSA conjugate 
on SAM of MHDA and MUA 
0.13 ng/mL (201) 
Ochratoxin A 
Covalent binding of OTA–
OVA conjugate 
on SAM of MUOH and MHA  
0.042 ng/mL (202) 
Environmental Monitoring： 
TNP Physical adsorption of TNP– 0.01 ng/ml (203) 
 




BSA conjugate  
Carbaryl 
Covalent coupling of 
BSA–CN4C conjugate to 
SAM of mercaptoundecanoic 
acid 




Covalent coupling of 
respective conjugates to SAM 





Physical adsorption of 
TNP–BSA conjugate 
0.06 ppb (206) 
TNT 
Immobilization of TNT 
analogs over OEG-thiol SAM 
1 ng/mL (98) 
TNT 
Physical adsorption of TNPh–
OVA conjugate 
0.001 ppb (179) 
HBP 
Physical adsorption of an 
analyte–protein conjugate 
0.1 ppb (207) 
2,4-D 
Binding concanavaline-2,4-D 
conjugate into 3-D dextran 
layer 
3 ppb (208) 
2,4-D 
Physical adsorption of 
2,4-D-BSA conjugate 
0.5 ppb (209) 
    
 
 




2.3 Silver Enhancement 
The idea of silver deposition enhancement in biochemistry was firstly 
borrowed from the photographical film developing process by Roberts in 1935 
210, 211 to determine gold distribution in animal tissues. The basic idea relied on 
the silver deposition from a developer containing silver ions on a substrate 
with submicroscopic gold grains produced by light exposure, and the metallic 
gold grains catalyzes the reduction of silver ions to metallic sliver. Holgate et 
al. 212 developed a silver staining method to enhance the sensitivity of an 
immunoassay compared with standard immunoperoxidase methods. In this 
study, a rabbit anti-human IgG first binds to a tissue containing human IgG. 
Then, a secondary antibody labeled with colloidal gold nanoparticles (AuNPs) 
(d=20 nm) was introduced to bind the primary antibody. Then the tissue 
substrate containing AuNPs was exposed to developer solution containing 
silver ions and a reducing agent hydroquinone. Then the silver ions were 
reduced to metallic silver and preferably deposited at the locations containing 
AuNPs, as shown in Figure 2.7. Later, Braun et al. 213 reported a silver 
deposition method to construct nanoscale conductive silver wires using a 
single-strand DNA (ssDNA) as template. After the ssDNA was placed 
between two electrodes, it was then treated with silver ions to replace the 
natural sodium counter ions and subjected to a chemical reduction process 
with the reducing agent hydroquinone. Then the small silver aggregates 
formed on the backbone serve as seeds for further silver cluster growth and 
eventually results in a continuous silver wire. The wire had a granular 
morphology with a typical width of 100 nm and provided an electrical contact 
between the electrodes.  
 





Figure 2.7 Schematic illustration of silver staining method in immunoassay. 
 
The application of silver deposition on DNA templates was first 
exploited for DNA detection by Wang et al. 214 to amplify electrochemical 
signal. In this study, a short ssDNA probe was first immobilized on an 
electrode. After DNA hybridization, the longer target DNA was captured and 
subjected to silver deposition on DNA as described by Braun et al. 213. After 
silver deposition, the electrode coated with metallic silver was immersed in 
HNO3 solution to strip silver and give electrical signals as shown in Figure 2.8. 
Although the LOD of this method can reach picomolar level, this approach is 
hampered by high background signal. To overcome this limitation, Hwang et 
al. 215 developed an enzymatic silver deposition method for DNA detection. In 
this method, neutravidin-conjugated alkaline phosphatase binds to the biotin-
labeled target DNA on the electrode surface and converts the non-reactive p-
aminophenyl phosphate to p-aminophenol, which can further reduces silver 
ions and leads to deposition of metallic silver onto the electrode surface. This 
process leads to great enhancement in signal due to the accumulation of 
metallic silver, and the LOD can reach 100 aM. Fanjul-Bolado et al. 216 
reported a similar approach to detect DNA from the genome of the pathogen 
 




Streptococcus pneumoniae by using substrate solution containing 3-indoxyl 
phosphate and silver ions for alkaline phosphatase-catalyzed silver deposition 
to enhance electrochemical signal. This method is able to detect 35 amol of the 
DNA target. 
 
Figure 2.8 Schematic illustration of silver deposition and silver stripping to 
enhance electrochemical signal for detection of DNA214. 
 
Although the above electrochemical methods can achieve low LOD, 
stripping voltammetry is needed. To develop an easier visualization or a 
simpler method, Tan et al.1 developed a liquid crystal optical biosensor using 
enzymatic silver deposition to enhance the binding signal, as shown in Figure 
2.9. Similar to Hwang’s work 215, the streptavidin alkaline phosphatase binds 
 




to the biotin of the detection DNA probe, which then catalyzes the hydrolysis 
of ascorbic acid 2-phosphate (AH2-p) to form ascorbic acid (AH2). The 
ascorbic acid reduces the silver ions in solution to metallic silver on the 
substrate surface, and the deposited silver in turn disrupts the homeotropic 
orientation of the LC and gives bright textures. One advantage of this method 
is that the biomolecular binding events can be transduced into optical signals 
which can be easily observed with a pair of crossed-polarizers. 
 
Figure 2.9 Schematics illustration of enzymatic silver deposition.1 
 
2.4 Liquid Crystal (LC) 
Liquid crystal is a state of matter that exhibits orientational ordering 
properties of solid crystalline, while it can flow as conventional amorphous 
liquids217, 218. There are three types of LCs that have been discovered so far: 
thermotropic, lyotropic and polymeric. Recently, thermotropic LCs have been 
studied extensively as an optical sensor for the detection of chemical reactions 
219, 220 and biological interactions 221-223 at LC/aqueous interface due to the 
unique optical properties of LCs and their sensitive response to minute change 
 




at the interface. The applications of LC-based sensors have attracted much 
attention mainly due to its easily visualized and label-free detection capability.  
There are three phases of thermotropic LC: the nematic, cholesteric, 
and smectic phases. The nematic phase is characterized by long-range 
orientational order. For example, the long axes of the molecules tend to align 
along a preferred direction, but their positions are not correlated. This 
preferred direction is called director, which can be denoted using a vector n. as 
shown in Figure 2.10A. A cholesteric liquid crystal phase is a type of liquid 
crystal with a helical structure, in which the variation of the director axis tends 
to be periodic. The period of this variation (the distance over which a full 
rotation of 360° is completed) is called the pitch, denoted as p, as shown in 
Figure 2.10B. The pitch varies with temperature and it can also be affected by 
the boundary conditions when the chiral nematic liquid crystal is sandwiched 
between two substrate planes. The smectic phase is a state of liquid crystal 
where the molecules are arranged in layers. The molecules within one layer 
are oriented along the layer normal or tilted away from the layer normal, as 
shown in Figure 2.10C. 
 
Figure 2.10 The arrangement of molecules in liquid crystal phases. (A) 
nematic phase, (B) cholesteric phase, and (C) smectic phase.  
 
 




In the literature, the most commonly used liquid crystal for sensing 
applications is 4-cyano-4′-pentylbiphenyl (5CB), the molecular structure of 
which is shown in Figure 2.11. 5CB process nematic phase between 
crystallization temperature (Tcr=22.5°C) and clearing temperature (TN-I=35°C). 
Tcr is the crystallization temperature from liquid crystal phase to solid phase, 
and TN-I is the clearing temperature from liquid crystal phase to isotropic 
liquid phase. The molecule of 5CB is about 20 Angstrom in length. The cyano 
group provides the high polarity of the molecule, and the biphenyl provides a 
rigid backbone of the molecule. 
 
Figure 2.11 Molecular structure of 4-cyano-4′-pentylbiphenyl (5CB).  
 
Liquid crystal is a birefringent material. As a result, liquid crystal 
orientations can be transduced to optical signals. For example, when the liquid 
crystal molecules are parallel to the substrate surface, it is called the planar 
orientation, and the optical appearance alternately changes from bright to dark 
with respect to the relative angle between the liquid crystal sample and the 
polarizer, as shown in Figure 2.12A. When the liquid crystal molecules are 
perpendicular to the substrate surface, it is called the homeotropic orientation, 
and the optical appearance of liquid crystal is dark at any angle, as shown in 
Figure 2.12B. Because the orientation of liquid crystal is closely related to the 
 




interfacial conditions, liquid crystal is a promising material to transduce 
minute changes at the interface into optical signals.  
 
Figure 2.12 Schematic illustration of liquid crystal orientations and optical 
appearances.  
 
2.5 Liquid Crystals for Detecting Proteins 
Applications of thermotropic LC for detecting proteins have been 
developed in Abbott’s group 2, 3, 220, 224, 225. LCs can be used to amplify protein 
binding events at LC/solid interfaces because the orientation of LC at solid 
surfaces can be easily disrupted by foreign molecules, and the reorientation of 
LC propagates from the interface to the bulk (~100 µm), which leads to optical 
transition of LC images under crossed polarizers. For example, Luk et al.226 
described an LC sensor to detect ribonuclease inhibitor (RI) on ribonuclease A 
(RNase A) modified surface, as shown in Figure 2.13. First, the LC orientation 
is uniform planar on glass surface due to the nanoscaled parallel-groove 
patterns. In this case, the optical appearance is dark (Figure 2.13A). When the 
glass slide is modified with RNase A, the uniform LC orientation is not 
disrupted if the surface density of RNase A does not exceed a critical value, 
and the optical appearance remains dark (Figure 2.13B). Once RI binds to 
RNase A, the nanoscaled pattern on the surface can be erased, and the uniform 
 




orientation of LC can be disrupted. In this case, the optical appearance 
changes to bright (Figure 2.13C).  
 
Figure 2.13 Orientations of LC at patterned glass slide surface. (A) uniform 
LC orientation, (B) uniform LC orientation after immobilization of 
ribonuclease, and (C) disrupt LC orientation after applying ribonuclease 
inhibitor.  
 
To quantitatively study the effect of protein to the optical appearance 
of LC , Skaife and Abbott 227 examined the optical appearance of LC with 
different thicknesses of protein. When the thickness of protein film was less 
than 0.25 nm, the optical images of LC were dark, suggesting insufficient 
protein was bound to the surface to disrupt LC orientation. When the thickness 
of protein film was more than 0.25 nm, the optical appearance of LC became 
bright, and the average luminance increased with concentration of protein, 
suggesting that the uniform LC orientation was disrupted. When the thickness 
of protein is more than 2.5 nm, the average luminance of LC approached to the 
maximum value of ~1. However, to pre-orientate LC, the above studies rely 
on deposition of gold film with nanoscaled parallel-groove patterns. To avoid 
this, Kim et al. 228 used a mechanically rubbed film of bovine serum albumin 
 




(BSA) to orientate the LC. First, the glass slide is covalent immobilized with a 
film of BSA. Next, this BSA film is mechanically rubbed by using a piece of 
velvet-type cloth to create parallelized grooves. The parallelized grooves lead 
to uniform planar orientation of LC, and the optical appearance of LC is dark. 
Once anti-BSA binds to the surface, the uniform orientation of LC is disrupted 
by the bound anti-BSA, and the optical appearance changes to bright.  
In the above three studies, the initial LC orientation is uniformly planar 
and the optical appearance of the LC is closely related to the azimuthal angle 
of the LC. When the LC cell is rotated, the optical appearance of LC changes 
with the angle because the optical appearance of LC in uniform planar is 
closely related to the angle between LC sample and the polarizer of the 
microscope. Therefore, the rotating angle should be precisely controlled to 
obtain a reproducible result. In contrast, Xue and Yang 5 used LC which are 
homeotropically oriented (perpendicular to the surface) to report protein 
binding events. Figure 2.14 shows that dark-to-bright optical responses of LC 
can be observed upon the binding of proteins. This homeotropic orientation of 
LC has several advantages. First, the optical appearance of LC is not affected 
by the angle of LC cell to the polarizer. Second, the orientations of LC exhibit 
rapid changes when the surface anchoring energy reaches a critical value 229, 
making the orientational transition very sensitive to small changes. Third, the 
LC cells with two homeotropic boundaries exhibit better contrast ratio 
compared to planar orientations. Later, Xue et al. 4 developed a label-free 
microfluidic immunoassays using LC to transduce the binding of antibodies to 
antigens into optical signals. The results show that the LC images are bright at 
line-line intersections where antibodies meet their specific target proteins, 
 




suggesting that the specific binding of both antigen/antibody pairs can be 
detected.  
 
Figure 2.14 (A) Optical images of 5CB in a glass cell fabricated by DMOAP-
coated slides. One of the slides was patterned with circular domains of protein 
IgG in an array format. The number shown above each circle indicates the 
concentration (µg/mL) of the protein solution applied to the surface. (B) 
Schematic illustration of LC orientation disrupted by protein. 
 
Short oligopeptides were also combined with LC to develop various 
bioassays in the past. For example, Clare and Abbott 223 developed an LC-
based assay to report protein-peptide binding events by using two synthetic 
oligopeptides, IYGEFKKKC (Src-tide) and IpYGEFKKKC, (p-Src-tide), 
supporting on a gold surface. After exposing to anti-phosphotyrosine IgG, the 
optical images of LC in contact with the surfaces immobilized with p-Src-tide 
remains bright, suggesting that the anti-phosphotyrosine IgG only binds to p-
Src-tide but not Src-tide. This is the first example of how short oligopeptides 
can be combined with LC to develop an assay. However, this assay is not real-
time and multiple steps are required before the final results can be obtained. 
To achieve real-time detection, Bi and Yang 230 developed an LC-based 
 




immunobiosensor to detect the binding of linear oligopeptide FLAG, 
CDYKDDDDK, to an anti-FLAG M2 antibody in buffer solution. The LC 
assumes a homeotropic orientation before exposing to anti-FLAG M2. When 
the anti-FLAG M2 binds to FLAP oligopeptide, the LC orientation at aqueous 
interface was disrupted, and gave a dark-to-bright optical transition within 1 h. 
 
2.6 Liquid Crystals for Detecting Small Molecules 
LC-based sensors for detection of small molecules are more 
challenging because the LC orientation cannot be easily disrupted by small 
molecules. Shah and Abbott 3 developed an LC-based optical sensor for 
detection of organoamines In this system, LC was supported on a surface 
decorated with carboxylic acid. After the surface was exposed to hexylamine 
vapor, hexylamine reacted with carboxylic acid, and disrupted LC to cause a 
bright spot which can be promptly observed with the naked eye. Later, the 
same group showed that LC supported on a solid surface decorated with 
copper ions can be used to detect dimethyl methylphosphonate (DMMP) 231-234. 
In both systems, functional molecules (carboxylic acid and copper ions) were 
immobilized on the surface to dictate the orientation of LC. However, the LC 
sensors with functional dopant usually respond to a class of chemicals with 
similar functional groups. To test the ability of LC sensors of distinguishing 
closely related vaporous compounds with the same functional group, Xu et al. 
235 developed an LC-based optical sensor for detection of thiols using metal-
ion microarrays. Upon exposure to vaporous thiols, the orientation of LC 
supported on metal-ion microarrays was disrupted to give a bright optical 
 




appearance. In contrast, LC can be doped with functional molecules to react 
with analytes. For example, Bungabong et al. 236 developed an LC-based 
optical sensor for detection of DMMP vapor by using LC doped with copper 
perchlorate. When the LC sensor was exposed to DMMP vapor, the LC 
appearance changed from dark to bright within a few minutes due to the 
binding of DMMP to copper ions. After the removal of DMMP, the optical 










LIQUID CRYSTAL BASED OPTICAL SENSOR FOR DETECTION OF 
VAPOROUS BUTYLAMINE IN AIR 
 
 
In this chapter, we aim to develop a liquid crystal-based optical sensor 
to detect vaporous butylamine in air. To render specificity, this LC sensor will 
be doped with lauric aldehyde (LA) to react with butylamine. Upon reaction, 
the imine product can trigger the orientational transition of LC at LC/glass 
interface or LC/air interface, which will result in optical transition of the LC 









Liquid crystals, which are widely used in flat panel displays, have 
found more and more applications in biological assays and chemical sensors 
over the past decade 2, 3, 232, 234. One of the most important advantages of LC-
based sensors is that they can produce optical signals which can be easily 
visualized with naked eye. Currently, the detection principle of most LC 
sensors is based upon the disruption of orientations of thermotropic LCs at 
LC/solid 4, 5, 237 or LC/aqueous 225, 230, 238-240 interfaces by analytes. Then, this 
interfacial orientational change of the LC can propagate into the bulk of LC 
phase over several micrometers 2. This global orientational change of the LC 
can be observed under crossed polarizers due to the birefringence of LC.  
Recently, orientational transition of LC at LC/solid interface triggered 
by gas molecules has been studied carefully. Many gas sensors based on this 
phenomenon have also been reported 3, 231-236, 241, 242. For example, Shah and 
Abbott 3, 241 reported an in-plane orientational transition of 4-cyano-4′-
pentylbiphenyl (5CB) supported on a carboxylic acid decorated surface when 
it was exposed to hexylamine. In this system, 5CB forms hydrogen bonds with 
carboxylic acid groups, and hexylamine can react with carboxylic acid groups, 
causing the in-plane orientational transition of 5CB. The same group also 
showed that 5CB supported on a solid surface decorated with copper ions 
exhibits orientational transition from homeotropic to planar (tilted) when it is 
exposed to dimethyl methylphosphonate (DMMP) 231-233, 242. Xu et al. 235 
developed a LC-based sensor for detecting vaporous thiols by using metal ions. 
In this sensor, the orientational transition of LC supported on copper ions was 
 




initiated by a chemical reaction between vaporous thiols and copper ions, and 
a distinct dark-to-bright signal can be observed. 
We point out that in the above three studies, the glass surface was 
modified with a sensing layer and pretreated with metal ions. After that, pure 
5CB was used for sensing. Thus, the orientational transition of 5CB is solely 
triggered by the surface reaction between gas molecules and surface functional 
groups. On the other hand, a number of recent studies were focused on LC 
doped with foreign molecules. For example, Haas et al. 243 reported that 
nematic LC anisylidene-p-n-butylaniline (ABUTA) doped with 0.5 wt% of 
polyamide resin assumes a homeotropic orientation at LC/glass interface. 
Haller and Huggins 244 also reported that doping LC with 0.25–2.5 wt% of 
hexadecyl trimethylammonium bromide (HMAB) or other additives causes a 
homeotropic orientation in the LC. They proposed that these dopants can 
adsorb on a polar glass surface and partition their long hydrocarbon tails into 
the LC phase, causing a homeotropic orientation of LC on the glass surface. 
More recently, Bungabong et al. 236 demonstrated that 5 mM of copper 
perchlorate dopant in 5CB can produce a homeotropic orientation in 5CB. 
This phenomenon is attributed to the formation of an electrical double layer 
near the surface. They also showed that, by exposing 5CB doped with copper 
salts to DMMP, a dark-to-bright optical response can be observed under 
crossed polarizers. This response is attributed to the binding of DMMP to 
copper ions which disrupts the homeotropic orientation of LC. In another 
study, Han et al. 245 doped reactive chiral compounds, (1R,2R)-1,2-diphenyl-
1,2-ethanediamine, and (R,R)-TADDOL derivative, into LC E7. When the LC 
 




film was exposed to CO2, the chiral dopant reacted with CO2 to form a 
carbamate, causing a color change from red to green in the LC film.  
Aliphatic amines with low molecular weight (C2–C8) are volatile 
organic compounds (VOCs) extensively present as air pollutants in chemical 
plants (e.g. fertilizers, pharmaceuticals, surfactants, and colorants). Aliphatic 
amines are also important marker compounds for quality control in food 
industry (such as fish products) 8 and medical diagnosis 9, 10, because amines 
can be produced in many biological processes through metabolism of proteins. 
Methods for detecting aliphatic amines have been developed in the past, 
including electrochemical 15-18, quartz crystal microbalance (QCM) 19, 20, 
enzymatic 24, 25, optical spectrophotometery 22, 23, and polymer-based 26, 27 
sensing techniques. However, these methods still suffer from disadvantages 
such as the requirement of large and complicated instrumentation or low 
specificity. For fast detection of amines, several colorimetric sensors were 
reported. For example, Kirchner et al. 31 reported an optical sensor to detect 
amine vapors by using cholesteric liquid crystals (CLCs) with trifluoroacetyl 
functional groups. A reversible color change from blue to green can be 
observed when the trifluoroacetyl functionalized CLC was exposed to 3000 
ppmv of butylamine vapor, because the trifluoroacetyl group reacts with 
amines to form a hemiaminal 22, 246. Besides, several other types of 
chromogenic sensors, which contain calixarene 28, bromocresol green dye 29, 
indium(III) octaethylporphyrin 23, and n-type organic semiconductor 
molecules 30, have been developed for detection of organic amines. 
 




Herein, driven by the interest for detecting amine vapors 23, 31, 32, 245, we 
studied optical responses of lauric aldehyde (LA)-doped 5CB to butylamine 
vapors. LA was chosen as a dopant because it can react with butylamine to 
form an imine. We first studied the effect of LA concentration on the optical 
response of LC to butylamine vapor. Next, we aimed to understand the 
reaction between LA and butylamine, and how it causes orientational 
transition in LC. Results reported in this study may provide a new principle for 
developing a real-time gas sensor which is simple, fast, and inexpensive. 
 
3.2 Experimental Section 
Materials 
Glass slides were obtained from Marienfeld (Germany). TEM copper 
grids (75 mesh) were purchased from Electron Microscopy Science (U.S.). LC 
4-cyano-4′-pentylbiphenyl (5CB) was purchased from Merck (Singapore). 
Butylamine (99.5%), diisopropylamine (DIPA), and octylamine were 
purchased from Sigma-Aldrich (Singapore). Lauric aldehyde (LA, >95%) was 
purchased from SAFC (Singapore). Methanol (HPLC grade), ethanol, acetone 
and hexane were purchased from Merck. All the chemicals were used as 
received. Deionized water, with a resistivity of 18.2 MΩ cm-1, was prepared 
by using a Milli-Q system. 
 
Cleaning of Glass Slides 
 




Cleaning process of glass slides can be found elsewhere 5, 247. Briefly, 
glass slides were immersed in a 5% (v/w) Decon-90 (a commercially available 
detergent) solution for 2 h, rinsed with copious amounts of deionized water 
and blown dry with nitrogen. The glass slides were further dried in a vacuum 
oven at 100 °C for 15 min to promote planar orientation of 5CB 248, 249. 
 
Preparation of LA-Doped LC   
First, LC doped with different concentrations of LA was prepared by 
diluting 10 wt% of LA-doped 5CB with pure 5CB at different ratios. Next, 
clean glass slide was cut into small squares (0.5 cm × 0.5 cm each). Then, an 
empty copper grid was placed on the top of the slide. Subsequently, 
approximately 0.5 μL of LA-doped 5CB was dispensed into a copper grid, and 
excess 5CB was removed by touching the grid surface with a capillary tube. In 
this configuration, the LC film has hybrid (LC/glass and LC/air) boundary 
conditions.   
 
Detection of Butylamine Vapor 
To prepare butylamine vapors for detection, 0.5 μL of butylamine or 
aqueous solution containing butylamine was pipetted onto a piece of filter 
paper placed inside a 200-mL syringe (See Appendix A). To avoid air leakage, 
the opening of the syringe was sealed with a Teflon plug. The barrel of the 
syringe was heated with a hair dryer to evaporate butylamine into vapor phase, 
and the syringe was cooled down to room temperature (25 °C) before 
 




exposing to LC gas sensors. The vapor concentration of butylamine was 
controlled by changing the butylamine concentration in the solution. For vapor 
detection, a small chamber was designed to host the LC gas sensors, as shown 
in Figure 3.1. The body of this chamber was made of stainless steel with a 
layer of Teflon inside. The whole chamber was sealed with silicone washer to 
provide an air-tight environment. A pair of glass window was installed on the 
chamber to permit the passage of light. The LC gas sensor was a TEM copper 
grid holding LA-doped 5CB. After the sensor was placed inside the chamber, 
the chamber was closed and tightened with screws. Finally, the butylamine 
vapor was injected, and the optical response of the gas sensor was observed 
under a polarized microscope. 
 
Figure 3.1 A gas detection chamber used in this study. The volume of the 
chamber is ~ 25 mL. LA-doped 5CB is dispensed in a copper grid supported 
on a clean glass slide. The vapor is injected into the chamber by using a 200-
mL syringe. 
 
To determine detection limits, six samples with different LA 
concentrations (0.01, 0.05, 0.1, 1.0, 2.0 and 4.0 wt%) were placed inside the 
gas chamber. Subsequently, butylamine vapor with a given concentration, 
starting from 1 ppmv, was injected into the gas chamber with a 200 mL 
 




syringe. A positive response means that more than 90% of the total sample 
area appears dark within 30 min. The light intensity of the optical images of 
LC sensor is obtained by using ImageJ. 
Examination of Optical Textures of LC Samples 
Optical appearance of LC was examined by using a polarized optical 
microscope (Nikon, LV100 POL) in a transmission mode. All images were 
captured by using a digital camera with an exposure time of 40 ms. A LC 
sample was placed on a circular stage between two crossed polarizers. In all 
experiments, the light intensity was set to 70% of full illumination and the 
aperture was set to full opening to control the incident light. Interpretation of 
different types of optical textures of LCs and their corresponding orientations 
can be found elsewhere 218, 250, 251. In brief, if an LC sample always shows a 
dark image upon rotation, the LC assumes a homeotropic orientation. If a 
sample shows modulation of light upon rotation, then the LC sample assumes 
a planar (tilted) orientation at least at one of the boundaries. To measure the 
light intensity of the LC sensor, ImageJ (1.42Q) was used to analyze all 
optical images. First, a 3×3 square region was cut from the original image, and 
a light intensity profile and an average intensity value for each square was 
established.      
 
ESI-MS Measurement of the Imine Product in 5CB 
First, 10 μL of 5.0 wt% LA-doped 5CB was dispensed on the surface 
of clean glass slide. Next, this glass slide and a piece of filter paper were 
 




moved into a glass petri-dish. Then 10 μL of pure butylamine was pipetted to 
the filter paper to initiate the reaction between LA and butylamine vapor. 
After that, the petri-dish was covered and sealed with Parafilm. After reacting 
overnight, the reacted 5CB mixture was examined with electrospray ionization 
mass spectrometry (ESI-MS, Bruker). In this ESI-MS experiment, 2 μL of the 
above LC samples was dissolved in 200 μL of methanol, and injected into the 
mass spectrometer at a flow-rate of 200 μL/h. Positive ionization was used in 
this ESI-MS measurement. 
 
Synthesis of Imine Product 
First, 200 mg of lauric aldehyde was mixed with 79.4 mg of 
butylamine and incubated for 30 min under vigorous shaking. After brief 
centrifugation, the oil-like imine product from the upper layer was collected 
and purified with column chromatography. Then, the purity of the imine 
product was verified by using ESI-MS (Bruker). After that, the purified imine 
product was doped to 5CB with concentrations of 0.1 wt%, 0.01 wt%, 0.001 








3.3 Results and Discussion 
3.3.1 Effect of LA Concentration 
The liquid crystal orientations are determined from the optical 
appearance observed under polarized microscope. To study the effect of LA 
on the optical appearance of LC, we placed copper grids on a glass slide, and 
filled them with LC doped with various concentrations of LA. In this 
configuration, the LC has a LC/air interface and a LC/glass interface. Figure 
3.2 shows that when the concentration of LA in LC is 0.1 wt% or below, the 
optical appearance of the LC is bright. The bright appearance of LC is caused 
by homeotropic orientation at the LC/air interface and planar (or tilted) 
orientation at the LC/glass interface (see Appendix A). This type of hybrid 
boundary condition can cause splay and bend distortion inside the LC film, 
and that leads to a bright image under crossed polarizers 233, 251. In contrast, 
when the LA concentration is 0.5 wt%, a uniform and stable dark image 
appears. The dark appearance of LC is caused by homeotropic orientations at 
both glass and air interfaces (uniform homeotropic orientation throughout the 
LC film) 233, 251. Interestingly, when the concentration of LA is 1.0 wt% and 
above, the optical images slowly become bright again after 2 h. It is probably 
because the LC orientation at glass interface is homeotropic, while the LC 
orientation at air interface gradually turns to planar (or tilted) due to the 
partitioning of LA at the interface (see Appendix A). This type of orientational 
profile gives rise to bright image under crossed polarizers.  
 





Figure 3.2 Effect of LA doping concentrations on the optical images (top) and 
orientations (bottom) of LC confined copper grids. The LA concentration 
ranges from 0% to 2.0% as indicated on top of each image. All the images 
were taken 2 h after sample preparation. Scale bar, 250 μm.   
 
3.3.2 Responses to Butylamine Vapors 
Next, we exposed LC doped with various concentrations of LA to 
butylamine vapor. In this experiment, the concentration of LA ranges from 0 
to 0.1wt% such that the initial optical appearance of LC is bright before the 
exposure to butylamine vapor. Figure 3.3 shows that when the LA 
concentration is lower than 0.001 wt%, the optical image of LC remains bright 
even when it is exposed to 500 ppmv of butylamine vapor. In contrast, when 
the LA concentration in 5CB is 0.01 wt%, the optical appearance of the LC 
changes from bright to dark after exposure to 100 ppmv of butylamine. We 
propose that this optical transition is caused by an orientational transition 
(from planar to homeotropic) at the LC/glass interface as shown in Figure 
3.5A. Moreover, we can see that the detection limit of the LC gas sensor 
decreases with the increasing LA concentration. When the LA concentration is 
0.05 wt%, the optical appearance of LC only partially changes to dark when 
exposed to 50 ppmv of butylamine. The non-uniformity in LC appearance is  
 





Figure 3.3 Optical images of LC sensors with LA doping concentration of 0, 
0.001, 0.01, 0.05, and 0.10 wt% when they were exposed to butylamine vapors. 
The vapor concentration of butylamine is indicated on the top of each image. 
All the images were taken after stabilized for 30 min at room temperature. 
Scale bar, 250 μm. 
 
 
Figure 3.4 Optical images of LC sensors with LA doping concentration of 1.0, 
2.0, and 4.0 wt% when they were exposed to butylamine vapors. The vapor 
concentration of butylamine is indicated on the top of each image. All the 








caused by the different reaction rate with different concentrations of 
butylamine. With prolonged reaction time, the LC appearance changes to 
completely dark in 1 h. When the LA concentration is 0.1 wt%, the LC gas 
sensor can respond to 10 ppmv of butylamine vapor. 
We also prepared LC doped with higher LA concentrations (from 1.0 
to 4.0 wt%) to study their response to butylamine vapor. At these LA 
concentrations, the initial optical appearance of LC is dark, but it gradually 
changes to bright and remains stable after 2h. Figure 3.4 shows that when the 
LA concentration in LC is 1.0 wt%, the LC responds to 20 ppmv of 
butylamine with a bright-to-dark optical transition. Unlike the case of lower 
LA concentrations, this bright-to-dark optical transition is caused by an 
orientational transition from planar to homeotropic at the air/LC interface 
(Figure 3.5B). Interestingly, Figure 3.3 and Figure 3.4 show that the detection 
limit decreases with the LA concentration from 0 wt% to 0.1 wt%, but then it 
increases with the LA concentration from 1.0 wt% and above. This trend 
implies that the response mechanisms are different in two different LA 
concentration regions. When the LA concentration is lower than 0.1 wt%, the 
LC orientation at the LC/glass interface is planar (or tilted) whereas the LC 
orientation at the LC/air interface is homeotropic as shown in Figure 3.2. In 
this case, butylamine molecules can diffuse into LC and react with LA dopant, 
forming imine. We propose that the imine product may adsorb at the LC/glass 
interface, reduce its surface energy 252 and trigger the orientational transition 
of LC from planar to homeotropic as shown in Figure 3.5A. Another possible 
explanation is that the adsorption of imine allows 5CB molecules to penetrate 
into the hydrocarbon chains of imine molecules, and the intermolecular forces 
 




between imine and 5CB cause the LC molecules to align homeotropically to 
the surface 248, 253. To test this hypothesis, we doped 5CB with different 
concentrations of imine product (formed from the reaction between lauric 
aldehyde and butylamine). Figure 3.6 shows that the imine product can cause 
homeotropic orientation at the LC/glass interface. In fact, the imine product is 
more effective than LA (Figure 3.2) to cause homeotropic orientation in LC. 
Only 0.01 wt% of imine product is enough to result in homeotropic orientation.  
 
Figure 3.5 (A) Orientational transition of LC at the LC/glass interface when a 
LC sensor doped with 0.1 wt% of LA is exposed to 10 ppmv of butylamine. 
(B) Orientational transition of LC at the LC/air interface when a LC sensor 
doped with 1.0 wt% LA is exposed to 20 ppmv of butylamine. 
 
On the other hand, when the LA concentration is 1.0 wt% or above, we 
propose that the surface concentration of LA at the LC/air interface is high 
enough to induce a planar (or tilted) orientation at the LC/air interface 
(whereas the LC orientation at the LC/glass interface remains homeotropic). 
When the LC gas sensor is exposed to butylamine vapor, LA is “neutralized” 
by the butylamine, and the orientation of LC gradually returns to homeotropic 
at the LC/air interface as shown in Figure 3.5B. Because the amount of 
 




butylamine needed to “neutralize” LA is proportional to the LA concentration, 
the sensitivity of the sensor decreases when the LA concentration is increased 
as shown in Figure 3.4. This LC-based optical sensor for detecting butylamine 
can response fast to butylamine vapor, and can be easily miniaturized. 
However, the unfavorable LOD is still a bottleneck for practical application. 
 
Figure 3.6 Optical images of 5CB doped with imine product with 
concentration of 0.1, 0.01, 0.001, and 0.0001 wt%. Scale bar, 250 μm.  
 
To further confirm that the response of LC is indeed caused by the 
reaction between LA and butylamine, we exposed LC (doped with 5% of LA) 
to butylamine vapor overnight, and then characterized the LC by using ESI-
MS. In Figure 3.7, a LA peak at 186.2 (m/z), and a 5CB (with Na+) peak at 
272.1 (m/z) can be seen. More importantly, a new peak appears at 240.2 (m/z) 
after the reaction. This peak can be assigned to the imine product (C16H33N, 
MW=239.4) formed by the reaction between LA and butylamine. However, 
the LA peak at 186.2 (m/z) still can be observed after the reaction, indicating 
that the reaction is not complete. Other peaks at 290.1(m/z) and 353.2 (m/z) 
may come from impurities in 5CB (See Appendix A). These results confirm 
the formation of imine when the LA-doped 5CB is exposed to butylamine 
vapor. 
 





Figure 3.7 ESI-MS spectrometry of 5.0 wt% LA-doped 5CB after exposing to 
butylamine vapor for overnight. 
 
To study the kinetics of the response, the LA doping concentration was 
fixed at 0.1 and 1.0 wt%, respectively, and the light intensities of LC sensor 
were recorded after the exposure. Figure 3.8A shows that when the LA doping 
concentration is 0.1 wt%, the light intensity of LC sensor decreases after the 
sensor is exposed to 10 ppmv of butylamine vapor, and the bright-to-dark 
optical transition is completed after 2 min.  After removing the LC sensor 
from the gas chamber and left the sample in open air, the optical image of the 
LC sensor changes gradually from dark to bright (~92.9% of the initial light 
intensity) in 30 min. Next, we repeated the same experiment for another 2 
cycles, and we found that the optical image of the LC sensor changes from 
bright to dark again upon exposure to 10 ppmv of butylamine. We also noticed 
that the optical image of the LC sensor only changes back to bright partially, 
and the light intensity only reaches 67.4% of the initial intensity after 3 
exposure cycles to butylamine. Figure 3.8B shows that when the LA 
concentration is 1.0 wt%, the light intensity of the LC sensor also decreases 
after exposure to 20 ppmv of butylamine, but it takes almost 10 min before the 
optical appearance of the LC sensor becomes completely dark. Subsequently, 
 




we removed the LC sensor from the chamber and left it in the open air. After 
that, the optical images gradually changes from dark to bright in 60 min. This 
reversible response can be attributed to the hydrolysis of imine in a moist 
environment (e.g. 5CB is known to contain up to 1% water 254-256). We point 
that the reversibility of imine formation reaction is advantageous in this case 
because this sensor can be used repeatedly. In Figure 3.8, we also notice that 
the optical response of LC sensors doped with 0.1 wt% LA is faster than the 
one doped with 1.0 wt% LA. This is because in the former case, very low 
concentration of the imine product can trigger orientational transition of LC at 
the LC/glass interface whereas in the latter case, LA in 5CB needs to be 
depleted with amine vapor before the optical response can be seen. After 5 
cycles of exposure to butylamine, only 27.6% of the initial light intensity 
recovers in 30 min. We propose this is caused by the accumulation of imine at 
glass slide surface. Because the performance is too poor, we did not continue 
the regeneration for more than 5 cycles. 
 
Figure 3.8 Reversible optical responses of the LC sensors to butylamine with 
(A) 0.1 wt%, and (B) 1.0 wt% of doping LA concentration in LC. Butylamine 
concentrations are 10 ppmv and 20 ppmv, respectively. The light intensity is 
the average value of nine compartments in a copper grid. 
 
 




3.3.3 Specificity of the LC-based Optical Sensors to Other Volatile 
Compounds 
To study the specificity of the sensor, we exposed the LC-based sensor 
(doped with 0.1 and 1.0 wt% LA in LC) to 1000 ppmv of water, ethanol, 
acetone, hexane, 200 ppmv of DIPA, and 20 ppmv of octylamine vapors, 
respectively. 
 
Figure 3.9 Optical images of the optical sensors with LA doping 
concentration of 0.1 wt% (above) and 1.0 wt% (below) in LC after the 
samples were exposed to 1000 ppmv of water, ethanol, acetone, and hexane, 
200 ppmv of DIPA, and 20 ppmv of octylamine vapors respectively. All the 
images were taken after the samples are stabilized for 1h at room temperature. 
Scale bar, 250 μm. 
 
 Figure 3.9 shows that the sensor does not respond to water, ethanol, 
acetone, and hexane, but it responds to all amine vapors including octylamine 
(a primary amine), and DIPA (a secondary amine). The reaction of octylamine 
with LA is similar to that of butylamine, but the reaction of DIPA with LA is 
different. This reaction produces enamine. However, the response takes 1 h, 
which is much longer than that of butylamine or octylamine (within 2 min). 
The optical appearance of LC for 1.0 wt% of LA and 200 ppmv of DIPA is 
only partially dark. This is because the orientational transition of LC is more 
 




difficult to take place at LC/air interface. This result suggests that the reaction 
with a secondary amine is much slower. These results, when combined, 
suggest that the LC-based gas sensor has good specificity toward all amine 
vapors.  
3.3.4 Comparison Between LC Sensor to Other Sensors 
The performance of LC sensor and other sensors in LOD is compared 
in Table 3.1. The LOD of this LC-based sensor is much higher than other 
analytical methods. However, the LOD of this LC sensor is comparable to 
other visual sensors by using polymer stabilized cholesteric liquid crystal. 
Table 3.1 Comparison of LODs between LC sensors and other sensors 
Sensors LOD Reference 
LC sensor 10 ppmv This work 
GC/MS 45 ppbv Kuwata et al.257 
HPLC/MS 1 nM Hansen et al.258 
electrochemical 1.15 nM Hidayat et al.15 
QCM 7.14 µL/L Wang et al.19 
spectrophotometery 0.3 mM Mohr et al.22 
conducting polymer 700 ppbv Sotzing et al.26 
cholesteric liquid crystal 3000 ppmv Kirchner et al.31 
polymer stabilized 
cholesteric liquid crystal 
2 ppmv Sutarlie et al.32 
 





In this chapter, we successfully developed an LC-based gas sensor for 
detecting butylamine vapor. LA is doped into LC to react with butylamine, 
and renders specificity to the gas sensor. Bright-to-dark optical response can 
be observed under crossed polarizers when the sensor is exposed to 
butylamine vapor. This optical response is caused by the orientational 
transition of LC at LC/glass or LC/air interfaces. The detection limit of this 
sensor depends on the LA doping concentration. This sensor is able to detect 
10 ppmv of butylamine within 2 min when 0.1 wt% LA is doped in LC. This 
novel LC-based optical sensor provides a new mechanism for the detection of 
gaseous amines in the air. However, the poor selectivity among other amines 
would limit the potential application of this LC sensor. To improve the 
selectivity, more selective sensing layer materials are need. We also point out 
that this LC sensor is a “Yes/No” sensor, which is difficult to find a linear 
optical signal change in a concentration dependent manner. 
 
 







OLIGOPEPTIDES FUNCTIONALIZED SURFACE PLASMON 
RESONANCE BIOSENSORS FOR DETECTING THIACLOPRID AND 
IMIDACLOPRID 
In this chapter, we aim to develop an SPR biosensor for detecting 
thiacloprid and imidacloprid. In Chapter 3, we have developed an LC-based 
sensor by doping a functional molecule, lauric aldehyde, to render specificity 
for detecting butylamine. However, doping of functional molecules is not 
applicable for the target molecules without specific functional groups to react 
with dopant. Besides, thiacloprid and imidacloprid do not disrupt liquid crystal 
orientation easily. Therefore, LC-based sensors are not suitable for detecting 
such molecules. To address this problem, we propose to use surface plasmon 
resonance (SPR) as a sensing platform to detect thiacloprid and imidacloprid 
because SPR is a label-free and sensitive method to detect surface bound mass. 
To render specificity, we aim to employ oligopeptides to serve as sensing 
layers. These oligopeptides will be identified by using phage display screening, 
and their cross-binding activities will be evaluated by using both fluorescence 
and SPR. Last, the identified oligopeptide will be immobilized on SPR sensor 









Neonicotinoids such as thiacloprid and imidacloprid are a class of 
small molecules which have molecular structures similar to nicotine. 
Therefore, they are able to block nicotinic acetylcholine receptors in the 
central nervous system of insects and act as pesticides 35, 259, 260. While the use 
of neonicotinoids has greatly improved crop production, abuse of these 
pesticides may cause potential risk to consumers and the environment. As a 
result, the maximum allowable thiacloprid or imidacloprid residues have been 
regulated by European Union (EU), ranging from 0.01 to 3 mg/kg for many 
fruits and vegetables 53. Detection of neonicotinoids can be accomplished by 
using standard analytical methods such as GC/MS 48-50 or LC/MS 53, 54. 
Recently, using ELISA for the detection of neonicotinoids, such as 
imidacloprid 65-67 and thiamethoxam 68 was also reported. These ELISA-based 
methods show decent selectivity and sensitivity (μg/L); however, the 
production of antibodies is time-consuming and expensive, and the batch-to-
batch variation is a concern. Furthermore, small molecules such as 
neonicotinoids do not trigger immune reaction in animal’s body easily 71, 72. 
These issues hinder the widespread use of ELISA for routine analysis of 
neonicotinoids.  
To develop a biosensor which can be used to detect and differentiate 
different types of neonicotinoids without using antibodies, the greatest 
challenge is how to design a neonicotinoid receptor which can bind to a 
particular neonicotinoid molecule with superior specificity. In the past, several 
groups have attempted to design sensing layers by using molecular imprinting 
 




techniques 93, 261. For example, Bi et al. 93 reported a two-dimensional 
molecular imprinted monolayer of alkanethiol which can recognize 
imidacloprid and thiacloprid. However, the mechanism of recognition sites of 
this molecular imprinting method is based only on differences in the size and 
shape of template molecules. As a result, some cross-binding still occurs 
because of the close similarity of neonicotinoid molecules. In contrast, 
synthetic oligopeptides can be used to mimic the binding domain of the 
antibody, and their sequence can be tailored to bind to a wide range of target 
molecules such as biomolecules 262-264, trinitrotoluene (TNT) 117, 118 or 2,4-
dinitrotoluene (DNT) 265. Compared to more complex antibody molecules, 
short oligopeptides have several potential advantages for the development of 
biosensors. For example, oligopeptides are more stable and resistant to harsh 
environments, and they can be synthesized with desired sequences 73, 115. 
Furthermore, additional amino acids (such as cysteine) can be incorporated 
into oligopeptides sequences to control its immobilization on solid surfaces 117, 
or obtain a desired orientation upon immobilization 119. 
Herein, inspired by the high specificity of neonicotinoid receptors to 
neonicotinoid in the central nervous system of insects 260, 266, we indentified 
two 12-mer oligopeptides which bind specifically to thiacloprid and 
imidacloprid, respectively, by using modified phage display library 118, 129, 131, 
267. In this phage display library, we used solid crystals of thiacloprid and 
imidacloprid (instead of coated petri dish) as targets because both thiacloprid 
and imidacloprid have low solubility in water. Thus, unbound phage can be 
washed out easily without losing thiacloprid and imidacloprid during 
screening. To the best of our knowledge, this is the first study showing that 
 




oligopeptide fragments can be used as a bio-recognition element for 
neonicotinoids. 
 
4.2 Experimental Section 
Materials 
Thiacloprid and imidacloprid were purchased from Fluka (Singapore). 
Ph.D.-12 phage display library kit was purchased from New England Biolabs 
(U.S.A). Luria broth base was purchased from Invitrogen (Singapore). Agar, 
isopropyl β-D-thiogalactoside (IPTG), Ethylenediaminetetraacetic acid 
(EDTA), polyethylene glycol (PEG, MW = 8000 g/mol), glycine, bovine 
serum albumin (BSA), Tween-20, fluorescein isothiocyanate isomer I (FITC), 
sodium hydroxide, sodium azide and sodium iodide were purchased from 
Sigma (Singapore). Sodium chloride (99.8%) was purchased from GCE 
Laboratory Chemicals (Singapore). 5-bromo-4-chloro-3-indolyl-β-D-
galactoside (X-gal) was purchased from Duchefa (Netherland). Tris buffer 
(1M, pH 8.0), phosphate buffer saline (PBS buffer, 10X) and sodium dodecyl 
sulfate (SDS) were purchased from 1st Base. Ethanol (AR grade) and 
hydrochloric acid (37%, fuming) were purchased from Merck (Singapore). 
Spectra/Por dialysis membrane (MWCO: 1000 Da) was purchased from Fisher 
Scientific (Singapore). Oligopeptides RKRIRRMMPRPS (P1), 
RNRHTHLRTRPR (P2), CGGGRKRIRRMMPRPS (Cys-P1) and 
CGGGRNRHTHLRTRPR (Cys-P2) were synthesized by Sigma-Aldrich with 
a purity ≥ 95%. BIAcore sensor chip Au (untreated gold surface), borate 
buffer (10 mM disodium tetraborate, pH 8.5, and 1 M NaCl), glycine-HCl (10 
 




mM glycine-HCl, pH 2.0), HBS-EP buffer (0.01 M HEPES, pH 7.4, 0.15 M 
sodium chloride, 3 mM EDTA, and 0.005% v/v surfactant P20) was purchased 
from GE Healthcare (Singapore). Deionized water (18 MΩ-cm) was obtained 
from a Millipore filtration system. 
 
Phage display 
Figure 4.1 is a schematic showing a standard protocol of phage display 
library employed in this study.  Briefly, 10 μL of phage library (1.5×1013 
pfu/mL, complexity 2.7×109) was added to 1.5 mL of 0.1 % TBST buffer 
which contains 50 mM of Tris-HCl (pH 7.4), 150 mM NaCl, and 0.1% v/v of 
Tween-20. Then, this solution was mixed with 5 mg of crystalline 
neonicotinoids (either thiacloprid or imidacloprid) and incubated under 
vigorous shaking. The size of the crystalline neonicotinoids ranges from 50 to 
500 µm.  Because the solubility of neonicotinoids is very low (0.185 mg/mL 
and 0.51 mg/mL for thiacloprid and imidacloprid, respectively), we used 
neonicotinoid crystals in the phage display instead of plate-coating methods, 
which are commonly used for immobilization of protein targets in the 
conventional biopanning procedures. After 30 min, the buffer solution was 
decanted, and the neonicotinoid crystals were washed with 2 mL of fresh 0.1% 
TBST buffer 10 times to remove non-specific adsorbed phages. Bound phages 
were eluted with 1 mL of 0.2 M glycine-HCl (pH 2.2), 1 mg/mL of BSA, and 
the solution was neutralized with 150 μL of 1 M Tris-HCl (pH 9.1). Next, the 
eluted phages were amplified with 20 mL of early-log phase Escherichia coli 
(E. coli) culture (ER2738) for 5 h at 35°C under vigorous shaking. The phage-
 




infected E. coli culture was centrifuged twice at 10,000 rpm for 10 min to 
remove cell debris of E. coli, and the supernatant containing amplified phages 
was collected. After that, 4 mL of PEG/NaCl solution (20% w/v PEG-8000, 
2.5 M NaCl) was added to the supernatant, and this solution was incubated at 
4°C. After 2h, the solution was centrifuged for 15 min at 10,000 rpm at 4°C to 
precipitate phages. The pellet containing phages were dissolved in 1 mL of 
TBS buffer containing 0.02% of NaN3. The amplified phages were titered on 
LB/IPTG/Xgal plates as recommend by the supplier (New England Biolabs), 
and the number of blue plaques was counted. This panning procedure was 
repeated for two more rounds by using the amplified phages eluate from the 
previous round as input phages to the subsequent round of panning. For the 
second and third round of screening, the concentration of Tween-20 was 
increased to 0.3% (v/v) and 0.5% (v/v), respectively, to increase stringency of 
binding to thiacloprid or imidacloprid targets.  
 
DNA sequencing 
The phages after three rounds of panning against thiacloprid or 
imidacloprid were purified with plate titering. First, we cultured uninfected E. 
coli overnight. Then, the culture was diluted (1:100) with LB medium. Then, 
the diluted culture was dispensed into 12 culture tubes (1.5 mL for each tube). 
Subsequently, a blue plaque was picked from the LB/IPTG/Xgal plate, and 
transferred to each culture tube. These tubes were incubated at 35°C under 
vigorous shaking, allowing the phage to infect E. coli. After 5 h, the phage-
containing cultures in these tubes were centrifuged twice at 10,000 rpm at 4°C 
 




(each time for 10 min) to remove E. coli cell debris. Subsequently, 1 mL of the 
supernatant was transferred to a microcentrifuge tube, and 400 μL of 
PEG/NaCl solution (20% (w/v) PEG-8000, 2.5 M NaCl) was added and 
incubated for 2 h at 4°C. After that, the solution was centrifuged at 10,000 rpm 
for 10 min and the phage was precipitated as a pellet. To extract phage DNA, 
the pellet was dissolved in 100 μL of iodide buffer (10 mM Tris-HCl, pH 8.0, 
1 mM EDTA, 4 M NaI) and 250 μL of ethanol. After incubation for 10 min, 
the DNA of phages was precipitated by centrifugation at 12,000 rpm for 15 
min. Then, the DNA was resuspended in 100 μL of TE buffer (10 mM Tris-
HCl, 1 mM EDTA, pH 8.0). The purified DNA from 12 single-clone phages 
was sequenced by AIT Biotech (Singapore) using the -96gIII sequencing 
primer provided in the Ph.D.-12 phage display kit. Finally, the oligopeptide 
sequence can be deduced according to codon table.  
 
Fluorescence test for binding specificity 
Two custom synthesized oligopeptides, RKRIRRMMPRPS (P1) and 
RNRHTHLRTRPR (P2), were labeled with FITC. First, 40 μM of 
oligopeptide (P1 or P2) was incubated in PBS buffer (pH 7.4) containing 10 
μg/mL of FITC for 2 h at room temperature. Subsequently, the FITC-labeled 
oligopeptide was dialyzed against fresh PBS buffer to remove unreacted FITC 
by using a dialysis membrane (MWCO: 1000 Da). Next, we added 5 mg of 
either thiacloprid or imidacloprid crystal into 200 μL of solution containing 
FITC-labeled P1 or P2. The solution was then shaken vigorously on a rocking 
platform for 30 min. After that, the thiacloprid and imidacloprid crystals were 
 




washed with 1% SDS solution for 5 times to remove unbound oligopeptides. 
Finally, fluorescence images of these crystals were taken by using a 
fluorescent microscope (Eclipse E200, Nikon) equipped with mercury lamp 
(Intensilight, Nikon). The exposure time was 1 s for all fluorescence images. 
 
Figure 4.1 Schematic illustration of the phage display screening protocol for 
identifying peptides binding to thiacloprid or imidacloprid molecules. (1) A 
phage library is incubated with molecular forms of neonicotinoids (thiacloprid 
or imidacloprid), (2) washing with TBST buffer to remove non-specific bind 
phages, (3) elute the binding phages by lowering the pH, (4) amplify the 
eluted phage with E. coli culture, (5) repeat the screening with amplified 
phage another two times for the strongest binding phages, (6) purification of 
phage colony with plate titering, (7) DNA sequencing. 
 
Liquid crystal sensors for detecting thiacloprid and imidacloprid 
To immobilize oligopeptides CGGGRKRIRRMMPRPS (Cys-P1) and 
CGGGRNRHTHLRTRPR (Cys-P2) on glass slide, 0.6 μL of carbonate buffer 
(50 mM of NaHCO3, pH 10.0 with 100 mM of MgCl2 and 10 mM of 
NaBH3CN) containing 100 μg/mL of Cys-P1 or Cys-P2 was spotted on an UV-
modified DMOAP-coated glass slide. After UV activation, the inert DMOAP 
 




surface is modified with aldehyde groups. Then the Cys-P1 or Cys-P2 is 
immobilized onto the glass slide surface by nucleophilic addition of thiolates 
(from cysteine motif) to surface aldehyde groups. After 2 h, the solution was 
rinsed with copious DI water and PBS buffer containing 0.05% v/v of Tween-
20, and then blown dry with nitrogen gas. Next, the oligopeptide immobilized 
glass slides were incubated in PBS buffer solution (pH 7.4) containing 
saturated thiacloprid or imidacloprid. After 30 min, the glass slides were 
rinsed with copious DI water to remove unbound neonicotinoids. This slide 
was paired with a DMOAP-coated slide to make a LC cell (thickness ∼6 μm). 
Approximately 5 μL of liquid crystal 5CB was drawn into the cavity via 
capillary force. Optical appearances of the samples were observed by using a 
polarizing optical microscope (Nikon Eclipse LV100POL, Japan) in the 
transmission mode. Each image was captured with a digital camera mounted 
on the microscope with an exposure time of 40 ms. 
 
Immobilization of oligopeptides on SPR sensor chip 
Oligopeptides Cys-P1 and Cys-P2 were also synthesized for SPR 
experiments. CGGG was added to the NH2-terminus of the original 
oligopeptide to provide an anchoring point (through cysteine) and a spacer. To 
immobilize the oligopeptides, borate buffer (10 mM disodium tetraborate and 
1 M NaCl, pH 8.5), containing 0.1 mg/mL of either Cys-P1 or Cys-P2, was 
injected slowly (1 μL/min) into a flow cell (FC-1 or FC-2) on a gold sensor 
chip (BIAcore) for 60 min. Then, the flow cell was flushed with fresh HBS-EP 
buffer (2 μL/min) for 60 min to remove unreacted oligopeptides. To increase 
 




the surface density of immobilized oligopeptides, the concentrations of Cys-P1 
and Cys-P2 were increased to 1.0 mg/mL, and the injection time was increased 
to 325 min for FC-3 and FC-4 flow cells.  
 
SPR experiment 
HBS-EP buffer containing 10 μM of thiacloprid was injected into a 
flow cell functionalized with Cys-P1 (FC-1) at 2 μL/min for 5 min. 
Subsequently, the flow cell was flushed with fresh HBS-EP buffer for 15 min 
to remove unbound thiacloprid. After that, the Cys-P1 functionalized surface 
was regenerated by flowing glycine-HCl (pH 2.0) buffer for 1 min (5 μL/min) 
to remove the bound thiacloprid. We refer to the three steps above (injection, 
flushing, and regeneration) as one “binding cycle”. In control experiment, 
HBS-EP buffer containing 100 μM thiacloprid or imidacloprid was injected 
into the non-functionalized bare gold surface of the sensor chip. HBS-EP 
buffer containing 100 μM of acetamiprid was also injected into the SPR sensor 
chip modified with Cys-P1 and Cys-P2, respectively. To test the cross-binding, 
HBS-EP buffer containing 10 μM of imidacloprid was injected into FC-1 with 
the same parameters as described above. Similarly, we repeated the same 
experiment by using another flow cell (FC-2) functionalized with Cys-P2, as 
shown in Figure 4.2. 
Next, HBS-EP buffer with increasing thiacloprid concentrations (2, 10, 
20, 40, 60, 80, and 100 μM) were injected sequentially into FC-1 (or FC-3) at 
a flow rate of 2 μL/min. Each injection step took 5 min. Similarly, after each 
injection, the flow cell was flushed with fresh HBS-EP buffer for 15 min to 
 




remove unbound thiacloprid, followed by glycine-HCl (pH 2.0) for 1 min (5 
μL/min) to regenerate the sensor chip. All experiments were repeated three 
times and the average binding responses were calculated and plotted. The 
same experiments were repeated for imidacloprid by using FC-2 (or FC-4). 
 
Figure 4.2 Schematic illustration for the design of each flow cell on SPR 
sensor chip. 
 
4.3 Results and Discussion 
4.3.1 Phage Display Results 
Table 4.1 shows the result of the screening experiments when two 
neonicotinoids, thiacloprid and imidacloprid, were used as target molecules 
after 3 rounds of panning. When thiacloprid was used, 5 (out of 12) colonies 
displayed oligopeptide RKRIRRMMPRPS (P1), and 2 colonies displayed 
TNLKSIRRPQIP. Interestingly, 7 out of 12 of the oligopeptides have Ile-Arg-
Arg (IRR) and one oligopeptide has Ile-Arg-Gln (IRQ) in their sequences. We 
point out that arginine (R) and glutamine (Q) have similar side chains and 
similar hydrophobicity at pH 7.0 268. Therefore, IRR or IRQ is most likely to 
 




be responsible for the binding of thiacloprid. In contrast, when imidacloprid 
was used, 6 (out of 12) colonies displayed oligopeptide RNRHTHLRTRPR 
(P2), and 2 displayed RRPKRKHRMHLS. Among all imidacloprid binding 
oligopeptides, 7 out of 12 of the oligopeptides show Arg-Pro-Arg (RPR) in 
their sequences, and 3 other oligopeptides have Arg-Pro-Lys (RPK). Because 
arginine (R) and lysine (K) exhibit similar side chains and similar 
hydrophobicity 268 at pH 7.0, RPR or RPK is the potential sequence to bind 
imidacloprid. We also noticed in both P1 and P2, highly positively charged 
amino acids (R and K) are abundant, showing that electrostatic interactions 
may be important for the binding of P1 (or P1) to thiacloprid (or imidacloprid). 
Tomizawa et al.260 reported K and R moieties are abundant in the 
neonicotinoid binding region of the insect nicotinic acetylcholine receptors 
(nAChR). Interestingly, from our phage display result, R and K are also 
abundant. However, although there are some homologies between the 
identified oligopeptides and the insect nAChR, the details in binding 
mechanism is still unknown. The average hydrophilicity of each oligopeptide 
is calculated by using a hydropathy scale, as shown in Table 4.2. The 
hydrophobic ratio is the percentage of hydrophobic amino acids whose 
hydropathy value is positive in a hydropathy scale. Although the nature of the 
peptide-neonicotinoid binding is still not completely understood, we 
hypothesize that the abundant amino acid residues, IRR or RPR, are 
responsible for the binding. However, they do not always appear at the N-
terminus of the oligopeptides, sometimes they also appear in the middle, or the 
C-terminus of oligopeptide sequence. This is different from previously 
reported results 118. Moreover, we notice that the two most abundant  
 




Table 4.1 Oligopeptide sequences and physical properties* identified from 
phage screening experiments against thiacloprid and imidacloprid after 3 
panning rounds   
Oligopeptide 







Thiacloprid     
RKRIRRMMPRPS 13  1.2 42% 5/12  
TNLKSIRRPQIP 12.4 0.3 50% 2/12 
LRKRNNPIRTKM 12.7 0.8 42% 1/12 
SSTRMISIRQST 12.4 0.1 42% 1/12 
KMPRQSNRRLMM 12.7 0.6 42% 1/12 
RHLQTSPIMLQI 11 -0.5 67% 1/12 
RHTNSTRLNRPT 12.7 0.5 50% 1/12 
Imidacloprid     
RNRHTHLRTRPR 13 1 50% 6/12 
RRPKRKHRMHLS 12.9 1.2 42% 2/12 
ISKHTPLRTRPR 12.7 0.6 58% 1/12 
RRPKRQHTMQLS 12.7 0.7 42% 1/12 
SMRMRIHIPSSH 12.4 0 58% 1/12 
RQIIQPSPKQRR 12.7 0.8 33% 1/12 
* The physical properties of oligopeptides, including pI, net charge, average 
hydrophilicity, and hydrophilic ratio are calculate from peptide property 
calculator: http://www.innovagen.se/custom-peptide-synthesis/peptide-
property-calculator/peptide-property-calculator.asp (accessed on June 28, 
2011).  
 
oligopeptides (RKRIRRMMPRPS (P1) and RNRHTHLRTRPR (P2)) show 
certain similarities in their sequences. For example, the positively charged 
 




residues, such as R, K, and H, are abundant. On the other hand, residues that 
heavily negatively charged, such as E and D, are absent. Table 4.1 also shows 
that the pI values and average hydrophilicity of P1 and P2 are similar. Because 
of the high abundance of these two oligopeptides P1 and P2, they are chosen as 
the best molecular receptors for binding thiacloprid and imidacloprid, 
respectively. 
Table 4.2 Amino acid hydropathy scale 
Amino Acid One Letter Code Hydropathy Score 
Isoleucine I 4.5 
Valine V 4.2 
Leucine L 3.8 
Phenylalanine F 2.8 
Cysteine C 2.5 
Methionine M 1.9 
Alanine A 1.8 
Glycine G -0.4 
Threonine T -0.7 
Tryptophan W -0.9 
Serine S -0.8 
Tyrosine Y -1.3 
Proline P -1.6 
Histidine H -3.2 
Glutamic acid E -3.5 
Glutamine Q -3.5 
Aspartic acid D -3.5 
Asparagine N -3.5 
Lysine K -3.9 
Arginine R -4.5 
 
 





Figure 4.3 Fluorescent images of thiacloprid and imidacloprid powders bind 
to oligopeptide P1 and P2, respectively. 
 
4.3.2 Fluorescent Test for Binding Specificity 
To test their specificity for binding their neonicotinoid targets, 
thiacloprid powder was incubated in PBS buffer (pH 7.4) containing 40 μM of 
either FITC-labeled P1 or P2 with vigorous shaking. After 2h, the solution was 
decanted, and the neonicotinoid solid was washed with 1.0% SDS for 5 times 
to remove unbound oligopeptides. Figure 4.3 shows that only P1 can bind to 
thiacloprid and gives green fluorescence, whereas P2 cannot bind to 
thiacloprid and no fluorescence can be observed. In contrast, when solid 
imidacloprid powder was used in the binding experiment, only P2 can bind to 
its surface and gives green fluorescence. This experiment suggests that 
oligopeptides P1 and P2 can bind to their respective targets specifically, and 
the cross-binding is minimal despite the similarity of P1 and P2. As mentioned 
earlier, this excellent binding specificity may come from IRR or RPR residues 
in P1 and P2, and some other factors, including charge distribution and polarity 
 




of these two oligopeptides. For example, both thiacloprid and imidacloprid 
have a negatively charged tip, such as cyano group or nitro groups, which can 
interact favorably with the positively charged amino acid residue (R and K) 
distributed on P1 or P2. However, the exact mechanism has not been confirmed 
yet. More experiments are needed to shed lights on the specificity.   
 
4.3.3 LC Sensors to Detect Thiacloprid and Imidacloprid 
To test the feasibility of using LC for label-free detection of thiacloprid 
and imidacloprid, the oligopeptide modified glass slides were incubated in 
PBS buffer solution containing saturated thiacloprid and imidacloprid. Figure 
4.4 shows that the optical images of LC sensors are all dark even the 
oligopeptides are incubated in saturated solution of thiacloprid and 
imidacloprid, suggesting that thiacloprid and imidacloprid cannot disrupt LC 
orientation easily. 
 
Figure 4.4 Optical appearance of LC sensor after incubating in PBS buffer 
solution containing saturated (A) thiacloprid and (B) imidacloprid. The 
circular areas are immobilized with 100 µg/mL of Cys-P1 and Cys-P2. 
 
 




4.3.4 SPR Measurement 
To design a biosensor for detecting thiacloprid by using SPR, a slightly 
different oligopeptide with a sequence of CGGGRKRIRRMMPRPS (Cys-P1) 
was synthesized. After immobilization of Cys-P1 on a sensor chip, SPR shows 
an increase of 50.2 resonance units (RU), corresponding to a surface density of 
0.016 molecule/nm2 on the surface (In BIAcore SPR system, a response of 
1000 RU corresponds to a change in surface density of about 1 ng/mm2 269). In 
contrast, when RKRIRRMMPRPS (P1) is used, the SPR signal only increases 
by 5 RU. These results suggest that Cys-P1 is immobilized on the gold sensor 
chip through the formation of an Au-S bond on the surface. To detect 
thiacloprid, 10 μM of thiacloprid solution was injected into the same flow cell 
at 2 μL/min. Sensorgram in Figure 4.5A shows that after one binding cycle, a 
net increase of 5.8 RU caused by the formation of oligopeptide (Cys-P1)-
thiacloprid complex on the surface can be observed. In contrast, when 10 μM 
of imidacloprid is used during the binding cycle, the net increase in the final 
response is negligible. This phenomenon indicates that imidacloprid cannot 
bind to Cys-P1 despite the similar molecular structures between thiacloprid 
and imidacloprid. Furthermore, nonspecific adsorption of thiacloprid or 
imidacloprid on a bare-gold SPR sensor chip, was also tested. Our result 
shows that the nonspecific binding is negligible, probably because both 
thiacloprid and imidacloprid are small molecules, they do not adsorb on solid 
surfaces like proteins. 
Figure 4.5B shows the binding curve for thiacloprid from 2 to 100 µM. 
We notice that when the bulk concentration of thiacloprid increased to 60 μM, 
 




the binding curve reaches plateau, indicating that the binding sites of 
immobilized Cys-P1 for thiacloprid are saturated. In the BIAcore SPR system, 
a response of 1000 RU corresponds to a change in surface density of about 1 
ng/mm2 269. In this case, we can calculate the surface mass density (Δm/A) of 
thiacloprid molecules that bind to surface immobilized oligopeptide. Then, 
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(4.1) 
where Δmmax/A is the maximum mass density, and C is the thiacloprid 
concentration in the bulk. We obtained a dissociation constant (KD) of 9.3 μM 
for thiacloprid by using least-squares fitting method (Bi and Yang, 2009).  
 
Figure 4.5 (A) Response of a Cys-P1 modified SPR gold chip to 10μM of 
thiacloprid (solid) and 10μM of imidacloprid (dashed), and (B) Binding curve 
of Cys-P1 modified SPR gold chip to HBS-EP buffer containing thiacloprid 
with concentration of 2, 10, 20, 40, 60, 80, and 100 μM. The error bars 
represent the standard deviation of three measurements. 
 
To detect imidacloprid, we synthesized oligopeptide Cys-P2, with a 
sequence of CGGGRNRHTHLRTRPR, and immobilized it on a sensor chip 
 




with a surface density of 0.022 molecule/nm2 (Net signal increase of SPR is 
72.6 RU after immobilization.). Then, we repeated the same binding 
experiment with 10 μM of imidacloprid as binding targets. Sensorgrams in 
Figure 4.6A show that imidacloprid molecules can bind to Cys-P2 
immobilized surface, and causes a net increase of 6.2 RU. In contrast, when 10 
μM of thiacloprid was used, the net increase in the binding signal is negligible. 
Therefore, we can conclude that thiacloprid cannot bind to Cys-P2. Figure 
4.6B also shows the sigmoidal correlation between the SPR binding signals 
and the imidacloprid concentration. Similarly, we obtained a dissociation 
constant (KD) of 11.5 μM for imidacloprid from Langmuir adsorption isotherm 
by using least-squares fitting method.  
 
Figure 4.6 (A) Response of a Cys-P2 modified SPR gold chip to 10μM of 
thiacloprid (solid) and 10μM of imidacloprid (dashed), and (B) Binding curve 
of Cys-P2 modified SPR gold chip to HBS-EP buffer containing imidacloprid 
with concentration of 2, 10, 20, 40, 60, 80, and 100 μM. The error bars 
represent the standard deviation of three measurements. 
 
Furthermore, in a control experiment, nonspecific adsorption of 
thiacloprid or imidacloprid on a bare-gold SPR sensor chip, was also tested. 
Table 4.3 shows that the nonspecific binding is negligible. This low 
 




nonspecific adsorption probably owes to the Surfactant P20 (0.005% v/v) in 
HBS-EP buffer. Because both thiacloprid and imidacloprid are small 
molecules, they do not adsorb on solid surfaces like proteins. In a negative 
control, a molecule other than thiacloprid and imidacloprid was also tested. 
When 100 µM of acetamiprid (another neonicotinoid analog) was injected into 
Cys-P1 and Cys-P2 modified SPR sensor chip, the SPR signal is minimal, 
showing that acetamiprid cannot bind to Cys-P1 or Cys-P2. 
Table 4.3 SPR responses in control experiments 
Surface modification  Target SPR response (RU) 
bare gold thiacloprid (100 µM) -1.8 
bare gold imidacloprid (100 µM) -0.7 
Cys-P1 acetamiprid (100 µM) -1.2 
Cys-P2 acetamiprid (100 µM) 0.6 
 
     
Figure 4.7 (A) The relationship of SPR final responses when HBS-EP buffer 
containing thiacloprid with concentration of 2, 10, 20, 40, 60, 80, and 100 μM 
flows over Cys-P1 modified surface. (B) The relationship of SPR final 
responses when HBS-EP buffer containing imidacloprid with concentration of 
2, 10, 20, 40, 60, 80, and 100 μM flows over Cys-P2 modified surface. The 
error bars represent the standard deviation of three measurements. 
 
 




Next, we noticed that when the bulk concentration of thiacloprid or 
imidacloprid is 60 μM, the binding signal has reached a plateau, indicating 
that the surface binding sites have been saturated. In this case, the linear 
response range to thiacloprid and imidacloprid is small. To address this issue, 
we increased the surface densities of immobilized Cys-P1 and Cys-P2 to 0.47 
molecule/nm2 and 0.60 molecule/nm2, respectively (After immobilization, the 
net signal increase of SPR are 1455.1 RU and 1864.2 RU, respectively). 
Figure 4.7 shows the SPR response to thiacloprid and imidacloprid from 2 to 
100 µM. In this case, the surface is not saturated even when the concentration 
is as high as 100 µM, which is close to the solubility of both compounds in the 
buffer solution. Since the response is linear in this range, we can estimate the 
sensitivity for thiacloprid and imidacloprid are 0.14 RU/μM and 0.16 RU/μM 
respectively. From Figure 4.7, we can also determine the LOD for thiacloprid 
and imidacloprid are 1.2 μM and 0.9 μM respectively. The LOD was 
determined by using the mean value of three measurements of blank samples 
plus three times of the standard deviation (SD) of the mean (LOD = Mean0 + 3 
SD0). The signal-to-noise ratio (S/N) at 2 µM was determined to be 5.1 and 
3.7 for thiacloprid and imidacloprid, respectively. The S/N at specific analyte 
concentration is defined by S/N= Mean/SD 
(http://calculator.tutorvista.com/signal-to-noise-ratio-calculator.html, accessed 
on August 20, 2014). Table 4.4 shows the comparison of LOD between the 
oligopeptide-based SPR sensors and other sensors such as GC, HPLC, and 
ELISA. Although our oligopeptide-based SPR sensors exhibit good binding 
specificity, the unfavorable LOD is still a concern compared to other sensors. 
This is because small molecules are difficult to generate detectable signal in 
 




SPR systems compared to proteins. Besides, this SPR sensor lacks an 
amplification mechanism like ELISA. 
Table 4.4 Comparison of LOD between oligopeptide-based SPR sensors and 
other sensors 
Target Sensors Sensing Material LOD Reference 
thiacloprid SPR RKRIRRMMPRPS 1.2 μM This work 
imidacloprid SPR RNRHTHLRTRPR 0.9 μM This work 
imidacloprid GC NPD1 9.8 nM Navalon et al.48 
imidacloprid HPLC DAD2 11.7 nM Ferrer et al.53 
acetamiprid ELISA Antibody 0.2 nM Watanabe et al.99 
imidacloprid ELISA Antibody 19.6 nM Lee et al.65 
thiamethoxam ELISA Antibody 0.3 nM Kim et al.68 
1 NPD: Nitrogen–phosphorus detector; 2 DAD: Diode-array detector 
4.4 Conclusions 
In conclusion, we successfully developed an SPR biosensor for 
detecting thiacloprid and imidacloprid. To render specificity, we identified 
two oligopeptides RKRIRRMMPRPS (P1) and RNRHTHLRTRPR (P2) by 
using phage display screening, and their binding capabilities for thiacloprid 
and imidacloprid were studied by using fluorescent and SPR. Surprisingly, 
despite the similar molecular structures between thiacloprid and imidacloprid, 
cross-binding of P1 and P2 to these two organic compounds is minimal. We 
believe that the abundant amino acid residues, IRR and RPR, are responsible 
for the binding. Next, P1 and P2 were immobilized on SPR sensor chip to 
fabricate a biosensor. The sensitivities for thiacloprid and imidacloprid are 
 




0.14 RU/μM and 0.16 RU/μM respectively, whereas the LODs are 1.2 μM and 
0.9 μM respectively. Oligopeptides identified in this study may also shed 
lights on the binding mechanism of neonicotinoids to nicotinic acetylcholine 
receptors. 
 







DEVELOPMENT OF AN OLIGOPEPTIDE FUNCTIONALIZED 
SURFACE PLASMON RESONANCE BIOSENSOR FOR ONLINE 
DETECTION OF GLYPHOSATE 
In this chapter, we aim to develop an SPR biosensor for online 
detection of glyphosate. In Chapter 4, we have developed an SPR biosensor 
for detecting thiacloprid and imidacloprid. In the biosensor, the sensing layers 
are oligopeptides which are identified by using phage display screening. 
However, this phage display screening protocol is not applicable for 
glyphosate because glyphosate is highly soluble in water, and the glyphosate 
target will be lost in the panning procedure. To address this problem, we aim 
to modify the phage display screening protocol by immobilizing glyphosate on 
glass beads, and then the glyphosate-immobilized glass beads are used for 
phage display screening. A “negative screening” of phage display will also be 
conducted to eliminate those phage binders to glass beads. To identify the 
oligopeptide that bind to glyphosate with highest binding affinity, a phage 
binding analysis will be conducted. Next, the identified oligopeptide will be 
immobilized on SPR sensor chip to fabricate a biosensor for online detection 
of glyphosate in buffer solution. The performances of SPR biosensor will also 
be investigated.  
  
 





Glyphosate (N-(phosphonomethyl)glycine) is a herbicide that is used to 
kill weeds in farms, parks and gardens 60. Glyphosate is toxic to plants because 
it can interfere the synthesis of aromatic amino acids, such as phenylalanine, 
tyrosine and tryptophan, by inhibiting the enzyme activity of 5-
enolpyruvylshikimate-3-phosphate synthase (EPSPS) 40. However, the 
widespread application of glyphosate has caused several problems. For 
example, residues of glyphosate in water may cause adverse effects on some 
aquatic plant species 43, 44. Recent studies also show that glyphosate is a 
potential endocrine disruptor 45. Currently, the maximum residue levels 
(MRLs) of glyphosate in United States and Canada are 0.70 μg/mL (4.14 μM) 
46 and 0.28 μg/mL (1.66 μM) 47, respectively. Therefore, monitoring of 
glyphosate in crops, fruits, vegetables, and drinking water has gained 
increasing importance. 
Among numerous analytical methods, high-performance liquid 
chromatography (HPLC) 55, 56 and gas chromatography-mass spectroscopy 
(GC-MS) 51, 52 are widely used for the detection of glyphosate and its main 
metabolite, aminomethylphosphonic acid (AMPA). However, to achieve the 
required limit of detection, derivatization of glyphosate to incorporate 
chromophores or fluorophores is often needed 57, 58. Some methods, such as 
coulometric 59, 60, capillary electrophoresis 61, 63, amperometry 62, and cyclic 
voltammetry 64, do not require the derivatization step, but these methods 
usually do not have high sensitivity and specificity. On the other hand, 
enzyme-linked immunosorbent assay (ELISA) can be used to detect 
 




glyphosate with high specificity. For example, Clegg et al. 69 used a 
competitive ELISA for the detection and quantitation of glyphosate with a 
detection limit of 7.6 μg/mL. Similarly, Rubio et al. 70 described an ELISA for 
the detection of glyphosate after it was derivatized with acetic anhydride. This 
ELISA has a detection limit as low as 0.6 ng/mL. Both methods show good 
specificity toward a wide range of agrochemicals and the cross-reactivity is 
less than 0.1%. However, a common problem in ELISA is the need to raise 
antibodies. Since glyphosate is a small molecule, it needs to be conjugated 
with bovine serum albumin (BSA) to form an immunogen which can elicit 
immune response in animals. The production of antibodies is time-consuming 
and expensive, and the batch-to-batch variation is a concern. Besides, despite 
their good binding affinity and specificity, the antibodies are vulnerable to 
environmental factors, especially high temperature 73.  
Oligopeptide is a good candidate to replace antibodies in immunoassay 
as a biomolecular receptor 73, 115. One important advantage for oligopeptides is 
that they are more stable and resistant to harsh environments 116. Secondly, it 
is easier to synthesize oligopeptides with desired sequences for binding 
specific targets 230. Previously, a large number of protein-binding oligopeptide 
sequences have been identified by using phage libraries. For example, Kim et 
al. 270 identified oligopeptides which bind to a cancer biomarker, tenascin C, 
by using phage library, and the selected oligopeptide can specifically 
recognize tenascin C protein in mouse tissue. Phage library was also employed 
to identify oligopeptides which bind to inorganic materials, such as ZnS 135, 
CdS 271, ZnO 272, and TiO2 273, and small organic molecules such as TNT and 
DNT 118. For example, Jaworski et al. 118 identified two oligopeptides that can 
 




specifically bind to TNT and DNT from phage library, and demonstrate that 
the oligopeptides embedded in a hydrogel can selectively bind to DNT 
molecules in gas phase. Cerruti et al. 117 demonstrated that the oligopeptides 
can be used as sensing layer for real-time detection of TNT in water using a 
quartz crystal microbalance (QCM). Recently, we have developed a SPR 
biosensor for the detection of two closely related neonicotinoids molecules, 
thiacloprid and imidacloprid 274. The main advantage of phage library is that 
they can be used to identify target-binding oligopeptides through screening. 
However, in the studies mentioned above, insoluble solids were used as 
binding targets during the screening procedure. Therefore, the original phage 
library is not suitable for molecules with high solubility such as thiamethoxam 
(TMX) or glyphosate. To overcome this problem, Cho et al. 275 reported a 
phage display in which saturated TMX solution was used to prevent the 
dissolution of TMX crystals. In another study, Cui et al. 276 immobilized 
octyltrimethoxysilane on a silicon wafer as the binding target. This study 
shows that M13 phage can recognize molecules immobilized on solid surface. 
They also introduced a “negative screening” method to eliminate those phages 
that bind to the substrate.  
Because glyphosate is highly soluble in water (10.1 mg/mL in water at 
20 °C), we modified the original phage library to overcome the high solubility 
issue. First of all, glyphosate was covalently immobilized on amine-
functionalized glass beads through EDC/NHS chemistry. The glass beads were 
used as a solid support to prevent the loss of glyphosate during screening 
procedures. Oligopeptides identified from phage library and their binding 
capabilities for glyphosate were characterized in details. We also developed a 
 




biosensor using SPR functionalized with the oligopeptides for on-line 
detection of glyphosate in buffer solution. 
 
5.2 Experimental Section 
Materials 
Glass slides and dialysis membrane (MWCO: 1000 Da) were obtained 
from Fisher (U.S.A). Glyphosate, thiacloprid, imidacloprid, and fluorescein 
isothiocyanate isomer I (FITC) were purchased from Sigma (Singapore). 
Glycine, cysteine, methanol (HPLC grade), and dimethyl sulfoxide (DMSO) 
were purchased from Merck (Singapore). Glass beads (Supelco, d=75 μm), N-
(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
Hydroxysulfosuccinimide sodium salt (Sulfo-NHS), Tween-20, (3-
aminopropyl)triethoxysilane (APES), sodium carbonate, agar, polyethylene 
glycol (PEG, MW = 8000 g/mol), and isopropyl β-D-thiogalactoside (IPTG) 
were purchased from Sigma (Singapore). Ph.D.-12 phage display library kit 
was purchased from New England Biolabs (U.S.A). Luria broth base was 
purchased from Invitrogen (Singapore). 5-bromo-4-chloro-3-indolyl-β-D-
galactoside (X-gal) was purchased from Duchefa (Netherland). Tris buffer 
(1M, pH 8.0), phosphate buffer saline (PBS buffer, 10X) and TE buffer (10 
mM Tris-HCl pH 8.0, 1 mM EDTA) were purchased from 1st Base. 
Oligopeptides TPFDLRPSSDTRGGGC (P1-cys) and 
TPFALAPSSATAGGGC (Pm-cys) (purity ≥ 95%) were synthesized by 
GenicBio (Shanghai, China). BIAcore gold sensor chip (uncoated), borate 
 




buffer (10 mM disodium tetraborate, pH 8.5, and 1 M NaCl), glycine-HCl (10 
mM glycine-HCl, pH 2.0), HBS-EP buffer (0.01 M HEPES, pH 7.4, 0.15 M 
sodium chloride, 3 mM EDTA, and 0.005% v/v surfactant P20) was purchased 
from GE Healthcare (Singapore). Deionized water (18 MΩ-cm) was obtained 
from a Millipore filtration system. 
 
Surface Functionalization of Glass Beads 
The schematic illustration for the functionalization of glass beads is 
shown in Figure 5.1. First, glass beads were functionalized with (3-
aminopropyl)triethoxysilane (APES). To clean the surface, 500 mg of the 
glass beads were immersed in a 5% Decon-90 solution (a commercially 
available detergent). After 2 h of constant shaking, the glass beads were 
sonicated in the solution for 15 min.  After this, they were rinsed with DI 
water and sonicated for 15 min twice. Clean glass beads were then rinsed with 
methanol twice, and dried at 50°C overnight. To silanize the glass beads, 50 
mg of the glass beads were incubated in 1 mL of aqueous solution containing 
90.4 mM of triethoxysilan APES at 50 °C under gentle rocking. After 1 h, the 
solution was decanted, and the glass beads were washed thoroughly with DI 
water and methanol to remove residual silanes. The APES-coated glass beads 
were heated in a 100°C vacuum oven for 15 min to allow the cross-linking of 
APES. To examine the surface density of amine groups, the APES-coated 
glass beads were incubated in sodium carbonate buffer (100 mM, pH 9.0) 
containing 10 μg/mL of FITC. After 1h, the glass beads were washed 
thoroughly with 0.1 wt% SDS solution and DI water to remove remaining  
 





Figure 5.1 Schematic illustration for the immobilization of glyphosate on 
amine-modified glass beads by using EDC/NHS chemistry. 
 
FITC. To observe fluorescent images, 2 μL of water containing suspended 
glass beads was dispensed onto a piece of glass slide. Fluorescent images of 
all samples were observed with a fluorescence microscope (Eclipse E200, 
Nikon, Japan), which was equipped with an FITC/EGFP filter (USA). All 
images were captured by using a digital camera (ACT-2U, Nikon) mounted on 
top of the fluorescence microscope with exposure time of 1s. The fluorescent 
images were analyzed by using ImageJ (1.42Q) to obtain fluorescent intensity 
profiles. After that, glyphosate was immobilized on the amine-functionalized 
glass beads. First, 10 mg/mL of glyphosate was dissolved in 10 mM HEPES 
buffer (pH 7.0) containing 200 mM of EDC and 50 mM of Sulfo-NHS to 
activate carbonyl groups on glyphosate. After 10 min, 200 μL of the solution 
was mixed with 50 mg of APES-coated glass beads. After 1 h of reaction, the 
supernatant was decanted, and the glass beads were washed twice with 0.1 
wt% SDS solution and DI water to remove non-reacted glyphosate. The 
 









Figure 5.2 Schematic illustration of using phage library for screening 
glyphosate-binding oligopeptides. (1) A phage library is incubated with glass 
beads functionalized with glyphosate, (2) elute the bound phages by lowering 
pH, (3) expose the phage to APES-coated glass beads for negative selection, 
(4) collect the phages that do not bind to the glass beads, (5) amplify the 
surviving phages, (6) repeat the screening procedure with amplified phage, (7) 
purification of phage colony with plate titering, and (8) DNA sequencing and 
deducing oligopeptide sequence from codon table. 
 
Figure 5.2 shows the phage display library screening employed in this 
study. Details of the experimental procedure are similar to that in the 
Experimental Section of Chapter 4 (Section 4.2) with some modifications. For 
example, to exclude phages which bind to the glass beads, the eluted phages 
were mixed with 20 mg of APES-coated glass beads for negative screening. 
After three rounds of phage screening, 36 of random phage plaques were 
picked for DNA sequencing. Experimental procedures for phage amplification, 
 




purification, and titering can be found in the manual of Ph.D-12 phage display 
kit277.  
 
Phage Binding Analysis 
We determined the strongest and most selective glyphosate-binding 
phages using single-phage binding assays. First, five single phage colonies 
expressing different oligopeptides, including TPFDLRPSSDTR (P1), 
TDIRLRPLDKRI (P2), RLKPRSDIKPIR (P3), SDTPLIKRLDFP (P4), and 
RRSDLKPIRPLK (P5), were amplified to ~1012 pfu/mL by using E. coli 
(ER2738). Then, 200 μL of the amplified phage solution, together with 
original phage library, were added to 20 mg of glyphosate-coated glass beads 
separately. After one round of screening, the bound phages were eluted from 
glyphosate-coated plates by 0.2 M glycine-HCl (pH 2.2), 1 mg/mL BSA 
solution, and then neutralized with 1 M Tris-HCl (pH 9.1). This eluted phage 
was titered on LB/IPTG/Xgal plates as described above, and the number of 
blue plaques was counted to determine phage titer in plaque forming units per 
mL (pfu/mL). 
 
Surface Plasmon Resonance (SPR) 
Glyphosate-binding oligopeptide TPFDLRPSSDTRGGGC (P1-cys) 
and alanine-substituted control oligopeptide TPFALAPSSATAGGGC (Pm-cys) 
were custom synthesized by GenicBio (Shanghai, China). GGGC was added 
to the carboxyl-terminus of the original sequence to provide a spacer and an 
 




anchoring point (through cysteine) for immobilization. To immobilize 
oligopeptide on a SPR gold sensor chip, the oligopeptide was dissolved in 
immobilization buffer (10 mM disodium tetraborate and 1 M NaCl, pH 8.5) to 
a final concentration of 1.0 mg/mL. Then, the solution was injected into a flow 
cell of a sensor chip under a constant flow rate of 1 μL/min for 325 min. After 
immobilization, the sensor chip was rinsed with HBS-EP buffer for 30 min to 
remove unreacted oligopeptides. To avoid nonspecific adsorption of 
glyphosate, we blocked the sensor chip with 10 mM of cysteine. In the 
BIAcore SPR system, a response of 1000 RU corresponds to a change in 
surface density of about 1 ng/mm2 269. The surface density of oligopeptides on 
SPR sensor chip surface was calculated based on this number. 
Next, HBS-EP buffer containing different concentrations of glyphosate 
were injected sequentially into a flow channel at a flow rate of 2 μL/min at the 
beginning of each cycle. Each cycle consists of a binding step for 3 min, a 
rinsing step with fresh HBS-EP buffer for 2.5 min, and a regeneration step 
with glycine-HCl solution (pH 2.0) for 1 min. To eliminate background signal, 
a reference flow channel (blocked with 10 mM of cysteine only) was subjected 
to the same binding cycle. Reported SPR sensorgrams are the difference 
between the test channel (immobilized with oligopeptide) and reference 
channel (only blocked with10 mM of cysteine). The final binding responses 
for different glyphosate concentrations are obtained from the SPR 
sensorgrams at 500s. 
 





5.3 Results and Discussion 
5.3.1 Immobilized Glyphosate on Glass Beads 
To immobilize glyphosate on the surface of glass beads, the glass 
beads were first functionalized with APES. The surface density of amine 
groups at different APES concentrations was quantified by using fluorescence 
as shown in Figure 5.3A. We note that the fluorescence intensity of the glass 
beads increases with the increasing of APES concentration. This is expected 
because a higher APES concentration can lead to a higher surface density of 
primary amine groups, which can react with FITC. The fluorescent intensity 
and amine density is in proportional relationship because free amine groups 
will react with the FITC. Figure 5.3B shows the calculated surface density of 
amine groups as a function of APES concentration. The calculation of amine 
group density is shown in Appendix B. The surface density of amine groups 
on APES-functionalized glass beads can be estimated by using the amounts of 
FTIC molecules reacting with the surface amine groups. The surface density 
of FITC is calculated by using calibration curve of FITC solution in a 
rectangular glass tube with thickness of 0.2 mm. When the APES 
concentration is 90.4 mM, the surface density of amine group reaches 0.58 
(amine/nm2), which is smaller than the reported value (2.5 amine/nm2) 278. 
This is probably because the surface density of the silanol group is lower (we 
did not activate the glass beads with strong acids/bases). From Figure 5.3B, 
we also noticed that the glass surface is saturated with amine group when the 
APES concentration is 90.4 mM. To achieve best result for glyphosate 
 




immobilization, we fixed the APES concentration at 90.4 mM in the following 
experiments.  
 
Figure 5.3 Determination of surface free amine density on the glass beads by 
using fluorescence method. (A) Fluorescence images of the glass beads after 
silanization at different APES concentrations, as indicated in the numbers 
below. The scale bar is 100 μm. (B) Surface free amine density as a function 
of APES concentration. 
 
Next, glyphosate was immobilized on the APES-coated glass beads by 
using NHS/EDC chemistry. To quantify the amount of glyphosate 
immobilized on the surface, we use fluorescence to determine the surface 
density of free amine group before and after the immobilization. Then, the 
difference in free amine group before and after the reaction is taken as the 
amount of immobilized glyphosate on the surface. Figure 5.4A shows the 
fluorescence images of the glass beads after they react with glyphosate at 
various concentrations. We note that the fluorescence intensity is in inverse 
proportional relationship with surface density of glyphosate because the free 
amine groups have been consumed by reacting with glyphosate. However, 
 




when the glyphosate concentration is 10 mg/mL, no fluorescence is observed, 
indicating that all free amine groups are consumed during the reaction. Figure 
5.4B shows the surface density of glyphosate as a function of glyphosate 
concentration used in the immobilization. We can see that the surface density 
of glyphosate increases when the glyphosate concentration is increased from 0 
to 10 mg/mL. When the glyphosate concentration is 10 mg/mL, the surface is 
already saturated with glyphosate. Therefore, we used 10 mg/mL of 
glyphosate to obtain a full coverage of glyphosate on the surface in the 
following experiments.  
 
Figure 5.4 Determination of surface glyphosate density on the glass beads by 
using fluorescence method. (A) Fluorescence images of the glass beads after 
immobilization of glyphosate at different glyphosate concentrations, as 
indicated in the numbers below. The scale bar is 100 μm. (B) Surface 
glyphosate density as a function of glyphosate concentration. 
 
5.3.2 Identification of the Glyphosate Binding Phage 
To obtain glyphosate-binding oligopeptides, we employed glyphosate-
decorated glass beads as our binding targets and APES-coated glass beads as 
 




negative screening during phage library screening process. After three rounds 
of screening, 36 of the blue phage plaques containing a single colony were 
isolated. Figure 5.5A shows that 26 out of 36 phage colonies display 
oligopeptide TPFDLRPSSDTR. In the literature, Schonbrunn et al. 279 
reported that glyphosate receptors, such as 5-enolpyruvylshikimate-3-
phosphate synthase (EPSPS), contains strictly conserved residues of Arg (R)-
124, Asp (D)-313, Arg (R)-344, and Arg (R)-386. Binding of glyphosate to 
these residues can inhibit the EPSPS activity and block the shikimate pathway 
for synthesis of the aromatic amino acids. Coincidently, our most abundant 
oligopeptide (TPFDLRPSSDTR), and second most abundant oligopeptide 
(TDIRLRPLDKRI), also contains two Arg (R) and two Asp (D) residues. 
Therefore, R and D are probably responsible for the binding of glyphosate 
through hydrogen bonding and electrostatic interaction. This is because 
glyphosate is a multi-charged compound and bears functional groups that are 
positively charged (secondary amino group) and negatively charged 
(phosphonic group and carboxylic group). Then the oligopeptide with highest 
binding affinity to glyphosate should be alternately negatively charged (D) and 
positively charged (R), which coordinate the electrostatic interaction. However, 
more studies and molecular simulations are needed to elucidate the exact 
binding mechanism of the oligopeptide to glyphosate.  
To compare the binding capability and specificity of phage containing 
glyphosate-binding oligopeptides, we amplified 5 single phage colonies 
expressing oligopeptide sequences TPFDLRPSSDTR (P1), TDIRLRPLDKRI 
(P2), RLKPRSDIKPIR (P3), SDTPLIKRLDFP (P4), and RRSDLKPIRPLK 
(P5), to a titering around 1012 pfu/mL. Then, these amplified phage colonies,  
 





Figure 5.5 (A) Oligopeptide sequences identified by using phage library 
screening against glyphosate-functionalized glass beads after 3 rounds. (B) 
Binding ratio of selected phage colonies to glyphosate-immobilized glass 
beads and plain glass beads. The phage colonies used in this experiment are 
isolated single-phage colonies which express oligopeptides P1, P2, P3, P4, P5 
or random oligopeptides. The error bar represents a standard deviation of three 
parallel experiments. 
 
together with original phage library, were introduced to glyphosate-
immobilized glass beads, respectively. After washing, the bound phage was 
eluted and tittered. The binding ratio is defined as the number of bound phage 
divided by the number of input phage. Figure 5.5B shows that the phage 
colony containing P1 has the highest binding ratio (19.2%), which is about 
2800 times higher than that of the original phage library. The second highest is 
P2 , which has a binding ratio of 5.2% (800 times higher than that of the 
original phage library). Interestingly, we notice that both P1 and P2 contain a 
homology tripeptide sequence DXR (X=L,T, I or K), which is probably 
responsible for the binding of glyphosate.  
 




For testing their binding specificity, we also introduced phage colonies 
expressing these oligopeptides to plain glass beads. In this experiment, P1, P2, 
P3, P4, and P5 have similar binding ratios, suggesting that the binding to plain 
glass beads is non-specific in nature. These results, when combined, suggest 
that the phage colony containing P1 has good selectivity to surface-
immobilized glyphosate. 
 
5.3.3 SPR Biosensor for Detecting Glyphosate 
To detect glyphosate, a SPR gold sensor chip was functionalized with 
an oligopeptide P1-cys in situ. After the immobilization, SPR shows an 
increase of 1659.3 RU, suggesting that oligopeptide is successfully 
immobilized, and the surface density is 0.6 molecule/nm2 274. To detect 
glyphosate, HBS-EP buffer containing glyphosate was injected to start a 
binding cycle which includes a binding step, a rinsing step, and a regeneration 
step. Sensorgrams at different concentrations of glyphosate in Figure 5.6A 
shows that with increasing concentration of glyphosate, the SPR response 
increases accordingly. To get the equilibrium binding constants of the 
oligopeptide receptor to glyphosate, we collected the final SPR response after 
each binding cycle at 500s and plot the final SPR responses against glyphosate 
concentration. 
Figure 5.6B shows the binding curve of glyphosate from 0 to 64 µM. 
The inset of Figure 5.6B shows a linear region of the binding curve between 0 
and 5 µM. From the slope of the straight line, we can determine that the 
sensitivity of the SPR sensor is 1.02 RU/ µM and the LOD is 0.58 µM by 
 




using the same method as we discussed in Chapter 4. By applying equilibrium 




= max     (5.1) 
where R is the SPR signal response, and C is the corresponding 
concentration of glyphosate in buffer solution, Rmax is the maximum SPR 
signal response, and KD is the equilibrium dissociation constant. Then Eq 5.1 
is rearranged, 
CRRKRC D max=+    (5.2) 
)(max C
RKRR D −⋅+=    (5.3) 
Then KD can be determined to be 8.6 μM by plotting R against (-R/C), 
where the equilibrium concentrations of glyphosate is known from sample 
preparation, as shown in Figure 5.6C. 
To identify the role of R and D on the oligopeptide’s binding 
specificity, we replaced R and D residues in P1-cys with A to obtain an 
alanine-substituted oligopeptide TPFALAPSSATAGGGC (Pm-cys) as control. 
To compare these two oligopeptides, HBS-EP buffer containing 16 μM of 
glyphosate was injected into the SPR sensor chip functionalized with P1-cys or 
Pm-cys. Figure 5.6D shows that, when 16 μM of glyphosate solution is 
injected, the SPR response on Pm-cys functionalized sensor chip is 1.4 RU, 
which is 6 times lower than the sensor chip functionalized with P1-cys (8.6 
RU). To test the binding specificity for glyphosate, buffer solution containing  
 





Figure 5.6 (A) SPR sensorgrams for different concentrations of glyphosate (0, 
2, 4, 8, 16, 32, and 64 μM). The sensor chip is modified with P1-cys with a 
surface density of 0.6 molecule/nm2. (B) SPR responses at various glyphosate 
concentrations. The inset shows a linear response region when the glyphosate 
concentration is below 5 μM. (C) Fitting SPR signal response R vs (-R/C) by 
using Langmuir isotherm. (D) SPR responses to 16 μM of glyphosate, glycine, 
thiacloprid, and imidacloprid by using a sensor chip decorated with either P1-
cys or Pm-cys. 
 
16 µM glycine, thiacloprid, and imidacloprid are sequentially injected into the 
SPR sensor chip. We choose glycine as an interferent because glyphosate is an 
aminophosphonic analogue of glycine. Therefore, we want to study the 
specificity of oligopeptide to glyphosate and glycine. Thiacloprid and 
imidacloprid are chosen because they are also widely used chemicals in 
agriculture. Figure 5.6D shows that the SPR responses for glycine, thiacloprid, 
and imidacloprid on P1-cys immobilized sensor chip are only about 1 RU. 
These results, when combined, suggest that the R and D motifs are responsible 
 




for binding glyphosate, and the SPR biosensor functionalized with 
oligopeptide P1-cys has good binding specificity toward glyphosate. 
Finally, to study the influence of ionic strength and pH on the binding 
strength, we first prepared HBS-EP buffer containing different concentrations 
of MgCl2 and 16 µM of glyphosate. Figure 5.7A shows that the SPR response 
decreases with increasing Mg2+ concentration. This is probably because the 
strong ionic strength can screen the electrostatic interactions between 
oligopeptide and glyphosate molecules, and reduce the binding strength. Next, 
to study the influence of pH on the binding strength, we adjusted the pH of the 
HBS-EP buffer (initial pH 7.4) by using hydrochloric solution (1 M). Figure 
5.7B shows that the SPR response decreases fast when the pH is below 6.5. 
We propose that this is because the net charge of oligopeptide (pI=6.93) 
changes from negative to positive, and the electrostatic interaction between 
oligopeptide and glyphosate is affected. This is not surprising because one 
common method to regenerate the SPR sensor chip (remove the bound 
molecules) is using low pH solution (such as glycine-HCl, pH 2.0). 
 
Figure 5.7 SPR results showing factors that influence the binding strength of 
oligopeptide to glyphosate. (A) effect of ionic strength and (B) effect of pH. 
 
 




Table 5.1 shows the comparison of LOD between the oligopeptide-
based SPR sensors in this work and other sensors such as HPLC, GC, 
fluorescent, electrochemical, and ELISA. The SPR sensor shows comparable 
LOD among GC, coulometric, amperometry, and capillary electrophoresis 
methods. However, the LOD of this SPR sensor is still not as good as 
fluorescent and ELISA methods. 
Table 5.1 Comparison of LODs between oligopeptide-based SPR sensors and 
other sensors to detect glyphosate 
Sensors LOD Reference 
SPR 0.58 µM This work 
HPLC 0.15 µM Khrolenko et al.55 
GC 0.62 µM Saito et al.52 
Fluorescent 0.006 µM Sancho et al.57 
Coulometric 0.22 µM Coutinho et al.59 
Amperometry 1.8 µM Sanchez-Bayo et al.62 
Cyclic voltammetry 0.01 µM Songa et al.64 
Capillary electrophoresis 1 µM Goodwin et al.61 
ELISA 0.004 µM Rubio et al.70 
 
5.4 Conclusions 
In conclusion, we successfully developed an SPR biosensor for online 
detection of glyphosate. The oligopeptide serving as sensing layer in the SPR 
biosensor is identified by using phage display screening. We addressed the 
problem of high solubility of glyphosate by immobilizing it on glass beads to 
prevent the loss of glyphosate in biopanning procedures. After each phage 
 




panning, a “negative screening” procedure was also conducted to eliminate the 
phage binders to the glass beads. After 3 rounds of biopanning, one 12-mer 
oligopeptide, TPFDLRPSSDTR, was identified from phage library. The phage 
binding affinity results also confirm of this oligopeptide shows the highest 
binding affinity to glyphosate. To develop a biosensor, the modified 
oligopeptide, TPFDLRPSSDTRGGGC, was immobilized on the SPR sensor 
chip, and the binding kinetics of glyphosate to oligopeptide was studied. The 
oligopeptide functionalized SPR biosensor showed good specificity toward 
solutions of glycine, thiacloprid, and imidacloprid. The LOD of this biosensor 
can achieve 0.58 µM. This LOD can meet the requirement regarding to the 
MRLs which were established by United States and Canada. However, this is 
only a “proof-of-concept” study, and spike recovery tests are also needed for 
real sample detection. 
 
 







ANTIBODY-FREE DETECTION OF HUMAN CHORIONIC 
GONADOTROPIN (HCG) BY USING LIQUID CRYSTALS 
In this chapter, we aim to develop an LC sensor for detecting human 
chorionic gonadotropin (hCG). In Chapter 3 we have demonstrated LC can be 
used to detect butylamine by doping of functional molecules, lauric aldehyde. 
The signal of this LC sensor can be easily visualized. However, this LC sensor 
suffers from poor specificity to other amine vapors. To improve specificity, in 
Chapter 4 and Chapter 5, we have developed SPR biosensors for detecting 
small molecules such as thiacloprid, imidacloprid, and glyphosate by using 
oligopeptide as sensing layers. The oligopeptides identified from phage 
display screening exhibit good binding affinity and binding specificity. 
However, these small molecules cannot disrupt LC orientation easily. To 
combine the advantages of LC and oligopeptides, we aim to develop an LC 
sensor for detecting hCG because hCG is a protein molecule which can easily 
disrupt LC orientation. First, we aim to identify hCG-binding oligopeptide by 
using phage display screening, and the binding affinity of identified 
oligopeptides will be studied by using SPR. Subsequently, this oligopeptide is 
employed as a sensing layer to bind hCG and LC is used to transduce the 
binding event into optical signals visible to the naked eye.  
 





Human chorionic gonadotropin (hCG), a glycoprotein hormone 
produced by the placental trophoblasts, is a common biomarker for the 
diagnosis of pregnancy 77, 78 and several cancers, such as prostate cancer, 
testicular cancer, trophoblastic cancer, and gestational choriocarcinoma 79-81. 
Therefore, detection of hCG in serum or urine is often carried out during 
routine medical screening. The most commonly used hCG diagnostic kit is 
based on lateral flow immunoassays which rely on a pair of specific anti-hCG 
antibodies. If hCG exists in test samples, hCG will bind to anti-hCG (labeled 
with gold nanoparticles) and form an antigen-antibody complex. Subsequently, 
this complex can be captured by a surface-immobilized antibody to form a 
sandwich-type structure, and a positive line will appear. This lateral-flow 
immunoassay is simple to use and it can readily give qualitative results with a 
LOD around 20 mIU/mL in urine samples. However, it is difficult to 
determine hCG concentration quantitatively by using lateral-flow 
immunoassays. Over the past decade, many immunoassays have been 
developed for quantitative detection of hCG. These immunoassays include 
radioimmunoassay 105, 107, 280-282, fluorescent immunoassay 111, 283, enzyme-
linked immunoassay (ELISA) 284-287 and electrochemical immunosensors 288-
294. However, these immunoassays are either expensive or time-consuming. 
Recently, new strategies have been developed to detect hCG. For example, 
Piliarik et al. 295 reported a label-free method to detect hCG by using surface 
plasmon resonance (SPR). In this study, changes in SPR signals can be 
observed when solutions containing hCG flow over a sensor chip decorated 
with anti-hCG. The LOD is 13 ng/mL (171.6 mIU/mL) in buffer and 100 
 




ng/mL (1320 mIU/mL) in diluted blood plasma samples. However, this LOD 
is still too high for early pregnancy test or cancer diagnosis. To achieve a 
lower LOD, Vareiro et al. 110 used surface plasmon field-enhanced 
fluorescence spectroscopy (SPFS) to detect hCG. In this technique, a 
fluorophore-labeled secondary antibody binds to surface-captured hCG, and 
the fluorophores can be excited to give fluorescence signals. By using this 
method, a LOD of 4 pM (2 mIU/mL) can be achieved. Although this 
technique has an extremely low LOD, it still relies on the use of antibodies, 
which are vulnerable to environmental factors, especially high temperature 73. 
Moreover, the production of antibodies is time-consuming and expensive, and 
batch-to-batch variation is also a concern. 
Previously, a large number of oligopeptide sequences for binding 
protein molecules have been identified by using phage libraries. For example, 
Devlin et al. 131 successfully identified oligopeptides containing a His-Pro-Gln 
(HPQ) motif that binds to streptavidin. However, in this study, the binding 
affinity of the oligopeptide to streptavidin is not known because phage 
particles, rather than oligopeptides, were used in the binding experiment. 
Pillutla et al. 132 identified oligopeptides which can bind to insulin receptor by 
using phage library. They also studied interactions between insulin and insulin 
receptor in the presence of oligopeptides by using radioreceptor assays. More 
recently, Fields et al. 133 identified oligopeptides which bind to Bowman-Birk 
inhibitor (BBI) by using phage library. They also used oligopeptide-modified 
magnetic particles to isolate BBI from soybean extracts. The above studies 
show that phage library is a powerful tool to identify oligopeptides which bind 
to target proteins with high affinity and specificity. However, binding of 
 




oligopeptide to target protein can only be observed by using instrumentation 
such as SPR. 
Liquid crystals are known to transduce the presence of proteins on 
solid surfaces into optical signals without any labeling procedures 2, 4, 5, 7, 224, 
296-298. For example, Xue and Yang 5 reported a LC-based protein assay based 
on the optical appearance of LCs. In the absence of protein, the LC assumes a 
homeotropic orientation and appears dark on a slide coated with N,N-
dimethyl-n-octadecyl-3-aminopropyltrimethoxysilyl chloride (DMOAP) 299. In 
contrast, in the presence of protein, the homeotropic orientation of the LC is 
disrupted and the LC gives bright textures. However, this study only relies on 
the physical adsorption of protein on glass slides without any specificity. To 
address this issue, Alino and Yang 6 developed an LC-based immunoassay to 
detect human serum albumin (HSA) in urine samples. In this study, anti-HSA 
antibody was immobilized on the DMOAP-coated glass slide to capture HSA, 
which can disrupt the orientation of the LC and give bright image. However, 
since anti-HSA and HSA are both proteins, anti-HSA can also disrupt the 
homeotropic LC orientation when its surface density exceeds a critical value 
(9.6 ×10-3 molecule/nm2). This is unfavorable because a higher surface density 
of immobilized antibody is often required to achieve a lower limit of detection. 
Oligopeptide is a good candidate to replace antibodies because it has a smaller 
size, and it will not disrupt LC orientation easily 300.  
In this paper, we address the issues associated with antibodies by using 
oligopeptides as receptors for binding hCG. The oligopeptides were identified 
by using phage library after five rounds of screening. To the best of our 
 




knowledge, this is the first study to screen for short oligopeptides that can bind 
to hCG molecules specifically. Next, we compared binding affinities of those 
oligopeptides to hCG by using SPR, and the oligopeptide that shows the 
highest binding affinity to hCG was chosen to develop a LC-based assay for 
label-free detection of hCG. This study provides a new principle for label-free 
detection of hCG with good specificity, and has the potential to be used in 
point-of-care (POC) detection of hCG.  
 
6.2 Experimental Section 
Materials 
Glass slides were obtained from Fisher Scientific (U.S.A.). LC 4-
cyano-4′-pentylbiphenyl (5CB) and dimethyl sulfoxide (DMSO) were 
purchased from Merck (Singapore). N,N-Dimethyl-n-octadecyl-3-
aminopropyltrimethoxysilyl chloride (DMOAP), fluorescein isothiocyanate 
isomer I (FITC), sodium bicarbonate, sodium hydroxide, sodium azide and 
sodium iodide, sodium cyanoborohydride (NaBH3CN), ammonium chloride, 
human chorionic gonadotropin (hCG) lyophilized powder, agar, isopropyl β-
D-thiogalactoside (IPTG), ethylenediaminetetraacetic acid (EDTA), 
polyethylene glycol (PEG, MW = 8000 g/mol), Tween-20, glycine, and 
bovine serum albumin (BSA) were purchased from Sigma (Singapore). Ph.D.-
12 phage display library kit was purchased from New England Biolabs 
(U.S.A). Luria broth base was purchased from Invitrogen (Singapore). Sodium 
chloride (99.8%) was purchased from GCE Laboratory Chemicals (Singapore). 
 




5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) was purchased from 
Duchefa (Netherland). Tris buffer (1M, pH 8.0), phosphate buffer saline (PBS 
buffer, 10X) and TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) were 
purchased from 1st Base. Ethanol (AR grade) and hydrochloric acid (37%, 
fuming) were purchased from Merck (Singapore). Spectra/Por dialysis 
membrane (MWCO: 1000 Da) was purchased from Fisher Scientific 
(Singapore). Oligopeptides (MHLMRMKPLLLTGGGC, 
STRLRRRSRRQTGGGC, PPLRINRHILTRGGGC, and 
MKLKPMRIMINPGGGC) were synthesized by GenicBio Ltd (Shanghai, 
China) with a purity ≥ 95%. BIAcore sensor chip Au (untreated gold surface), 
borate buffer (10 mM disodium tetraborate, pH 8.5, and 1 M NaCl), glycine-
HCl (10 mM glycine-HCl, pH 2.0), HBS-EP buffer (0.01 M HEPES, pH 7.4, 
0.15 M sodium chloride, 3 mM EDTA, and 0.005% v/v surfactant P20) was 
purchased from GE Healthcare (Singapore). Deionized water (18 MΩ-cm) 
was obtained from a Millipore filtration system. 
 
Phage Display for the Selection of hCG Binding Peptides 
Details of phage display procedure can be found in Section 4.2 with 
some modifications. To coat hCG on a 24-well plate, 500 μL of 0.1 M 
NaHCO3 (pH 8.6) solution containing 2 μM of hCG (~1000 IU/mL) was 
added to a well in a 24-well plate, and incubated at 4°C. After incubation 
overnight, the solution was decanted, and the surface was blocked with 
5mg/mL of BSA solution (0.1 M NaHCO3, pH 8.6 containing 0.02% of NaN3). 
After 2 h, the blocking buffer was discarded, and the plate was washed 6 times 
 




with 0.1% v/v of TBST buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, and 
0.1% v/v Tween-20). After 5 rounds of screening, the phage colony exhibited 
the highest binding affinity was collected, and the oligopeptide sequence was 
obtained by translating the DNA sequences in the pIII protein domain.  
 
Phage Binding Analysis 
In a single-phage binding assay 118, 275, six phage colonies expressing 
oligopeptides, MHLMRMKPLLLT (P1), MHPRKMLQLMLN (P2), 
STRLRRRSRRQT (P3), PPLRINRHILTR (P4), MKLKPMRIMINP (P5), and 
MKSRMLPLNRRL (P6), respectively, were amplified to ~1012 pfu/mL by 
using E. coli (ER2738). Then, each phage-containing solution was introduced 
to an hCG-coated well for binding with hCG. After one round of phage 
screening, the bound phages were eluted from hCG-coated plates. The input 
phages and bound phages were titered, and the binding ratio of the single 
phage to hCG was defined as the titer (in pfu/mL) of bound phage divided by 
the titer of input phage 275. In control experiment, the original phage library 
bearing random oligopeptides, was diluted to 1012 pfu/mL, and introduced to 
hCG-coated plate separately. 
 
SPR Experiments 
Four oligopeptides, MHLMRMKPLLLT (P1), STRLRRRSRRQT (P3), 
PPLRINRHILTR (P4), and MKLKPMRIMINP (P5) were synthesized by 
GenicBio Ltd (Shanghai, China). A linker, GGGC, was added to all 
 




oligopeptides at the carboxyl-terminus to provide spacer and cysteine for 
immobilization of these oligopeptides on gold surface 274. To immobilize the 
oligopeptides, they were first dissolved in borate buffer (10 mM disodium 
tetraborate and 1 M NaCl, pH 8.5) to a concentration of 1.0 mg/mL. Then, an 
oligopeptide solution was injected into a flow cell on the SPR sensor chip at a 
flow rate of 1 μL/min for 325 min. The surface density of immobilized 
oligopeptide was determined by using the net increase of the SPR response 
(1000 RU corresponds to a surface oligopeptide density of 1 ng/mm2) 269. Next, 
the sensor chip was flushed with HBS-EP buffer for 30 min to remove 
unreacted oligopeptides. After immobilization of oligopeptide, the sensor chip 
surface was blocked with 10 mM of cysteine. To observe the binding of hCG 
to immobilized oligopeptide, HBS-EP buffer containing hCG was injected into 
the flow cell at 2 μL/min over a period of 2.5 min. After injection, the flow 
cell was flushed with fresh HBS-EP buffer for 2 min to remove unbound hCG. 
Finally, the flow cell was regenerated with glycine-HCl solution (pH 2.0) for 1 
min. To obtain background signal, a blank flow cell (blocked with cysteine 
only) was used in parallel. This background signal was then subtracted from 
the binding signal.  
 
Fluorescence Test for Oligopeptide-hCG Binding 
First, hCG was labeled with FITC by using a standard protocol. Briefly, 
2 mL of 0.1 M sodium carbonate buffer containing 10 μM of hCG (5000 
IU/mL) was mixed with 50 μL anhydrous DMSO solution containing 1 
mg/mL FITC. After 8 h, unreacted FITC was removed by using dialysis in 
 




PBS buffer (pH 7.4) with a membrane (MWCO: 1000 Da). The 
fluorescein/protein molar ratio (F/P) of FITC-hCG was determined to be 0.61. 
The FITC-hCG solution was stored at 4 °C in dark before use. 
To coat a layer of streptavidin on the slide, 0.6 μL of carbonate buffer 
(50 mM of NaHCO3, pH 10.0 with 100 mM of MgCl2 and 10 mM of 
NaBH3CN) containing 100 μg/mL of streptavidin was spotted on an UV-
modified DMOAP-coated glass slide 300. Briefly, the DMOAP was first 
activated by shining with UV light. After activation, the inert DMOAP surface 
is modified with aldehyde groups. The aldehyde groups react with the amine 
groups of streptavidin to imine bond. The imine bond was further reduced by 
sodium cyanoborohydride (NaBH3CN) in buffer solution to form more stable 
secondary amines. After 2 h, the solution was rinsed with DI water and PBS 
buffer containing 0.05% v/v of Tween-20, and then blown dry with nitrogen 
gas. Next, PBS buffer (pH 7.4) containing 100 μg/mL of biotinylated 
oligopeptide (PPLRINRHILTRGGG-biotin, P4-biotin) was spotted on the 
glass slide to immobilize oligopeptide through biotin-streptavidin conjugation. 
After 2h, the glass was rinsed with DI water and PBS buffer containing 0.05% 
v/v of Tween-20. Thirdly, PBS buffer containing 100 mIU/mL (0.2 nM) of 
FITC-hCG and 0.005% v/v Tween-20 was dispensed onto the glass slide. 
Tween-20 (0.005% v/v) was added to reduce non-specific adsorption of hCG 
on DMOAP-coated glass slide. After 1 h, the glass slide was rinsed and blown 
dry under nitrogen gas. Fluorescent images on the glass slides were obtained 
by using a laser scanner (GenePix 4100A). 
 
 




Label-free Detection of hCG with LC 
First, 10 μg/mL of oligopeptide P4-biotin was immobilized on a 
streptavidin-coated glass slide. Next, PBS buffer (pH 7.4) containing different 
concentrations (0, 0.1, 1, 10, and 50 IU/mL) of hCG and 0.005% v/v Tween-
20 was dispensed onto the oligopeptide (P4) functionalized glass slide in an 
array format. Surfactant Tween-20 was added to reduce non-specific 
adsorption of hCG. After 1 h, the glass slide was washed with PBST buffer 
(PBS buffer with 0.05% v/v of Tween-20) and DI water, and blown dried 
under a stream of nitrogen gas. This slide was paired with a DMOAP-coated 
slide to make a LC cell (thickness ∼6 μm) 300. Approximately 5 μL of liquid 
crystal 5CB was drawn into the cavity by using capillary force. To detect hCG 
in urine samples, hCG was spiked into negative urine to the final 
concentrations of 0, 0.1, 1, 10, and 50 IU/mL. Next, the urine samples were 
applied to the P4 functionalized glass slide, as described above. Optical 
appearances of the samples were observed by using a polarizing optical 
microscope (Nikon ECLIPSE LV100POL, Japan) in the transmission mode. 
Each image was captured with a digital camera mounted on the microscope 
with an exposure time of 40 ms. 
6.3 Results and Discussion 
6.3.1 Selection of hCG Binding Phage 
To obtain hCG-binding oligopeptides, we employed phage library 
screening against immobilized hCG as our target. After five rounds of 
screening, 20 blue phage colonies were picked, and their DNA sequence was 
translated to oligopeptide sequences. Table 6.1 shows oligopeptide sequences 
 




expressed by these phages from third, fourth, and fifth round of phage display 
biopanning. For the fifth round of biopanning, it is noticeable that positively 
charged amino acids (29.2%, R, H, K) and non-polar hydrophobic amino acids 
(27.5%, L, I) are abundant whereas negatively charged residues (such as D 
and E) are absent. This is probably because hCG (pI=2.95) is negatively 
charged in TBST buffer (pH 7.5) during the screening process. Moreover, only 
three consensus sequences, MHLMRMKPLLLT (P1), MHPRKMLQLMLN 
(P2), and STRLRRRSRRQT (P3), appear twice among 20 samples. This is 
probably because there are many possible binding sites on hCG molecules. 
Interestingly, we also noticed that several other oligopeptide sequences, 
PPLRINRHILTR (P4), MKLKPMRIMINP (P5), and MKSRMLPLNRRL (P6) 
appear repeatedly from third to fifth round of screening. These oligopeptides 
were also selected for binding test.  
To test which oligopeptide sequence has the highest binding specificity 
for hCG, we amplified 6 isolated phage colonies (which express P1 to P6) for 
phage binding analysis. The binding ratio was defined as the titer (in pfu/mL) 
of the bound phage over the titer of the input phage (pfu/mL).  
Table 6.2 shows that the phage colony of P4 gives the highest binding 
ratio, which is about 2000 times higher than that of original phage library 
bearing random oligopeptide sequences. We notice that there is high 
abundance of positively charged residues (R and H) and hydrophobic residues 
(L and I) in P4. This suggests that the binding between hCG and the 
oligopeptide are probably through both electrostatic and hydrophobic 
interactions.  
 




Table 6.1 Oligopeptide sequences binding to hCG and their physical 
properties obtained from fifth round of phage display biopanning. 
 











P1  1,400 5.2 0.37 
P2    2,100 1.6 0.07 
P3 1,200 11 0.92 
P4 1,500 24 1.60 
P5 800 5 0.62 
P6 1,300 1.5 0.11 
Random oligopeptides 1,000 0.0075 7.5×10-4  
* The binding ratio is defined as the bound phage titer over the input phage 
titer.   
 
 




6.3.2 SPR Measurement 
Figure 6.1A shows SPR sensorgrams when different concentrations of 
hCG (0, 100, 200, 400, 800, and 1600 mIU/mL) were injected into the sensor 
chip decorated with P4. Figure 6.1A shows that when the hCG concentration is 
increased, the SPR response also increases. When the hCG concentration 
reaches 1600 mIU/mL, the final response is 21.8 RU, which is equivalent to a 
surface density of hCG at 3.5×10-4 molecule/nm2. Because the surface density 
of immobilized P4 is 0.57 molecule/nm2 (Table 6.3), we can estimate that the 
ratio of hCG molecule to oligopeptide receptor is about 1:1600. The low ratio 
is probably because of the relative large size of hCG (MW=37.9 kDa) 
compared to the size of the oligopeptide. In contrast, when the same hCG 
solution was injected into a sensor chip decorated with a scrambled 
oligopeptide, TPFDLRPSSDTRGGGC, the binding signal is minimal, (see 
Appendix C). This result shows that P4 can bind hCG specifically.  
 
Figure 6.1 (A) SPR binding sensorgrams for detecting hCG in HBS-EP buffer 
by using a P4 functionalized sensor chip. The hCG concentrations are 0, 100, 
200, 400, 800, and 1600 (mIU/mL), respectively. (B) Comparison of SPR 






















P1  1758.2 0.58 1.4 69.1 0.014 
P3  1847.1 0.58 4.4 56.8 0.017 
P4  1760.1 0.57 0.9 31.7 0.030 
P5  1746.2 0.55 2.8 72.2 0.013 
1The LOD was determined by using the mean value of three measurements of 
blank samples plus three times of the standard deviation (SD) of the mean 
(LOD = Mean + 3 SD). 2Sensitivity is defined as the slope of SPR response vs 
hCG concentration. 
 
Similarly, we also employed SPR to test 3 other oligopeptides P1, P3, 
and P5 at various hCG concentrations and compared their final SPR responses 
with P4. Figure 6.1B shows that the SPR response is linearly proportional to 
the hCG concentration when it is below 200 mIU/mL (0.4 nM). From the 
slope, sensitivity and LOD for each oligopeptide was calculated as shown in 
Table 6.3. Among them, the LOD of the SPR biosensor modified with P4 can 
reach 31.7 mIU/mL, and the sensitivity is 0.03 RU/(mIU/mL). For comparison, 
a SPR biosensor in which anti-hCG antibody was used to detect hCG, has an 
LOD of 26.4 mIU/mL in a direct binding format 181, which is slightly better 
than P4. Table 6.3 also shows dissociation constants of these oligopeptides. 
For P4, the equilibrium dissociation (KD) constant is 0.9 nM by using the same 
method as shown in Chapter 4 and Chapter 5. From kinetics analysis of the 
 




sensorgram (Figure 6.1A), the association rate kon is 5.04×106 M-1s-1, and the 
dissociation rate koff is 3.98×10-3 s-1. By applying KD′ = koff / kon, the kinetics 
dissociation constant KD′ can be determined to be 0.79 nM, which is close to 
the equilibrium value. The KD of P4 to hCG is 2 order of magnitude higher 
than that of commercial antibodies, but is comparable to a single chain 
fragment variable (ScFv) in hCG receptor (KD = 0.16 nM) 301. However, ScFv 
consists of more than 200 amino acids and needs to be harvested from cell 
culture and purified, whereas P4 can be synthesized directly.  
To further confirm the binding of oligopeptide P4 to hCG molecules, 
an inhibition assay was carried out. First, HBS-EP buffer solution containing 
1000 mIU/mL (2 nM) of hCG and different concentrations of oligopeptide P4 
(0, 0.001, 0.01, 0.1, 1, 10, 100, and 1000 nM) was mixed together, and 
injected into the SPR sensor chip decorated with P4 sequentially. Figure 6.2A 
shows SPR sensorgrams in this experiment. When the concentration of P4 in 
the bulk is 0.01 nM or below, the decrease in SPR signal is negligible. This is 
because only a few hCG molecules (<0.5%)  bind to P4 in the bulk solution, 
and the binding of hCG to the surface immobilized P4 is not affected. When 
the concentration of P4 is 0.1 nM or above, the SPR signal decreases with 
increasing P4 concentration as shown in Figure 6.2B. This is consistent with 
the principle of indirect competitive inhibition, in which free P4 in solution 
binds to hCG, and inhibits its binding with surface immobilized P4. Figure 
6.2B also shows that when the P4 concentration is 10 nM or above, the SPR 
binding signal is minimal, suggesting that most of hCG molecules bind to free 
P4 in the bulk solution such that they cannot bind to surface immobilized P4. 
 





Figure 6.2 (A) SPR binding sensorgrams for an inhibition assay using HBS-
EP buffer containing 1000 mIU/mL (2 nM) of hCG and different 
concentrations of free P4 . The sensor surface was also modified with P4. (B) 
Average SPR responses to hCG at different concentrations of free P4. The 
error bar indicates standard deviation of three measurements. 
 
6.3.3 Fluorescent Test for Oligopeptide-hCG Binding 
To study the binding specificity of oligopeptide to hCG using 
fluorescence, we immobilized oligopeptide P4-biotin on a streptavidin-coated 
slide. Then, PBS buffer containing 100 mIU/mL (0.2 nM) of FITC-hCG or 0.2 
nM of FITC-IgG was dispensed onto the surface for binding with P4. Green 
fluorescent spots in Figure 6.3A suggest that FITC-hCG binds to oligopeptide 
P4 on the surface. On the other hand, Figure 6.3B shows that FITC-IgG cannot 
bind to oligopeptide P4. Moreover, Figure 6.3C and Figure 6.3D show that 
when there is no immobilized oligopeptide P4 on the surface, FITC-hCG does 
not bind to the surface nonspecifically. These results, when combined, suggest 
that biotin-labeled P4 immobilized on the surface can bind hCG specifically.  
 





Figure 6.3 Fluorescence test for binding specificity of oligopeptide P4 
immobilized on a streptavidin-coated surface. The surface was incubated in (A, 
C, D) FITC-hCG and (B) FITC-IgG. (C-D) are control experiments in which 
the surface was only modified with (C) streptavidin and (D) no protein, to test 
nonspecific adsorption of FITC-hCG. The concentration of FITC-hCG is 100 
mIU/mL, and the concentration of FITC-IgG is 0.2 nM. The scale bar is 1 mm. 
 
To determine LOD in the fluorescence assay, solutions containing 
different concentrations of FITC-hCG were dispensed on an oligopeptide-
functionalized glass slide. After incubation and rinsing, the average 
fluorescence intensity of each spot, corresponding to different concentrations 
of FITC-hCG), was measured. Figure 6.4 shows that when the concentration 
of FITC-hCG is lower than 12.5 mIU/mL, no fluorescence signal can be 
observed. When the concentration of FITC-hCG is from 12.5 to 100 mIU/mL, 
the fluorescent intensity increases linearly with the increasing concentration of 
FITC-hCG. When the hCG concentration is 100 mIU/mL, the fluorescence 
intensity is 30.7 (a.u.), which corresponds to a surface density of 2.7×10-5 
molecule/nm2 (see Appendix C). When the concentration of FITC-hCG is 100 
mIU/mL or above, the fluorescent intensity only increases slightly, suggesting 
 




that the binding sites of the surface immobilized oligopeptides have been 
saturated. Figure 6.4 suggests that the dynamic range for this fluorescence 
assay is between 12.5 and 100 mIU/ml of hCG.  
 
Figure 6.4 Effect of FITC-hCG concentration on the fluorescent intensity. 
 
6.3.4 Label-free Detection of hCG by Using LC 
To test the feasibility of using LC for label-free detection of hCG, 
solution containing 10 IU/mL (20 nM) of hCG was dispensed as droplets on to 
a surface decorated with 1.0 μg/mL of streptavidin and 10 μg/mL of P4-biotin. 
For comparison, 20 nM of IgG was also dispensed on the same surface. After 
rinsing, an LC cell was made by using the surface as shown in Figure 6.5. 
Figure 6.5A shows that the presence of hCG leads to a bright spot, suggesting 
that hCG can bind to the surface and disrupt the homeotropic orientation of the 
LC. In contrast, IgG does not cause a bright spot in Figure 6.5B, suggesting 
that IgG cannot bind to the oligopeptide. In our control experiments, 10 IU/mL 
(20 nM) of hCG was dispensed on to a surface decorated with either 1.0 
μg/mL of streptavidin or no protein. Figure 6.5C and Figure 6.5D show that  
 





Figure 6.5 Application of LC for testing the binding specificity of hCG to 
oligopeptide P4 immobilized on a streptavidin-coated surface. The surface was 
incubated in (A, C, D) hCG and (B) IgG. (C-D) are control experiments in 
which the surface was only modified with (C) streptavidin and (D) no protein, 
to test nonspecific adsorption of hCG. The concentration of hCG is 10 IU/mL, 
and the concentration of IgG is 20 nM. The image was an LC cell under 
crossed polarizers. The scale bar is 1 mm. 
 
optical images of the LC were both dark. This result confirms that the 
oligopeptide P4 plays a crucial role to capture hCG molecules from solution. 
The total assay time is about 1 h, which is longer than the commercial lateral-
flow immunoassay. However, this LC-based array-format sensing platform 
has not been optimized. By shortening the incubation time to 15 min, it is 
promising to complete the total assay within 20 min. This LC-based hCG 
sensor also has some advantages over lateral-flow immunoassays such as 
possibility of detecting multiple analytes and high-throughput screening. Since 
the detection principle reported herein is universal, as long as we can identify 
specific oligopeptide sequences for all relevant biomarkers by using phage 
 




display, we will be able to combine the oligopeptide and LC to develop an 
oligopeptide microarray to detect these biomarkers. This is also the main 
advantage of this system, because once the oligopeptides are identified, we 
can custom-synthesize them without raising antibody using animals. 
Incorporation of LC allows us to deliver the result as an optical output which 
is visible with the naked eye. 
To determine the optimal surface density of oligopeptide and LOD of 
this detection method, we decorated streptavidin-modified slides with different 
concentrations (1, 5, and 10 μg/mL) of P4-biotin, and then dispensed buffer 
containing different concentrations of hCG ranging from 0 to 50 IU/mL. 
Figure 6.6A shows that when the oligopeptide concentration is 10 μg/mL, 
hCG can be detected at 1 IU/mL. We note that the 1 IU/mL spots are uneven 
(probably due to coffee ring effect during the drying process), but the Saturn 
rings are sufficient to indicate the presence of hCG in the solution. Figure 
6.6B shows that when the oligopeptide concentration is 5 μg/mL, hCG can 
still be detected at 1 IU/mL, but the signal is weaker than that in Figure 6.6A. 
When the immobilized oligopeptide concentration is further reduced to 1 
μg/mL, the 1 IU/mL spot of hCG cannot be detected (Figure 6.6C). This is 
because not enough hCG molecules can be captured by the surface 
immobilized oligopeptide to disrupt LC orientation. Therefore, we conclude 
that the practical LOD of this LC-based assay is 1 IU/mL (2 nM). This value, 
however, is about 80 times higher than that in the fluorescence assay and 
about 30 times higher than that in the SPR result. Table 6.4 shows the 
comparison of LODs between oligopeptide-based LC sensors and other 
sensors to detect hCG. Compared to other immunoassay-based sensors, the 
 




LOD of the LC sensor is still too high at the current stage. Although it is 
apparent that the LOD in the LC-based assay can be further improved by 
increasing the streptavidin concentration (and therefore the oligopeptide 
density), the streptavidin concentration must be below 1 μg/mL to ensure 
streptavidin itself will not disrupt LC orientation before hCG binding events.  
Table 6.4 Comparison of LODs between oligopeptide-based LC sensors and 
other sensors to detect hCG 
Sensors LOD Reference 
LC sensor 1000 mIU/mL This work 
Fluorescent immunosensor 0.3 mIU/mL He et al.111 
ELISA 2.2 mIU/mL Longhi et al.284 
Electrochemical 
immunosensor 
0.3 mIU/mL Chai et al.288 
SPR immunosensor 171.3 mIU/mL Piliarik et al.295 
 
Finally, because hCG is either present in urine or serum in most 
applications, we also tested this assay by using urine samples containing hCG. 
In this experiment, the oligopeptide concentration is 10 μg/mL, which is 
similar to that in Figure 6.6A. Figure 6.6D shows that the detection limit is 
still 1 IU/mL even when hCG was present in the urine sample. This result 
suggests that the hCG assay is specific to hCG and is applicable for the 
detection of hCG in real biological samples. This is also the first antibody-free 
and label-free hCG assay based on LC, but more efforts are needed to improve 
the LOD to below 25 mIU/mL. 
 





Figure 6.6 LOD of the LC-based hCG assay and effect of immobilized 
oligopeptide density. The oligopeptide concentrations used during 
immobilization are (A) 10 μg/mL (B) 5 μg/mL (C) 1 μg/mL and (D) 10 μg/mL. 
Concentrations of hCG are 0, 0.1, 1, 10, and 50 IU/mL (from left to right). 
hCG was dissolved in (A-C) PBS buffer and (D) urine. Scale bar is 1 mm. 
 
6.4 Conclusions 
In conclusion, we successfully developed an LC sensor for detecting 
hCG. An hCG-binding oligopeptide P4 (PPLRINRHILTR) is identified by 
using phage display screening to replace anti-hCG antibody in immunoassays. 
The phage binding analysis showed that the single phage colonies carrying 
oligopeptide P4 exhibited the highest binding affinity to hCG. The SPR results 
also confirm P4 binds to hCG specifically with a dissociation constant of 0.9 
nM. This novel oligopeptide was used in SPR assay, fluorescence assay and an 
LC-based assay for the detection of hCG, and LODs were found to be 31.7 
 




mIU/mL, 12.5 mIU/mL and 1 IU/mL, respectively. The LC-based assay is the 
first antibody-free, label-free method for detecting hCG in both PBS buffer 
and urine samples. This detection principle can also be applied for the 
detection of other biomolecules if specific binding oligopeptides can be 
identified through phage display screening. However, the unfavorable LOD 
limits the practical application of this LC sensor. As a result, more efforts are 
still needed to develop a mechanism for signal amplification of LC sensors. 
 








ENZYMATIC SILVER DEPOSITION TO ENHANCE LIQUID CRYSTAL 
SIGNAL  
 
In this chapter, we aim to develop a method to enhance LC signal by 
using enzymatic silver deposition (ESD). In Chapter 6, an LC-based biosensor 
is developed for label-free detection of hCG. However, the LOD of the LC 
sensor is still unfavorable. As a result, new mechanism to enhance LC signal 
is required to achieve an even lower LOD. To address this problem, 
streptavidin-alkaline phosphatase (SA-ALP) is immobilized on an 
oligopeptide-functionalized glass slide to catalyze a dephosphorylation 
reaction of ascorbic acid 2-phosphate (AH2-p) to produce ascorbic acid, which 
in turn reduces silver ions to metallic silver. The silver particles can be 
deposited on the glass slide to disrupt a thin layer of LC supported on the 
surface. To understand enzymatic reaction, the kinetics of enzymatic silver 
deposition will be investigated both in bulk solution and on solid surface.  
  
 





In the past, LC-based assays have been developed to report proteins on 
a solid surface 2, 4, 5, 222, 228. As described in Section 2.5, the mechanism of LC-
based protein assays relies on the disruption of LC orientation on the solid 
surface. Because of its elastic properties, the orientational transition of LC 
propagates into the bulk, and optical transition can be observed under a pair of 
crossed polarizers due to birefringence of LCs. The LC-based protein assays 
does not require labeling of the target proteins, and the presence of proteins 
can be transduced into optical signals which can be easily observed with naked 
eye. Therefore, the label-free and easily-visualized nature of LC-based protein 
assays have found applications in medical diagnostics and protein toxin 
detection. However, the LOD of LC-based protein assays is restricted to 
µg/mL or nano-molar level, which is not sufficient for applications of 
ultrasensitive protein assays. To enhance the LC signal, Chen and Yang 7 
employed a secondary antibody to amplify LC signal for hepatitis B antibody 
detection. By employing the secondary antibody, the LOD was improved by 
10-fold, from 150 nM to 15 nM. However, raising a secondary antibody can 
be problematic, and the improvement in LOD is not impressive. To 
circumvent this problem, new strategies are needed to enhance LC signal. 
Enzymatic silver deposition is a promising way to enhance LC signal. 
In this technique, an enzyme is immobilized on a solid surface to catalyze 
dephosphorylation reaction in the substrate solution. Then, the product of the 
enzymatic reaction reduces silver ions in the substrate solution to metallic 
silver, which can be deposited on a solid surface for signal amplification 
 




through electrochemical or optical manners. For example, Hwang et al.215 first 
developed an enzymatic silver deposition method to detect DNA hybridization 
by using electrochemical method. In this study, a target DNA molecule and a 
biotinylated detection DNA probe first hybridize to a capture DNA probe 
immobilized on a gold electrode. Then, neutravidin- alkaline phosphatase 
binds to biotin of the detection DNA probe and converts non-reactive p-
aminophenyl phosphate into p-aminophenol, a reducing agent which can 
reduce silver ions in aqueous solution to deposit a layer of metallic silver on 
the electrode. Thus, the enzymatic silver deposition process results in great 
enhancement in signal due to the accumulation of metallic silver on the 
electrode. Fanjul-Bolado et al. 216 reported a similar approach to detect DNA 
hybridization by using alkaline phosphatase-catalyzed silver deposition to 
enhance electrochemical signal. Later, Tan et al. 1 developed a LC optical 
biosensor using enzymatic silver deposition to enhance the binding signal. 
Similar to Hwang’s work 215, the streptavidin-labeled alkaline phosphatase 
(SA-ALP) binds to the biotin of the detection DNA probe, which then 
catalyzes the hydrolysis of ascorbic acid 2-phosphate (AH2-p) to form ascorbic 
acid (AH2). The ascorbic acid can reduce silver ions in the solution and 
deposit metallic silver on a solid surface. Unlike previous study in which 
silver was detected electrochemically, the deposited silver layer was used to 
disrupt a homeotropic orientation of LC supported on the solid surface and 
gives bright textures. After enzymatic silver deposition, the LOD for DNA can 
be improved to 0.1 pM. One of the advantages of this method is that the 
biomolecular binding events can be transduced into optical signals which can 
be easily observed with a pair of crossed-polarizers. However, in the previous 
 




study, the enzymatic silver deposition method was applied to DNA samples 
because DNA molecules are negatively charged, making it easier to promote 
accumulation of silver ions around DNA molecules. To the best of our 
knowledge, the applicability and kinetics of the enzymatic silver deposition 
for LC-based protein assay is still unknown. To address this issue, in this 
study, we aim to investigate how effective the enzymatic silver deposition can 
enhance the LC signal for protein assay. Next, we compared the enzymatic 
reaction kinetics of SA-ALP both in buffer solution and on surface. These 
kinetic parameters are important to understand the mechanism of the 
enzymatic reaction, and design proper conditions for development of portable 
biosensors with a signal amplification mechanism. 
 
7.2 Experimental Section 
Materials 
SA-ALP from Streptomyces avidinii, ascorbic acid 2-phosphate (AH2-
p), L-ascorbic acid (AH2), sodium cyanoborohydride (NaBH3CN), sodium 
bicarbonate, sodium hydroxide, silver nitrate, Tween-20, and N,N-Dimethyl-n-
octadecyl-3-aminopropyltrimethoxysilyl chloride (DMOAP) were purchased 
from Sigma (Singapore). LC 4-cyano-4′-pentylbiphenyl  (5CB), magnesium 
chloride, and glycine were purchased from Merck (Singapore). HEPES and 
phosphate buffered saline (PBS) were purchased from 1st Base (Singapore). 
Sodium chloride (99.8%) was purchased from GCE Laboratory Chemicals 
(Singapore). Cy3 monofunctional reactive dye was purchased from GE 
 




Healthcare (Singapore). Biotinylated oligopeptide (PPLRINRHILTRGGG-
biotin, P-biotin) was synthesized by GenicBio (Shanghai, China) with a purity 
≥ 95%. Glass slides were obtained from Fisher Scientific (U.S.A.). Deionized 
water (18 MΩ-cm) was obtained from a Millipore filtration system. 
 
Immobilization of SA-ALP on DMOAP Glass Slide 
First, plain glass slides were cleaned and coated with DMOAP as 
described in Chapter 6.  The DMOAP-coated slide was then placed 3.0 cm 
below a UV pen lamp (254 nm, Spectroline), and exposed to UV for 40 s 
under ambient condition. To immobilize biotinylated oligopeptide (P-biotin) 
on a glass slide, 2 μL of carbonate buffer (50 mM of NaHCO3, pH 10.0 with 
100 mM of MgCl2 and 10 mM of NaBH3CN) containing 100 μg/mL of P-
biotin was spotted on a UV-modified DMOAP-coated glass slide 300. The 
mechanism for immobilization of oligopeptide is described in Chapter 6 by 
replacing streptavidin with P-biotin. After incubation in a humidified chamber 
for 2 h, the oligopeptide solution was removed, and the glass slide was rinsed 
with deionized water. Then, the glass slide was washed again using 0.05% v/v 
of PBST (PBS buffer containing 0.05% v/v of Tween-20) to remove non-
immobilized oligopeptide, and blown dry under a stream of nitrogen. To 
immobilize SA-ALP, 2 μL of buffer solution (10 mM HEPES and 150mM 
NaCl, pH 7.5) containing 44 nM of SA-ALP was spotted onto the glass slide 
through streptavidin-biotin conjugation. After 2h, the glass slide was rinsed 
with 0.05% v/v of PBST and deionized water to remove non-immobilized SA-
ALP. 
 




Measurements of Reaction Kinetics 
To measure the enzymatic reaction kinetics of SA-ALP in bulk 
solution, 120 μL of glycine buffer (80 mM, pH 9.0) containing 1.0 mM of 
AgNO3, 22 nM of SA-ALP, and different concentrations of AH2-p was 
prepared. The glycine buffer was used to maintain pH of the solution because 
the reaction of ascorbic acid and silver ions produces H+. The sample solution 
was kept in 37 °C thermo mixer prior use. After every 2.5 min, the absorbance 
of the solution at 260 nm was measured by using a NanoDrop 1000 
spectrophotometer (Thermo Scientific). To measure the enzymatic reaction 
rate kinetics of surface-immobilized SA-ALP, 2 μL of glycine buffer (80 mM, 
pH 9.0) containing 1.0 mM AgNO3 and different concentrations of AH2-p was 
spotted onto SA-ALP immobilized glass slide in an array format and kept in a 
humidified chamber at 37 °C. After every 2.5 min, the absorbance of each 
solution spot was measured as described above. Three parallel experiments 
were performed to obtain an average. 
 
Enzymatic Silver Deposition to Enhance LC Signal 
First, DMOAP-coated glass slide was immobilized with biotinylated 
oligopeptide as described above. Then 2 μL of buffer solution (10 mM HEPES 
and 150mM NaCl, pH 7.5) containing different concentrations of SA-ALP 
(4.4-44 nM) was spotted onto the glass slide to immobilize SA-ALP in situ. 
After immobilization for 2 h, the glass slide was sequentially washed with 
0.05% v/v PBST and deionized water, and blown dried under a stream of 
nitrogen gas. This slide was paired with a plain glass slide to make a cell with 
 




thickness of ~100 μm. Approximately 30 μL of glycine/NaOH solution (80 
mM, pH 9.0) containing 1.0 mM AgNO3 and 1.5 mM AH2-p was drawn into 
the cavity by using capillary force. After incubating at 37 °C for 30 min, the 
glass cell was disassembled and the SA-ALP functionalized glass slide was 
sequentially washed with 0.05% v/v PBST and deionized water, and blown 
dried under a stream of nitrogen gas. Next, the glass slide deposited with silver 
was paired with a DMOAP-coated slide to make a LC cell with thickness of 
~6 μm, as described in Chapter 6. Approximately 5 μL of liquid crystal 5CB 
was drawn into the cavity by using capillary force. Optical appearances of the 
samples were observed by using a polarizing optical microscope in the 
transmission mode. Each image was captured with a digital camera mounted 
on the microscope with an exposure time of 40 ms. 
 
7.3 Results and Discussion 
 7.3.1 Immobilization of SA-ALP 
To confirm the immobilization of SA-ALP, buffer solution (10 mM 
HEPES and 150mM NaCl, pH 7.5) containing 44 nM of Cy3-labeled SA-ALP 
was spotted on the biotinylated oligopeptide modified surface. Figure 7.1A 
shows the fluorescence image of Cy3-SA-ALP after immobilization on 
biotinylated oligopeptide modified surface. Red fluorescence color can be 
observed after washing with 0.05% v/v PBST, showing that the 
immobilization of SA-ALP is successful. In contrast, on a DMOAP surface 
without biotinylated oligopeptide, Cy3-SA-ALP was removed from DMOAP 
surface after same washing steps, and no fluorescence can be observed, as 
 




shown in Figure 7.1B. This result confirmed the successful immobilization of 
SA-ALP on biotinylated oligopeptide modified surface. Moreover, the surface 
density of SA-ALP was determined to be 110.4±6.7 fmole/mm2 (see Appendix 
D).  
 
Figure 7.1 Fluorescent images of Cy3-labeled SA-ALP immobilized on (A) 
biotinylated oligopeptide modified surface, and (B) DMOAP surface. The 
scale bar is 500 µm. 
 
7.3.2 Enzymatic Reaction Kinetics of SA-ALP  
Enzymatic reaction kinetics is important to understand enzymatic 
activity. The enzymatic silver deposition includes two steps. First, the 
phosphate groups of AH2-p was removed by dephosphorylation of ALP, and 
then, the product of AH2, was oxidized by the silver ions in substrate solution, 
as shown in Equation 7.1 and 7.2. 
pp   AHAH 2
k  ALP,
2
1 + →−                               (7.1) 
++ ++→+ 2H2AgA2AgAH 0k2 2                       (7.2) 
where A is dehydro-ascorbic acid (oxidized form of AH2), k1 and k2 
are reaction rate constant of reaction (7.1) and (7.2), defined as, 
 v1=k1[AH2-p]                                           (7.3) 
 




v2=k2[AH2][Ag+]/[H+]                                   (7.4) 
where v1 and v2 are reaction rate of reaction (7.1) and (7.2), 
respectively. From Equation 7.4, the reaction rate of Equation 7.2 is in first-
order dependences on both AH2 and Ag+ concentration, and in inverse first-
order dependence on [H+] 302, the reaction rate constant k2 was determined to 
be 1.7×106 L mol-1s-1 at pH 9.0 ([H+]=10-9 M), which is much larger than the 
reported value of k1 (3.0×104 L mol-1s-1) 303. As a result, the enzymatic 
reaction (Equation 7.1) is the controlling step. 
To confirm the value of k2, pseudo-first-order rate constants (k2*) was 
calculated as described by Mushran et al.302 , as shown in Table 7.1. Therefore, 
the average reaction rate constant (k2) is calculated (1.49±0.17) ×106 L mol-1 s-
1 by using k2= k2*/[ AH2]. This k2 value is close to the calculated value as 
described above. 
Table 7.1 Determination of k2* and k2 at different concentrations of AH2 and 














1 1 50 1.48 1.48 
2 0.8 50 1.29  1.61  
3 0.6 50 0.75  1.25  
4 0.5 50 0.63 1.26 
5 1 60 1.53 1.53 
6 1 80 1.68 1.68 
7 1 100 1.66 1.66 
 




To study the enzymatic reaction rate in bulk solution, buffer solution 
(80 mM glycine, pH 9.0) containing 22 nM of SA-ALP, 1.0 mM of AgNO3, 
and different concentrations of AH2-p as substrate were prepared and kept at 
37 °C.  Figure 7.2 shows the plot of 1/v against 1/[AH2-p] to determine the 
Michaelis constant (Km= 593 µM) and the maximum enzymatic reaction rate 
(Vmax= 31.2 µM/min) by using Lineweaver-Burk method. The turnover 
number (kcat) is calculated to be 1.4×103 min-1 using kcat=Vmax/[SA-ALP]. This 
is consistent with reported values in literature 303, 304. 
In real applications, SA-ALP was immobilized on glass surface to 
catalyze the dephosphorylation reaction and promote silver deposition in situ. 
As a result, we need to compare the enzymatic reaction rate of SA-ALP in 
both cases. To study the enzymatic kinetics of surface-immobilized SA-ALP, 
we first immobilize SA-ALP on a glass slide through biotin-streptavidin 
conjugation, and then the buffer solution (80 mM glycine, pH 9.0) containing 
1.0 mM of AgNO3, and different concentrations of AH2-p was dispensed on 
SA-ALP functionalized slide. Figure 7.2 shows that the K′ m is 481 µM and 
V′max is 18.5 µM/min for surface-immobilized SA-ALP. The surface density 
of SA-ALP is determined to be 110.4±6.7 fmole/mm2 by using fluorescence 
method. Therefore, the k′cat is 0.2×103 min-1 which is 7-fold lower than that of 
SA-ALP in bulk solution. Similarly, the enzymatic reaction rate constant can 
be determined to be 6.9×103 L mol-1s-1 by using k′1= k′cat /K′m. Therefore, the 
enzymatic reaction rate of surface-immobilized SA-ALP is 5.7-fold lower than 
that in bulk solution. 
 





Figure 7.2 Lineweaver-Burk plot for determination of Vmax and Km of 
SA−ALP on a solid surface (open circles) and in bulk solution (solid circles). 
The error bar indicates the standard deviation of three measurements. 
 
7.3.3 Enzymatic Silver Deposition to Enhance LC Signal 
Next, we studied the feasibility of using the enzymatic silver 
deposition to enhance LC signal. Figure 7.3 shows a schematic of a possible 
mechanism to enhance LC signal by using enzymatic silver deposition. Before 
silver deposition, the surface immobilized oligopeptide and SA-ALP cannot 
disrupt LC orientation when the surface density of SA-ALP is below a critical 
value, as shown in Figure 7.3A. In this case, the LC molecules assume 
homeotropic orientation at glass surface and gives dark optical appearance 
under crossed-polarizers. After silver deposition, the metallic silver deposited 
at glass surface may promote homeotropic to planar orientational transition of 
LC due to the rough surface morphologies 305. In this case, bright optical 
appearance of LC can be observed, as shown in Figure 7.3B. 
 
 





Figure 7.3 Schematic illustration of a possible mechanism to enhance LC 
signal by using enzymatic silver deposition. (A) Before silver deposition, and 
(B) after silver deposition. 
 
 
Figure 7.4 Optical images of LC supported on glass slide immobilized with 
SA-ALP before silver deposition. The concentrations of SA-ALP are denoted 
above the image. The scale bar is 2 mm. 
 
Figure 7.4 shows that before silver deposition, the surface immobilized 
SA-ALP can only disrupt LC orientation when the concentration of SA-ALP 
is 44 nM or above, and gives a bright optical signal. Otherwise, the LC 
 




orientation cannot be disrupted, and gives a dark optical image. To study how 
effective the silver deposition can enhance the LC signal, the glass slide was 
immersed in a solution containing 1.5 mM of AH2-p and 1.0 mM of AgNO3 to 
allow silver deposition on the surface. After 30 min, the glass slide with 
deposited silver was paired with a DMOAP-coated slide to make a LC cell. 
Figure 7.5 shows that when the concentration of SA-ALP is 13.2 nM or above, 
the LC orientation on the glass surface can be disrupt, and bright texture can 
be seen under crossed polarizers. This result shows that the LOD of SA-ALP 
is 3.3-fold improved after silver deposition. Furthermore, from the turnover 
number (kcat=0.2×103 min-1) of surface-immobilized SA-ALP, we can estimate 
the amount of silver that required to disrupt LC orientation. For example, from 
fluorescent study, the surface density of SA-ALP is 31.7 fmole/mm2 (see 
Appendix D). Then, the amount of silver deposited on glass slide surface can 
be determined to be 1.9×105 fmole/mm2 (see Appendix D).  
 
Figure 7.5 Optical images of LC supported on glass slide immobilized with 
SA-ALP after silver deposition. The concentrations of SA-ALP are denoted 
above the image. The scale bar is 2 mm. 
 
 




The scanning electron microscope (SEM) images in Figure 7.6 show 
that the size of the silver particles is not affected by the surface density of SA-
ALP. Figure 7.6 also shows disruption of LC orientation dependent on the 
amount of the silver particles. We propose the size of the silver particles and 
the surface morphology will also affect the LC orientation. This will be an 
interesting topic to study in the future. 
 
Figure 7.6 SEM images of silver particles deposited on glass slides 
immobilized with 0.20 molecule/nm2 of P-biotin. Enzymatic silver deposition 
was carried out after the slides were incubated in solution containing (A) 10 
ng/mL, (B) 100 ng/mL, and (C) 500 ng/mL of trypsin. (D) is a magnified view 
of (A) with 3-times higher magnification. Individual silver particles can be 
seen clearly. 
 
We also find the silver deposition on the glass slide can be seen with 
naked eye before paring an LC cell. Figure 7.7 shows the images of glass 
slides immobilized with SA-ALP after silver deposition.  Interestingly, we 
find that when the SA-ALP concentration is 8.8 nM, the silver deposition can 
be seen with the naked eye. In this case, we can estimate the amount of silver 
deposited on glass slide surface to be 1.4×105 fmole/mm2 (see Appendix D). 
However, it cannot disrupt LC orientation to give a positive signal. This result 
 




may suggest, although the silver deposition can moderately enhance LC signal, 
it is not as effective as we expected.  
 
Figure 7.7 Images of glass slides after enzymatic silver deposition. The 




In this chapter, we investigated the feasibility of enhancing LC signal 
by using enzymatic silver deposition. SA-ALP was immobilized on a glass 
slide as a model system. The study on enzymatic reaction kinetics shows that 
turnover number (kcat) of the surface immobilized SA-ALP is 7-fold lower 
than that of SA-ALP in bulk solution. Metallic silver deposited on the glass 
slide can moderately enhance LC signal by lowering the LOD of SA-ALP 
from 44 nM to 13.2 nM. However, the enhancement caused by silver 
deposition is not as apparent as we expected. 
 


















Biosensors usually consist of a sensing layer and a signal transducer. 
The function of the sensing layer is to capture or react with target molecules, 
while the function of the signal transducer is to transduce binding or reaction 
of the target molecules into readable signal. In this thesis, we validate the 
application of functional molecules and oligopeptides as sensing layers, and 
explore the application of LC as a novel signal transducer for detecting 
purposes. 
In Chapter 3, we developed an LC-based optical sensor for detecting 
vaporous butylamine in air. In this study, we doped an active agent, LA into 
bulk LC (5CB) to react with butylamine, and render specificity to the gas 
sensor. The LA molecules can modulate the orientation of LC at either 
LC/glass or LC/air interface upon exposure to butylamine in the air. Fast and 
distinct bright-to-dark optical response can be observed under crossed 
polarizers due to the orientational transition of LC. This LC-based optical 
sensor is capable of detecting butylamine vapors in real-time fashion and 
allows the discrimination of amines with other molecules, such as water, 
ethanol, acetone, and hexane. The LOD to butylamine vapor can reach 10 
ppmv. This technique provides a new mechanism for portable detection of 
gaseous amines in the air. 
Although the doping of functional molecules is able to render 
specificity to different classes of molecules, it is not able to discriminate 
molecules with similar functional groups. To address this issue, in Chapter 4, 
we identified oligopeptides that can specifically bind to thiacloprid and 
 




imidacloprid from phage library, and employed the oligopeptides as sensing 
layer in SPR biosensor. The identified oligopeptides, RKRIRRMMPRPS and 
RNRHTHLRTRPR, show good binding specificity toward thiacloprid and 
imidacloprid respectively, and the cross-binding is minimal despite the 
similarity of the two molecules. We propose that the abundant amino acid 
residues, IRR and RPR, are responsible for the binding. This oligopeptide 
functionalized SPR biosensor can rapidly detect thiacloprid and imidacloprid 
in buffer solutions in a real-time manner. The LOD for thiacloprid and 
imidacloprid is 1.2 µM and 0.9 µM, respectively.  
To expand the application of phage library to soluble targets, in 
Chapter 5, we developed a modified phage display screening method by 
immobilizing a highly soluble target, glyphosate, on amine-modified glass 
beads as our screening target in phage library. After three rounds of 
biopanning, one 12-mer oligopeptide, TPFDLRPSSDTR, was identified from 
the phage library. The repeatedly and alternately appearing amino acid 
residues of R and D in the oligopeptide sequence may be responsible for the 
high binding affinity and specificity. To develop a SPR biosensor for online 
detection of glyphosate in buffer solution, the modified oligopeptide, 
TPFDLRPSSDTRGGGC, was immobilized on the gold surface of a SPR 
sensor chip. The glyphosate biosensor showed good specificity, and the LOD 
for glyphosate can reach 0.58 μM. Chapter 4 and Chapter 5 show that 
oligopeptides identified from phage library can bind to small molecules and 
therefore they are capable to be applied as sensing layers in biosensors for 
detection purpose. 
 




Phage display library for proteins is more challenging because multiple 
binding sites may render difficulties to obtain consensus sequences. In Chapter 
6, we identified oligopeptides for hCG binding to develop an antibody-free 
detection of human chorionic gonadotropin (hCG) by using LC. The 
oligopeptide sequences, MHLMRMKPLLLT, MHPRKMLQLMLN, 
STRLRRRSRRQT, and PPLRINRHILTR, were identified from phage library. 
SPR study shows that PPLRINRHILTR gives highest binding affinity. After 
binding kinetics study, LC is used to transduce the binding event into optical 
signals. The binding of hCG can disrupt the orientation of a thin layer (~6 μm) 
of LC covered on the surface. Depending on the initial concentration of hCG, 
LC gives distinct optical signals visible to the naked eye. The LOD for this 
method is approximately 1 IU/mL (2 nM) in both PBS buffer and urine 
samples, and only 0.6 μL of hCG solution is required. Compared to other 
detection methods for hCG, this detection method does not require the use of 
antibody and is label-free. It has the potential to become a portable diagnostic 
kit for hCG. Chapter 6 shows that oligopeptides can bind to protein 
biomarkers, such as hCG, and the binding event can be amplified and 
transduced into optical signals using LC.  
Although the output signal of LC-based protein assay can be easily 
read-out using a pair of crossed polarizers, the LOD is restricted to µg/mL or 
nM levels, which is not sufficient for applications of ultrasensitive protein assays. 
To achieve lower LOD, a new mechanism to enhance LC signal is required. In 
Chapter 7, we tried to enhance LC signal by using enzymatic silver deposition. 
After silver deposition, the LOD of SA-ALP protein on glass slide surface 
 




decreases from 44 nM to 13.2 nM, which is 3.3-fold improved. However, the 
enhancement caused by silver deposition is not as promising as we expected. 
 
8.2 Recommendations 
Based on the experimental results and discussions from this thesis, we 
make some recommendations for future study.  
(1) For the LC-based sensors for detection of butylamine (in Chapter 
3), 5CB was used as LC material to produce optical signals. The application 
temperature must be maintained between the crystallization temperature 
(Tcr=22.5°C) and clearing point (TN-I=35°C). If the temperature is above the 
clearing temperature, then 5CB becomes an isotropic liquid and loses its 
optical response. Due to the doping of lauric aldehyde (LA), the clearing point 
temperature (TN-I) of the LA/5CB mixture will be further lowered. As a result, 
the working temperature range of the LC sensor is very narrow for practical 
application. To address this issue, we recommend to use other commercial 
liquid crystals, such as E7, to give a broader temperature range (-10.1°C to 
59.5°C).  
 (2) For the phage display experiments as described in Chapter 4, a 
“negative screening” procedure is recommended to eliminate phage binders to 
the container itself where the positive screening was conducted. It also should 
be careful in assuming that high frequency peptide binders are the best binders 
to the target. As a result, single-phage binding affinity tests should be 
conducted in Chapter 4. For the SPR biosensors for detection of small 
 




molecules, such as thiacloprid, imidacloprid, and glyphosate (as described in 
Chapter 4 and Chapter 5), the oligopeptides were directly immobilized on the 
SPR sensor chip. It will be interesting to study the immobilization of 
oligopeptides in the presence of specific targets as templates. After removal of 
the target molecules, the cavities formed in the oligopeptide layers may further 
improve the binding affinity to target molecules. Besides, the specificity of 
identified oligopeptide to other herbicides, such as 2,4-dichlorophenoxyacetic 
acid should be studied for practical application. The stability and reusability of 
the SPR biosensor should also be studied in the future work. Last, further 
study regarding the specificity of the probes in selective recognition of the 
target is required by using a mixture of other components in addition to the 
target. It is also necessary to conduct “spike recovery” tests to assess any 
potential positive or negative interference. After completing the above studies, 
quantitative analysis should be provided to compare the performance of this 
oligopeptide-based SPR sensor with other sensors reported elsewhere. 
(3) For Chapter 6, the binding affinities of the selected oligopeptides to 
hCG were studied individually. However, no consensus oligopeptide sequence 
was obtained after 5 rounds of biopanning, suggesting that the oligopeptides 
may bind to multiple domains in hCG molecules. Taking into account of this 
possibility, we propose to use a mixture of oligopeptides as a sensing layer for 
hCG binding. Thus the hCG molecules with different orientations can all be 
captured. To shorten the total assay time, the incubation time of hCG sample 
to oligopeptide modified glass slide surface should be studied in the future. 
 




(4) For Chapter 7, although we find limited effect (3.3-fold) of 
enzymatic silver deposition to enhance LC signal, we may explore the 
enzymatic silver deposition for LC-based protease assay. For example, the 
biotinylated oligopeptide is first immobilized on UV-modified DMOAP 
surface to provide a binding site to conjugate to SA-ALP. If the oligopeptide is 
cleaved by protease (such as trypsin or chymotrypsin), the binding site of 
biotin is removed, and SA-ALP cannot conjugate to the surface, and vice versa. 
Because the cleavage of the protease is highly site-specific, we are able to 
design an oligopeptide microarray to distinguish different protease from the 
reading of the LC images. Besides, it will be interesting to study the effect of 
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A.1 Determination of butylamine concentration in vapor phase 
To prepare butylamine vapors for detection, 0.5 μL of butylamine or 
aqueous solution containing butylamine was pipetted onto a piece of filter 
paper inside a 200-mL syringe, which was sealed with a Teflon plug. Then the 
barrel of the syringe was heated with a hair dryer to evaporate the butylamine 
into vapor phase. The vapor concentration of butylamine was controlled by 
changing the butylamine concentration in the solution. By applying ideal gas 
assumption at 1 atmosphere of pressure, the molar volume of butylamine Vm is 
24.4 L/mol at room temperature (25 °C). Then the butylamine vapor 
concentration can be calculated from Eq. A1,  












= ×    (A.1) 
where the density of butylamine ρ is 0.74 g/cm3, the molar mass of butylamine 
M is 73.14 g/mol, the volume of butylamine or aqueous solution containing 
butylamine that pipette into the syringe V0 was 0.5 μL, and the total volume of 
the syringe was 200 mL. Then the relationship of butylamine vapor 
concentration c (ppmv) and the concentration of butylamine in the aqueous 
solution x (wt%) can be reducted to 6.172c x= . Table S1 shows the initial 
concentration of butylamine in aqueous solution and corresponding 






butylamine was 10 ppmv, and the aqueous butylamine solutions were prepared 
by serial dilution from 16.2 wt% stock.  
Table A.1 The relationship between butylamine vapor concentration (ppmv) 
and initial concentration of butylamine (wt%) in aqueous solution with 
interval of 10 ppmv 
Concentration of 
butylamine (x, wt%) 
Vapor concentration of 













A.2 Effect of LA on the orientations of LC at LC/air interfaces 
To investigate the influence of lauric aldehyde (LA) on the orientations 
of LC at LC/air interface, we prepared LA-doped LC with different LA 
concentrations, ranging from 0 to 2 wt%. Then 0.5 μL of the LC (or LA-doped 
LC) was dispensed to a TEM copper grid, and the excess of the LC was 






tweezers at the edge, with two surfaces in contact with air. Finally, the optical 
textures of the LCs inside the copper grid were observed using a microscope 
with crossed polarizers (Nikon, LV100 POL). Figure A.1 shows the optical 
image of a thin layer of LC with two LC/air interfaces. It can be seen that 
when the LA concentration is 0.5 wt% or below, the LC appears dark. This 
means that orientations of the LC at both LC/air interfaces are homeotropic 306, 
307. This result suggests that when the LA concentration is 0.5 wt% or below, 
the amount of LA adsorbs at the LC/air interface is insufficient to disrupt the 
homeotropic orientation of LC at the LC/air interface. In contrast, when the 
LA concentration is 1.0 wt% or above, the LC image gradually changes from 
dark to bright over 2h, indicating that the orientation of LC gradually changes 
from homeotropic to planar (or tilted) at one or both LC/air interfaces. We 
propose that this optical transition is caused by the gradual adsorption of LA at 
the LC/air interface. Judging from the molecular structure of LA, we 
anticipate that the hydrocarbon chain of LA molecule prefers the air phase, 
while the more polar aldehyde group prefers the LC phase. The amphiphilic 
nature of LA causes the preferential adsorption of LA at the LC/air interface 
and forms a barrier between LC and air. When the LA concentration in 5CB is 
increased to 1.0 wt% or above, the amount of LA adsorbs at the LC/air 
interface can trigger the orientational transition of LC from homeotropic to 








Figure A.1 Optical images (top) and corresponding interfacial orientational 
profiles (bottom) of a thin layer of LC containing pure 5CB, or 5CB doped 
with 0.1, 0.5, 1.0 and 2.0 wt% LA. The thin layer of LC has a thickness of ~ 
20 µm and is in contact with air at both sides. All the images were taken after 
the samples are stabilized for 2h at room temperature. Scale bar, 250 μm. 
 
A.3 Effect of LA on the orientations of LC at LC/glass interfaces 
To investigate the influence of lauric aldehyde (LA) on the orientations 
of LC at LC/glass interface, we prepared LC cells by pairing two pieces of 
clean glass slides. The fabrication of LC cells has been described previously 4. 
Briefly, two clean glass slides were paired and separated from each other with 
a fixed distance (~20 μm) by using two strips of Mylar films at both ends of 
the glass slides. The optical cell was secured with two binder clips. To fill up 
the empty cell, a drop of LC 5CB (or LA-doped 5CB) was dispensed onto the 
edge of the cell, and the 5CB was withdrawn to the space between two glass 
slides by capillary force. Finally, the optical textures of the LCs inside the 
optical cell were observed using a microscope with crossed polarizers (Nikon, 
LV100 POL). Figure A.2 shows the optical image of a thin layer of LA-doped 






5CB is 0.1 wt% or below, the optical appearance of the LC is bright. This 
situation resembles the case of pure 5CB, which assumes a randomly planar 
orientation on a clean glass slide 249, 308.  
 
Figure A.2 Optical images (top) and corresponding interfacial orientational 
profiles (bottom) of a thin layer of LC containing pure 5CB, or 5CB doped 
with 0.1, 0.5, 1.0 and 2.0 wt% LA. The thin layer of LC has a thickness of ~ 
20 µm and is in contact with glass at both sides. All the images were taken 
after the samples are stabilized for 2 h at room temperature. Scale bar, 1000 
μm. 
 
In contrast, when the LA concentration in 5CB is 0.5 wt% or above, 
the optical appearance of the LC is dark. In this case, LA molecules probably 
adsorb at LC/glass interface through hydrogen bonds formed between 
aldehyde groups and silanol groups 309, and that causes the homeotropic 
orientation of LC. Past studies have also shown that adsorption of surfactant-
like molecules at LC interfaces can result in homeotropic orientation of LC 243, 
249, 253. One explanation is that the adsorption of LA molecules on the glass 
slide reduces the critical surface tension248, 252. Another possible explanation is 
that the spacing between the hydrocarbon tails of LA allows the LC molecules 






can align the LC molecules in homeotropic orientation at the LC/glass 
interface. 
A.4 Role of water in the optical reversibility of LC sensor 
To prove that water dissolved in 5CB plays a role in the reversible 
response, we compared the response of and dehydrated 5CB and 5CB without 
dehydration. First, we dehydrated 400 μL of 5CB with 500 mg of magnesium 
sulfate packed inside a glass pipet. Next, two samples were prepared using 
dehydrated 5CB doped with 0.1 wt% LA. After the optical image was 
stabilized and gave bright image, the LC sensors were exposed to 10 ppmv of 
butylamine vapor. After 2 min, the optical image changes from bright to dark, 
and then the LC sensors were taken out from gas chamber. One sample was 
placed in a preheated glass petri-dish, and stored in a desiccator containing 
silica gel, whereas the control sample was left in open-air. Figure A.3 shows 
that the optical image of LC sensor placed in open air gradually changes to 
bright in 2h. This is probably because water vapor in the air can diffuse into 
LC and hydrolyze the imine product (please be noticed that this experiment is 
conducted in Singapore, where the moisture in the air is considerably high in 
experimental environment.) We also noticed that for the LC sensor placed in 
the air, the optical image changes to bright in 2h, which is much longer than 
that reported in our main manuscript (about 30 min). This is because the 5CB 
we use in this study is dehydrated before experiment, whereas in the 
experiments that we reported in the manuscript, the 5CB is directly used 







Figure A.3 Optical evolution of dehydrated 5CB doped with 0.1 wt% LA in 










B.1 Fluorescence test for binding specificity 
An oligopeptide with a sequence of TPFDLRPSSDTRGGGC (P1-cys) 
was synthesized by GenicBio (Shanghai, China) and labeled with FITC 
(Sigma). Briefly, 50 μL of 1 mg/mL FITC solution in anhydrous DMSO was 
added to 1 mL of 0.1 M sodium carbonate buffer (pH 9.0) containing 2 mg/mL 
of oligopeptide. Then, the reaction mixture was incubated in the dark at 4 °C 
for 8 h. Next, 1.0 M of NH4Cl in sodium carbonate buffer (pH 9.0) was added 
to the reaction mixture to a final concentration of 50 mM. After 2 h, the 
fluorescently labeled oligopeptide was purified by using membrane dialysis 
(MWCO: 1000 Da), and then stored at 4 °C prior to use. Next, 200 μL of PBS 
buffer (pH 7.4) containing 100 μg/mL of FITC-labeled oligopeptide was 
added to 20 mg of glyphosate-coated glass beads. The mixture was incubated 
for 30 min under constant shaking, allowing the binding of FITC-labeled 
oligopeptide to the beads. Finally, the glass beads were rinsed with PBS buffer 
(pH 7.4) containing 0.05% v/v of Tween-20 to remove unbound oligopeptides. 
Fluorescence images of the beads were obtained by using a fluorescent 
microscope with an exposure time of 1 s. To test binding specificity, the 
solution containing FITC-labeled P1 was also introduced to glycine-coated and 
plain glass beads respectively. Figure B.1 shows that among three types of 
glass beads, the FITC-labeled P1 can only bind to glyphosate-coated glass 








Figure B.1 Fluorescence images of the glass beads bind to FITC-labeled 
oligopeptide. The glass beads used in this experiment are (A) plain glass beads, 
(B) glycine-immobilized glass beads, and (C) glyphosate-immobilized glass 
beads. The fluorescent intensities indicate the amount of oligopeptides binding 
to different substrates. The scale bar is 100 μm.  
 
B.2 Surface density conversion 
The surface density of amine groups on APES-functionalized glass 
beads can be estimated by using the amounts of FTIC molecules reacting with 
the surface amine groups.  Fluorescence intensity is then used to calculate the 
surface density of FITC. To obtain a calibration curve between fluorescence 
intensity and FITC surface density, solutions containing different 
concentrations of FITC (10, 20, 50, 100, 150, 200, 300, 400, 500, 600, 700, 
1000, 1500, and 2000 ng/mL) were prepared. Each solution was dispensed 
into a rectangular glass tube (VitroCom) whose dimension is 0.2 × 2.0 mm 
(height × width). The glass tube was placed under a fluorescence microscope, 
and the fluorescence intensity of each image was obtained by using ImageJ.   
FITC surface density (ΓFITC) in each sample can be calculated as 
follows: 
 
2 3 1(1/ nm )  (ng/nm )   (nm)  (1/mol)
MW (ng/mol)FITC A








where C is FITC concentration (ng/nm3), h is the height of the glass 
tube (h = 0.2×106 nm), MW is the molecular weight for FTIC (MW= 389.38 × 
109 ng/mol), and NA is Avogadro’s number (NA=6.02×1023 1/mol).  After 
simplifying (1), we can obtain: 
2 17(1/ ) 3.092 10FITC nm CΓ = ×                                (B.2) 
Figure B.2 shows a calibration curve which can be used to convert 
fluorescence intensity into surface density of FITC. 
 
Figure B.2 Calibration curve to convert fluorescence intensity to surface 
density of FITC molecules. The unit of 1/nm2 presents the number of FITC 








C.1 Phage display results of third, fourth and fifth round biopanning 
Twenty different single phage colonies were picked and their 
oligopeptide sequences were identified from third, fourth, and fifth round of 
biopanning, respectively. Table C.1 shows the oligopeptide sequences and 
their physical properties of the oligopeptides from third, fourth, and fifth 
round biopannings, including pI value, ratio of acidic, basic, neutral, and 
hydrophobic residues to total number of residues. We find that several 
particular sequences, such as PPLRINRHILTR, STRLRRRSRRQT, 
MKLKPMRIMINP, MHLMRMKPLLLT, MHPRKMLQLMLN, and 
MKSRMLPLNRRL, appear repeatedly in the third, fourth, and fifth round of 
biopanning, and thus the phage colonies bearing these oligopeptide sequences 
were selected for phage binding analysis. 
Table C.1 Oligopeptide sequences binding to hCG and their physical 
properties obtained from (A) third round, (B) fourth round, and (C) fifth round 









C.2 SPR experiments using scrambled oligopeptide 
To test the binding specificity, one scrambled oligopeptide, 
TPFDLRPSSDTRGGGC (MW=1665.8 Da), was immobilized on the SPR 
sensor chip as described in the main text. After immobilization of the 
oligopeptide, SPR shows an increase of 1736.4 resonance units (RU), 
corresponding to a surface density of 0.62 1/nm2 on the surface. Figure C.1 
shows the SPR response after 1600 mIU/mL hCG was injected to the sensor 






is minimal, suggesting that the hCG molecules cannot bind to the surface 
where immobilized with scrambled oligopeptide. 
 
Figure C.1 SPR binding sensorgrams of hCG in HBS-EP buffer solution on 
scrambled oligopeptide (TPFDLRPSSDTRGGGC) immobilized sensor chip. 
The hCG concentration in HBS-EP buffer solution is 1600 mIU/mL. 
 
C.3 Surface density of FITC-labeled hCG 
To calculate the surface density of FITC-hCG, PBS buffer containing 
FITC-hCG (2, 10, 20, 40, 80, and 120 mIU/mL) was dispensed onto a 
DMOAP-coated glass slide in an array format. The volume of each spot was 
0.6 μL. After the spots were dried in dark, fluorescent images of the glass slide 
were obtained by using a laser scanner (GenePix 4100A). Figure C.2A shows 
the fluorescent images with different concentration of FITC-hCG. The 
fluorescence intensity of each spot was obtained by using ImageJ, and the 
fluorescence intensity calibration curve was plotted as shown in Figure C.3B. 
The surface density of FITC-hCG in each spot can be calculated as follows: 
2
2















where C is the concentration of FITC-hCG, V is the volume of each 
spot (V=0.6×10-6 L), NA is Avogadro’s number (NA=6.02×1023 1/mol), A is the 
area of each spot (A≈1.5 mm2=1.5×1012 nm2). For hCG, the concentration 
can be converted from mIU/mL to mol/L by using a conversion factor 1 
mIU/mL = 2 × 10-12 mol/L 110. After simplifying (1), we can obtain: 
2 5 7(1/ nm ) 2.408 10  (mol/L) 4.816 10  (mIU/mL)FITC hCG C C
−
−Γ = × = ×         (C.2) 
From Figure C.2B, we can estimate the surface density of FITC-hCG. 
For example, when the hCG concentration is 100 mIU/mL in the binding 
experiment, the fluorescence intensity is 30.7 (a.u.). We can estimate that the 
amount of FITC-hCG binds to the surface to be 2.7×10-5 1/nm2 as shown in 
Figure 6.3.  
 
Figure C.2 (A) Fluorescence images of the FITC-hCG spots with 
concentration of 2, 10, 20, 40, 80, and 120 mIU/mL (from left to right). Scale 
bar is 1 mm. (B) Calibration curve for the fluorescence intensities against the 








D.1 Molecular Weight of SA-ALP  
Because the molecular weight (MW) of SA-ALP is unknown form the 
supplier (Sigma-Aldrich), to determine the MW of SA-ALP, we first 
performed sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) 310. SDS-PAGE was performed by using home-made Tris–glycine gels 
which contain 10 % separating gel and 5 % stacking gel. Prestained protein 
marker pageruler plus (Thermo Scientific) was used as a protein ladder. To 
load dye to SA-ALP protein, 10 µL of SA-ALP solution (1.0 mg/mL) was 
mixed with 10 µL of denature solution (50 mM Tris-HCl, pH6.8; 100 mM 
DTT; 2% SDS; 0.1% Bromophenol blue; 10% Glycerol) and heated for 10 
min at 100 °C in a thermo mixer. 20 μL of prestained protein marker solution 
and 20 μl of the denatured SA-ALP solution were loaded into two gel wells 
separately, and electrophoresis was carried out for 60 min at 200 V (constant 
voltage). The gel was stained in Coomassie staining solution (Bio-Safe) for 2 
h and destained in deionized water before taking images. Images of SDS-
PAGE gel were captured by using Gel Doc system (Bio-Rad, USA). The 
images were analyzed by using ImageJ. The molecular weight of SA-ALP was 
calculated from the calibration curve, plotted between log (MW) of standard 
proteins versus their relative mobility. 
Figure D.1A shows that two bands (A and B) can be seen from the 
sample lane (S) of the gel after running SDS-PAGE, indicating that the SA-
ALP protein dissociates into two subunits after being denatured by SDS. 






proteins. We can estimate the MW of subunit A and B of SA-ALP are 128.8 
kDa and 97.7 kDa, respectively. Therefore, the MW of SA-ALP is 226.5 kDa. 
 
Figure D.1 (A) SDS-PAGE analysis to calculate the molecular weight of SA-
ALP. The left lane is molecular weight marker (M), and the right lane (S) is 
SA-ALP sample. Two bands A and B were indicated in the sample lane. (B) 
Linear fitting of log (MW) vs. distance to determine the molecular weight of 
two subunits of SA-ALP. 
 
D.2 Cy3-labelling of SA-ALP 
SA-ALP was labeled with Cy3 following a standard protocol. Briefly, 
1 mL of 0.1 M sodium carbonate buffer (pH 9.3) containing 4.4 μM of SA-
ALP was mixed with 1 aliquot of Cy3 in anhydrous DMSO. After 30 min, 
unreacted Cy3 was removed by using dialysis in PBS buffer (pH 7.4) with a 
membrane (MWCO: 1000 Da). The dye/protein molar ratio (D/P) of Cy3-
labeled SA-ALP was determined to be 1.6. The Cy3-labeled SA-ALP solution 







D.3 Surface Density of SA-ALP 
To obtain a calibration curve between fluorescence intensity and the 
surface density of Cy3-labeled SA-ALP, solutions containing different 
concentrations of Cy3-labeled SA-ALP (0.1, 0.2, 0.4, 0.6, 0.8, and 1.0 µM) 
were prepared. Each solution was dispensed into a rectangular glass tube 
(VitroCom) whose dimension is 0.2 × 2.0 mm (height × width). The glass tube 
was placed under a fluorescence microscope (Eclipse LV100POL, Nikon, 
Japan), which was equipped with an FITC/Cy3 filter (Nikon). All images were 
captured by using a digital camera (ACT-2U, Nikon) mounted on top of the 
fluorescence microscope with exposure time of 15 s. The fluorescent images 
were analyzed by using ImageJ (1.42Q) to obtain fluorescent intensity profiles. 
To determine the surface density of SA-ALP (ΓSA-ALP), a calibration 
curve was measured using Cy3-labeled SA-ALP solution in rectangular glass 
tubes. The rectangular tubes were used to produce a thin layer of Cy3-labeled 
SA-ALP solution with uniform thickness (0.2 mm). In the calibration curve, 













where C is the concentration of  Cy3-labeled SA-ALP in µmole/L, 
which is equal to pmole/mm3, h is the thickness of the Cy3-SA-ALP solution 
layer, which is defined by the height of rectangular glass tube (h = 0.2 mm). 
The fluorescent calibration curve shows linear relationship of fluorescence 
intensities respect to surface density of SA-ALP. By applying this calibration 






oligopeptide modified surface (as shown in Figure 1A) can be determined to 
be 110.4±6.7, 31.7±5.3, and 23.2±4.4 fmole/mm2 when the initial 
concentration of SA-ALP is 44, 13.2, and 8.8 nM, respectively.  
The amount of silver deposited on glass can be calculated as follows: 
M (fmole/mm2) = ΓSA-ALP (fmole/mm2) × kcat (min-1) × t (min)      (D.2) 
where kcat is the turnover number of surface-immobilized SA-ALP 
(kcat=0.2×103 min-1), and t is the time for enzymatic silver deposition (t=30 
min). As a result, the amount of silver deposited on glass is 1.9×105 and 
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